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CHAPTER 1
INTRODUCTION
The accumulation of oxidatively modified proteins is observed in aging, oxidative
stress and neurodegenerative diseases like Alzheimer disease (AD).1 These proteins are
oxidized by reactive oxygen species (ROS) such as the hydroxyl radical (HO•),
superoxide anion (O2•-) and singlet oxygen (1O2•).2 Because ROS are responsible for the
formation of the oxidized proteins observed in aging and AD, the oxidation of proteins
and amino acids with ROS has been thoroughly studied.3,4,5 On the other hand, the
oxidation of proteins and amino acids with metal-based oxidants has not been deeply
investigated. Metal-based oxidants are selective, non-diffusible and their reactivity can be
tuned by modifying the structure of the ligand. In addition, nature uses metal-based
oxidants in several biological transformations such as the breakdown of toxins by
cytochrome P450 and oxygen sensing by proline hydroxylase.6,7,8,9,10 Furthermore, metalbased oxidants like ferryl (iron(IV)-oxo) species have demonstrated their ability to
oxidize strong C-H bonds such as the C-H bond in cyclohexane (BDE = 99 Kcal/mol).11
All these properties of metal-based oxidants give them the potential to oxidize amino
acids and proteins.
The lack of information about how these metal-based oxidants react with amino acids
and proteins motivated our group to investigate the reactivity of ferryl species with amino
acid substrates.12,13,14 The study of amino acid substrates with ferryl species provided
preliminary results that showed that ferryl species are more selective than ROS.14 These
results stimulated our group to investigate other studies relevant to our research like the
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design, synthesis and characterization of new ligands and their metal complexes in order
to improve the oxidation properties of these metal-based oxidants. Examples of these
studies include the synthesis, characterization of Bn-CDPy3 (derivative of the Bn-TPEN
ligand) and its metal complexes and the synthesis of new derivatives of Bn-TPEN
ligand.15,16
This dissertation will describe my research contributions to the Kodanko group in the
study of reactivity of amino acid substrates with ferryl species and the synthesis and
characterization of new Bn-TPEN derivatives and their metal complexes. The first
chapter of the dissertation will provide an overview of the background relevant to our
research in the Kodanko group in addition to the previous research work in our group.
The overview will start with a discussion of the reactive oxygen species (ROS) and their
applications, followed by a discussion about metal-based oxidants, with a focus on ironbased oxidants. Subsequently, important examples of oxidation enzymes and molecules
in nature that use iron-based oxidants in their biological transformations will be
described, followed by an overview of the synthetic heme and non-heme iron-based
oxidant models and their applications in oxidation and biomimetic studies. Furthermore,
the chapter will describe the Kodanko group’s research studies in the field of amino acid
oxidation with ferryl species, the synthesis of new ligands and studying their coordination
environment. Finally, the last section of this chapter will describe the thesis statement.
1.1. Reactive Oxygen Species (ROS)
Oxidative stress and aging occur primarily due to the generation of reactive oxygen
species (ROS).2 These species are the superoxide anion O2•-, the protonated form HO2•
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and HO•. Superoxide radical O2•- is formed by aerobic cell metabolism and is removed by
superoxide dismutase to give hydrogen peroxide and oxygen (reaction 1 in Scheme 1.1).4
Part of the generated hydrogen peroxide is subjected to iron-catalyzed Haber-Weiss
mechanism producing hydroxyl radicals while the other part is quenched by catalase
(reaction 2 and 3, Scheme 1.1).4,17
Scheme 1.1. Reactions of superoxide radical anion

Protein oxidation with ROS and the factors that control these oxidations were
determined.4 The characterization of the oxidation products was achieved18 by exposing
the proteins to ionizing radiation. These studies showed that proteins were oxidized by
HO•. Further studies showed that ROS oxidize proteins by either oxidation of amino acid
side chains, backbone cleavage or formation of cross-linkages between proteins.19 The
oxidative damage of proteins by ROS depends on the oxidant, where powerful oxidants
such as HO• are more destructive while the less powerful oxidants superoxide anion and
hydrogen peroxide are more selective and can target single residues in proteins.5
Aside from producing aging and oxidative stress, ROS have been used in valuable
applications. Examples of these applications that use ROS include studying the protein
structure and protein targeting. The determination of protein structure includes foot
printing, which is achieved by the use of radiolysis or metal complexes that can generate
diffusible hydroxyl radicals such as the FeII ethylenediaminetetraacetic acid (EDTA)
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complex.20 The generated HO• is capable of cleaving the protein backbone into fragments
which are identified using several techniques including chromatography, mass
spectrometry and electrophoresis.20
Protein targeting is achieved using redox active Cu2+ or Fe3+ complexes that generate
HO• radicals. Selective targeting is performed by linking these complexes that generate
HO• radicals to a targeting ligand where the ligand’s non-covalent interactions localize
the reagent at specific binding site where it can cleave the protein.21 Examples of
selective protein cleavage include the site-specific cleavage of the protein calmodulin
with the trifluoperazine-EDTA (TFE, Figure 1.1) which chelates to iron to produce the
iron complex of EDTA bound to trifluoperazine (calmodulin antagonist).21 The sitespecific protein cleavage event starts by the binding of the TFE to calmodulin in the
presence of Fe, O2 and dithiothreitol (DTT). The TFE complex generates HO• which
cleaves the calmodulin producing six major fragments that are identified with SDSPAGE.21,22 Another important example is the selective cleavage of streptavidin in which
EDTA was appended to biotin.23 This EDTA-biotin complex generates redox-active Cu2+
or Fe3+ at the biotin binding site of streptavidin, these redox-active species cause cleavage
of the backbone of streptavidin.23

Figure 1.1. Trifluoperazine-EDTA (TFE) structure
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Interestingly, the oxidative damage caused by ROS species has potential for medical
applications. This is observed in the process of chromophore-assisted light inactivation
(CALI).24,25,26 In this process, a photosensitizer that generates singlet oxygen (1O2•), for
instance RuII(bipy)3, is attached to a selective binding peptoid that directs the
photosensitizer to a specific site on the protein. Irradiation of the RuII(bipy)3-peptoid
conjugate with visible light generates singlet oxygen that produces oxidative damage to
the protein located within 40 to 80 Å of the generation site causing specific inactivation
of the target protein.27 Despite the selective oxidation obtained with this method, this
technique has limited applications in cancer therapy as the light irradiation can penetrate
only 1 cm of skin.28
1.2. Metal-Based Oxidants
In contrast to the ROS which are highly reactive, toxic and freely diffusible species,
metal-based oxidants are more selective because their reactive oxygen is bound to the
metal center. This selectivity enables metal-based oxidants to be a good substitute for
ROS in protein oxidation. In addition, the reactivity of metal-based oxidants can be
controlled by modifying the ligand structure.
An example of a system that generates a metal-based oxidant is the Ni-bound GlyGly-His tripeptide which has been tethered to trifluoperazine.29 This nickel-based oxidant
produces site-specific oxidation of calmodulin in presence of an oxidant.29 This reaction
occurred in presence of the enzyme catalase and was not affected by O2 thus, metal-based
oxidants were suggested to be the species that promoted the oxidation of calmodulin and
not ROS species.29 Furthermore, catalytic inactivation of enzymes was demonstrated
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using peptide-based copper reagents.30 This enzyme inactivation was achieved by the
incubation of the protein with the copper-peptide complex in presence of O2 and
ascorbate.30 Recently, inactivation of the enzyme carbonic anhydrase was achieved by a
sulfonamide derivative of the CuII-bound Gly-Gly-His.31 The nature of the oxidant was
not determined, but the observation of oxidized tryptophan and histidine side chains that
were localized close to the active site suggested that non-diffusive metal-based oxidants
mediate the oxidation.31 These studies indicated that metal-based oxidants are capable of
protein cleavage and enzyme inhibition.
1.3. Iron-Based Oxidants
Iron-based oxidants may be the ideal reagents for targeting proteins amongst other
metal-based oxidants, because iron is bioavailable and is the most available transition
metal in the human body.32 Other metals are not as bioavailable as iron for example (Cu
and Ni) or highly toxic (Ni).33,34,35 Iron is found in the body as a common cofactor in
oxidation enzymes,36,32,37 and it is present in ferritin, which is an intracellular protein that
stores iron in the body.38,39 In addition, iron-based oxidants can be generated by
bioavailable oxidants like H2O2 or O2 in the presence of an electron source.40,41,42 More
importantly, iron-based oxidants are used in several biological systems to oxidize
inorganic and organic substrates.43 Examples of these systems include the iron-containing
oxidases and oxygenases.
1.4. Iron-Containing Oxidation Enzymes
Iron-containing oxidation enzymes are classified into the oxidases and the oxygenases.
The oxidases reduce O2 to water by an electron-transfer process.43,44 The oxygenases use
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O2 to oxidize substrates.43,44 The oxygenases are divided into two subclasses based on
their oxidation mechanism: the monooxygenases and the dioxygenases. The
monooxygenases act by transferring one oxygen atom from O2 into the substrate and by
reducing the other oxygen atom to water.44 On the other hand, the dioxygenases transfer
both oxygen atoms from the molecular oxygen to the substrate.44 The oxygenases are also
classified as heme or non-heme based on the structure of the ligand attached to the metal
ion.44 In the following four sections (Sections 1.4.1. to 1.4.4.), an overview of some
important examples of oxygenases that use iron-based oxidants will be discussed.
1.4.1. Cytochrome P450
Cytochrome P-450s are a large family of heme monooxygenases that the body uses to
breakdown and metabolize toxins. They catalyze key transformations in lipid metabolism
and corticosteroid biosynthesis.44,45 Cytochrome P-450 binds to the iron by its
protoporphyrin IX moiety and has a cysteinyl thiolate axial ligand. (Figure 1.2).44, 46

Figure 1.2. Structure of FeIV-oxo porphyrin π-cation radical in cytochrome P-450
The proposed catalytic cycle of dioxygen activation and oxygen-atom transfer by
cytochrome P-450 is described in Scheme 1.2.46 The cycle shows that an iron(IV)-oxo
porphyrin π-cation radical (V) transfers its oxygen atom to organic substrates (Scheme
1.2).46
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Scheme 1.2. Proposed catalytic cycle for cytochrome P-450.46

(

The catalytic reaction starts with the binding of molecular oxygen to the iron(II) center
(structure I in Scheme 1.2). This binding is followed by one electron reduction to form
the peroxyanion species (III). Subsequently, a proton is added to the peroxyanion to form
the iron(III) hydroperoxo species (IV) which upon protonation and water removal
produces the reactive iron(IV)-oxo porphyrin π-cation radical (V).46 The high-valent
iron(IV)-oxo species transfers its oxygen atom to the substrate. The structure of an
iron(IV)-oxo porphyrin π-cation radical has been characterized in cytochrome P-450.6,46
In addition, the characterization of iron(IV)-oxo porphyrin π-cation radicals in synthetic
iron-porphyrin models and the investigation of their oxidation reactions with alkanes and
alkenes helped in understanding more mechanistic details in the dioxygen activation and
oxygen-atom transfer reactions of cytochrome P-450.
1.4.2. Taurine: α-Ketoglutarate Dioxygenase (TauD)
Taurine α-ketoglutarate dioxygenase (TauD) is an α-ketoglutarate dependent nonheme
iron oxygenase that is crucial for the aerobic growth of microorganisms like Escherichia
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Coli in the absence of cysteine or sulfate.47,48 In Escherichia Coli, the role of TauD is
attributed to its ability to catalyze the hydroxylation of 2-aminoethanesulfonic acid
(taurine) located at the alpha position to sulfonate, resulting in sulfite release to be used
as a sulfur source.47 The catalytic cycle starts by oxidative decarboxylation of αketoglutarate to succinate and carbon dioxide to form the reactive iron(IV)-oxo
species.46,47 The reactive iron(IV)-oxo species abstracts a hydrogen atom from the taurine
substrate alpha to sulfonate generating a radical that rebounds with the hydroxyferryl
species to form the hydroxytaurine and the FeII species (Scheme 1.3).46, 47

(

Scheme 1.3. Proposed catalytic cycle for TauD46

The proposed catalytic cycle is supported by the isolation and characterization of the
high-spin (S = 2) iron(IV)-oxo by Mössbauer, resonance Raman and X-ray absorption
spectroscopy.46 A hydrogen-atom transfer (HAT) mechanism is proposed for the
oxidation of taurine by the iron(IV)-oxo species based on a large primary kinetic isotope
effect obtained of 37 when deuterated substrate was used.46,49 This large KIE indicates
that the C-H bond cleavage is before the rate determining step in the mechanism.41,46
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1.4.3. Hydroxylases
The tetrahydropterin dependent aromatic amino acid hydroxylases family includes
tyrosine hydroxylase (TyrH), tryptophan hydroxylase (TrpH) and phenylalanine
hydroxylase (PheH).37 This enzyme family has physiological importance in several
organs as TyrH catalyzes the first step in the biosynthesis of catecholamines and the
hydroxylation of tyrosine to form the dihydroxyphenylalanine (L-DOPA) in the central
nervous system.37 In addition, PheH promotes the metabolism of excess phenylalanine to
tyrosine in the liver and the TrpH catalyzes the hydroxylation of the tryptophan in the
brain to produce the 5-hydroxytryptophan which is the first step in serotonin
biosynthesis.37 These enzymes catalyze the hydroxylation of the aromatic side chains of
tyrosine, tryptophan and phenylalanine.37 These hydroxylases are tetrahydropterin
dependent as they use tetrahydropterin as a source of two electrons to reduce one oxygen
atom of molecular oxygen to water (monooxygenases).37
Due to the similarity of the catalytic domains of the PheH, TyrH and TrpH, the same
mechanism is suggested for them.37 This mechanism is divided into two main reactions.
The first reaction is the formation of the hydroxylating intermediate (the ferryl species)
and the second is the transfer of an oxygen atom to the amino acid substrate to form the
hydroxylated product (Scheme 1.4).37 Although none of these intermediates were
isolated, the mechanism of aromatic hydroxylation of amino acids by hydroxylases was
proposed based on kinetic and computational studies.37 Several lines of evidence for an
iron(IV)-oxo species being responsible for the oxygen-atom transfer and hydroxylation of
the amino acid substrates were provided.37 The proposed mechanism for the TyrH
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catalysis is described in Scheme 1.4. The mechanism of tyrosine and phenylalanine
aromatic hydroxylations was supported by a study in which para-tritio-phenylalanine was
incubated with phenylalanine hydroxylase followed by incubation of the resulting
tyrosine with tyrosine hydroxylase.50 Product analysis indicated the formation of tritiumlabeled DOPA, THO (tritium-labeled water) and tyrosine labeled with tritium in the
meta-position.50 This observed migration of tritium from the para-position to the metaposition suggested an electrophilic aromatic substitution mechanism that has a cationic σ
complex as an intermediate.37,50
Scheme 1.4. Proposed mechanism for TyrH37

The α-KG-dependent prolyl-4-hydroxylases (P4Hs) are another example of
hydroxylases that play important biological roles. The prolyl-4-hydroxylases catalyze the
C4 hydroxylation of proline residues.9 This reaction is important for the biosynthesis of
collagen and oxygen sensing. The role of P4Hs in collagen biosynthesis is explained by
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its ability to cross-link the helices of collagen9 while their role in oxygen sensing is
explained by their ability to hydroxylate the hypoxia induced factor (HIF) proteins in the
presence of oxygen making these proteins ready for degradation, which prevents the
induction of a hypoxic response.9,51 In case of oxygen insufficiency, the HIF proteins are
not hydroxylated by P4Hs and promote the transcription of genes that are responsible for
the global hypoxic response.9,51
Recently, direct spectroscopic evidence of a high-valent Fe(IV) complex species that
oxidizes C-H bonds was detected in prolyl-4-hydroxylase.9 Evidence for the presence of
this Fe(IV) complex species was identified by FQ (frozen-quenched) Mössbauer and SF
(stopped-flow) absorption.9 Based on the KIE of 50 that was obtained for the decay of the
high-valent Fe(IV) complex species, this species was suggested to be the reactive species
that cleaves the C-H bond of substrate by an HAT mechanism. This high-valent Fe(IV)
complex species was assigned as an Fe(IV)-oxo species based on its kinetic and
spectroscopic similarity to the species J which is a ferryl species in the catalytic cycle of
TauD that was characterized in previous studies 49,52,53,54 (Scheme 1.5).9,52
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Scheme 1.5. Consensus mechanism for α-KG-dependent dioxygenases9,52
(

(

(

(

1.4.4. CytC3 Halogenase
Halogenases are a class of mononuclear nonheme iron enzymes that require αketoglutarate, chloride and oxygen to halogenate unactivated C-H bonds during the
biosynthesis of many natural products of nonribosomal peptide origin.55,56,57 The
mechanism of catalysis for halogenase is described in Scheme 1.6.58 The Cl-FeIV-oxo
species is the key intermediate in the mechanism that abstracts a hydrogen atom from the
substrates producing Cl-FeIII-OH complex and a substrate radical.58 Radical rebound of
the chlorine radical produces the chlorinated substrate, in contrast to the hydroxyl radical
rebound observed in hydroxylases.46,59 The formation of the Cl-Fe(IV)-oxo species in the
halogenation of substrates using streptomycete aliphatic halogenase was supported by
kinetic and spectroscopic evidence.58
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Scheme 1.6. Proposed mechanism for α-KG-dependent halogenases

(

(

1.5. Bleomycin
Bleomycin (BLM) is a glycopeptide-derived antibiotic isolated from Streptomyces
verticillus that has been used in anticancer treatment.44,60,61,62 The bleomycin anticancer
effect is caused by oxidative degradation of the DNA using iron and molecular oxygen.44
Such oxidative degradation of DNA causes double-strand breaks in DNA. Bleomycin has
two moieties: a DNA recognition component, which increases its affinity to DNA, and a
metal-binding moiety.63 The metal-binding unit binds to iron and catalyzes the oxidative
degradation of DNA with high affinity due to the DNA recognition component. In
addition to its ability to cleave DNA, bleomycin catalyzes the oxidation of alkenes
including cis-stilbene, styrene, norbornene and cyclohexene.64,65,66 The structure of Fe(II)
BLM includes an octahedral iron center with five coordination sites linked to N-donor
moieties from BLM while the sixth coordination site is exposed for oxygen binding
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(Figure 1.3).63,67 This proposed structure is supported by several spectroscopic studies of
Co-BLM and the paramagnetic FeII-BLM.68,69

Figure 1.3. Structure of BLM with the 5 nitrogen donors that coordinate with iron
marked with asterisks and the suggested DNA recognition components.63
The catalytic cycle of iron-BLM starts with the binding of FeII-BLM with molecular
oxygen to form BLM-FeII-O2 which is reduced to produce the activated BLM species
BLM-FeIII-OOH,

which

was

characterized

by

EXAFS,

EPR,

ESMS

and

Mössbauer.44,70,71,72 The activated BLM cleaves the DNA and forms the FeIII-BLM which
upon reduction regenerates the FeII-BLM (Scheme 1.7).44
Scheme 1.7. Proposed catalytic cycle for Fe-BLM44
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1.6. Biomimetic Studies
In order to gain further knowledge about iron-containing enzymes, their reactivity and
their mechanism of catalysis, biomimetic studies were conducted. In these studies, the
synthesis of small models that mimic these heme and non-heme oxygenases was achieved
to learn about the essential structural features, mechanism of action and the reactivity of
these enzymes.44,73 These models are easily obtained and can be synthesized in larger
quantities in contrast to the difficult processes needed for the isolation of most of the
natural enzymes. This availability of enzyme model systems makes them a valuable tool
for investigating and studying the mechanisms and the characterization and isolation of
reactive intermediates in reactions catalyzed by natural enzymes. New evidence provided
by the model systems and biomimetic studies added new insights that support or disprove
the currently proposed mechanisms of action and biological reaction pathways. More
importantly, by changing the structure of these synthetic models through the modification
of steric and electronic properties, the reactivity of these synthetic models can be tuned
which leads to the formation of new models with higher reactivity, stability and
selectivity. In the next sections, an overview of several heme and non-heme iron-based
oxidant models will be described and their synthesis, reactivity, uses and applications will
be discussed.
1.6.1. Heme Iron-Oxo Models
Heme is an iron protoporphyrin which is highly abundant in nature.74 In nature, the
majority of porphyrins have eight alkyl or alkenyl groups as peripheral substituents.74
Long syntheses or complex purification techniques are required to obtain these

17

octasubstituted porphyrins.74 As an alternative, meso-tetraarylporphyrins, which are
easily synthesized and mimic the natural porphyrins, were synthesized.74 These mesotetraarylporphyrins have similar electronic properties to the natural octasubstituted
porphyrins but they differ sterically.74 In the meso-tetraarylporphyrins, the four aryl
groups are orthogonal to the porphyrin macrocycle, which can protect the top and bottom
faces of the porphyrin.74 The first synthesis of meso-tetraarylporphyrin was achieved by
reacting benzaldhyde and pyrrole.75 Development of more efficient syntheses for mesotetraarylporphyrins that produced gram quantities were achieved later.74 In 1979, the
catalytic

activity

of

the

iron(III)

porphyrin

complexes

chloro-α,β,γ,δ-tetra-

phenylporphinatoiron(III) and chlorodimethylferriprotoporphyrin IX was investigated.76
The chloro-α,β,γ,δ-tetra-phenylporphinatoiron(III) complex catalyzed the epoxidation of
cyclohexene and the hydroxylation of cyclohexane and admantane in the presence of
iodosylbenzene (PhIO) to form cyclohexene oxide, cyclohexanol and admantol,
respectively.76 The chlorodimethylferriprotoporphyrin IX catalyzed the epoxidation of
cis- and trans-stilbene with complete retention of configuration in the presence of
iodosylbenzene (PhIO), in contrast to the chloro-α,β,γ,δ-tetra-phenylporphinatoiron(III)
complex, which catalyzed the epoxidation of cis-stilbene only and did not react with the
trans-stilbene.76
This

significant

difference

in

the

observed

selectivity

of

these

meso-

tetraarylporphyrins was produced by the different substitutents on the porphyrin and
supported that oxygen-atom transfer was a crucial step in the catalytic reaction.76
Although the catalytic reactivity of these synthetic porphyrins was promising, their
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reactivity was affected by the oxidative decomposition of the metalloporphyrin.74 After
this study, several iron(III) porphyrin complexes with aryl groups at the meso position
were synthesized (Figure 1.4) and used in oxidation catalysis.46 New synthetic porphyrins
like iron meso-tetramesitylporphyrin chloride Fe(TMP)Cl and Fe(TPFPP)Cl [TPFPP =
meso-tetrakis (pentafluorophenyl)porphyrin] have demonstrated higher resistance to the
destruction of the porphyrin ligands due to their steric and electronic properties.74 These
new synthetic porphyrins showed higher efficiency in catalyzing the oxidation of
hydrocabons.77,78 This higher catalytic activity is attributed to their ability to generate a
more stable high-valent iron porphyrin radical cation.77,78 In addition, the introduction of
a chloride group at the eight o-phenyl positions of TPP activated the metalloporphyrin
and protected it sterically at the same time.74 This observation lead to the synthesis of the
iron(III) meso-tetrakis (2,6-dichlorophenyl)porphyrin chloride Fe(TDCPP)Cl which
showed high turnovers for the epoxidation of alkenes (300 turnovers for norbornene).79
Higher turnover numbers and lower catalyst decomposition were observed when
iodosylpentafluorobenzene was used as oxidant.79
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Figure 1.4. Structures of some important synthetic iron porphyrin complexes
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More importantly, these synthetic electron-deficient iron porphyrins showed their
ability to catalyze the epoxidation of olefins using the biologically important hydrogen
peroxide.80,81,82 The factors controlling the catalytic reactivity of these electron-deficient
iron porphyrins in the epoxidation of alkenes were investigated thoroughly.82 In addition,
the electron-deficient porphyrins demonstrated high catalytic reactivity in the oxidation
of hydrocarbons in the presence of H2O2.79,81,82 This catalytic activity was demonstrated
by the ability of Fe(TF4TMAP)5+ [TF4TMAP = meso-tetrakis (2,3,5,6-tetrafluoro-4N,N,N-trimethylaniliniumyl)porphyrinato]83 to catalyze the hydroxylation of cyclohexane
and cyclooctane in good yield with high alcohol to ketone ratios.81
The catalytic oxidation properties of these synthetic iron porphyrins were attributed to
the formation of the reactive iron(IV)-oxo porphyrin π-cation radical species.46
Subsequently, the synthesis and characterization of the iron(IV)-oxo porphyrin π-cation
radical intermediate was achieved.46,77 This species was generated from the reaction of mchloroperbenzoic acid (m-CPBA) with Fe(TMP)Cl (TMP = tetramesitylporphyrin).77
This iron(IV)-oxo porphyrin π-cation radical species resulted from O_O heterolytic bond
cleavage of the iron(III)-hydroperoxo species and was established as a strong oxidant in
olefin epoxidation by spectroscopic studies.77
In order to determine the factors that control the reactivity of the iron(IV)-oxo
porphyrin π-cation radical species, several studies focused on the synthesis of electronrich and electron-deficient iron(IV)-oxo porphyrins bearing different axial ligands with
subsequent study of their oxygenation behavior.46,84 These studies demonstrated that the
efficiency of the catalytic oxidation of the iron(IV)-oxo porphyrin is dependent on the
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electronic properties of the porphyrin ligands.46,85 This is demonstrated by the fact that
iron(IV)-oxo

porphyrin

π-cation

radical

complexes

with

electron-withdrawing

substituents are more efficient catalysts for oxygen-atom transfer reactions from PhIO
and H2O2 than those bearing electron-releasing substituents.74,84,85 Another important
factor that controls the reactivity of iron(IV)-oxo porphyrin is the nature of the axial
ligand trans to the iron(IV)-oxo group, where ligating anionic ligands like chloride and
fluoride increase the reactivity more than non-ligating anionic ligands like triflate and
perchlorate in the epoxidation of styrene.86 In addition, the nature of the axial ligand
affects the reactivity pattern of the iron(IV)-oxo porphyrin; for instance the selectivity of
cis- versus trans- olefins in the epoxidation of olefins and the efficiency of the catalytic
oxidation in C-H oxidations.46,87 The study of these synthetic iron(IV)-oxo porphyrins
resulted in a better understanding of the mechanism of catalysis and the factors affecting
the reactivity of both the synthetic and the natural heme systems like the cytochrome
P450 family.
1.6.2. Non-Heme Iron-Oxo Models
Investigation and trials to generate non-heme iron(IV)-oxo started in 1990 by studying
the catalytic oxidation of alkanes with Fe(TPA) in the presence of tert-BuOOH oxidant.
[TPA = tris(2-pyridylmethyl)amine]. In this study, the authors showed indirect evidence
for the generation of the iron(IV)-oxo species in solution.46,88,89 Another important
contribution was the detection of the iron(IV)-oxo species by ESIMS (electrospray
ionization mass spectrometry), which appeared as fragments resulting from the FeIIIOOH(L) molecular ion.89,90,91
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The generation of the first mononuclear non-heme iron(IV)-oxo intermediate was
achieved in 2000 when [FeIII(cyclam-acetato)(CF3SO3)]+ was reacted with ozone in
acetone/water solvent mixture at _80 oC.92 This reaction generated a green species that
was identified as a low-spin iron(IV)-oxo species (S = 1) by EPR and Mössbauer
spectroscopy.46,92 The first X-ray structure of an iron(IV)-oxo species was obtained for
the

[FeIV(O)(TMC)(MeCN)]2+

(TMC

=

1,4,8,11-tetramethyl-1,4,8,11-

tetraazacyclotetradecane) in 2003.93 The iron(IV)-oxo species [FeIV(O)(TMC)(MeCN)]2+
was generated from the reaction of [FeII(TMC)](CF3SO3)2 with PhIO at low temperature
(_40 oC).46,93 The structural X-ray analysis showed a characteristic short Fe_O bond
distance of ~1.64 Ǻ demonstrating that the bond between iron and the oxygen atom has a
double-bond character.46,93 The detected pale green ferryl species has a characteristic λmax
(absorption

maximum

wavelength)

at

820

nm

(є

=

400

M-1cm-1).93

The

[FeIV(O)(TMC)(MeCN)]2+ species was characterized by several spectroscopic techniques
beside X-ray crystallography and UV-vis spectroscopy, including EPR, Mössbauer,
magnetic circular dichroism (MCD), resonance Raman spectroscopy and ESIMS.46, 94,93,95
The generation of the non-heme iron(IV)-oxo species from the tetradentate tripodal
ligand TPA was achieved by reacting the [FeII(TPA)(MeCN)2]2+ with peracetic acid or mCPBA at _40 oC.96 The [FeIV(O)(TPA)(MeCN)]2+ has proven great oxygen-atom transfer
capability through its ability to oxidize thioanisole and cyclooctene.96 Subsequently,
several mononuclear non-heme iron(IV)-oxo complex species were generated from the
iron(II) complexes of different types of neutral ligand (Figure 1.5), including
pentadentate ligands like N4Py and R-TPEN family,11,97,98 linear tetradentate ligands like
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BPMCN

(BPMCN

=

N,N’-Bis(2-pyridylmethyl)

N,N’–dimethyl-trans-1,2-

diaminocyclohexane) with a β topology99 and the tripodal tetradentate ligand TPA [TPA
= tris(2-pyridylmethyl)amine].96,97,100 An important example of the pentadentate ligand
that generate ferryl is the synthesis of [FeIV(O)(N4Py)]2+ (N4Py = N,N-bis(2pyridylmethyl)bis(2-pyridyl)-methylamine),

which

was

characterized

by

X-ray

crystallography, ESMS and UV-vis spectroscopy (λmax at 780 nm, є = 400 M-1cm-1).11,101
In addition to its remarkable catalytic power in the oxidation of organic substrates, N4Py
ferryl species is stable for days (t1/2 = 60 h) in acetonitrile at room temperature.11
Another example of ferryl species bearing pentadentate ligand is the R-TPEN ferryl
species including the Bn-TPEN. The generation of [FeIV(O)(Bn-TPEN)]2+ (Bn-TPEN =
N-benzyl, N,N’,N’-tris(2-pyridylmethyl)-1,2-diaminoethane) was achieved by treating the
[FeII(Bn-TPEN)(OTf)](OTf) with PhIO; this ferryl species is green colored with a λmax at
739 nm (є = 400 M-1cm-1) and is less stable (t1/2 = 6 h) than the N4Py ferryl.11

Figure 1.5. Penta- and tetra-dentate ligands that are used to generate non-heme iron(IV)oxo species

23

The ferryl species bearing the linear tetradentate ligand [FeIV(O)(BPMCN)(MeCN)]2+,
was

generated

from

the

alkylperoxoiron(III)

intermediate

[FeIII(BPMCN)(OOtBu)(MeCN)]2+, which is formed from the reaction of [FeII(βBPMCN)(OTf)2]2+ with tert-BuOOH at low temperature (_45 oC). The pale green
[FeIV(O)(BPMCN)(MeCN)2]2+ species has a λmax at 753 nm (є = 280 M-1cm-1) and was
identified as a low-spin iron(IV)-oxo species by Mössbauer spectroscopy with a λmax at
753 nm (є = 280 M-1cm-1).99,102 The [FeIV(O)(TPA)(MeCN)]2+, which is an example of
ferryl species containing a tripodal tetradentate ligand, has a λmax at 724 nm (є = 300 M-1
cm-1) and was identified using several spectroscopic techniques, including X-ray
crystallography and Mössbauer spectroscopy.96,100 The generation of these mononuclear
non-heme iron(IV)-oxo species was achieved using a variety of oxidants such as
PhIO11,103,104,105,93, NaOCl106, RCO3H103,107,108,96,109, hydroperoxides109,100,103, KHSO5103,
O3110,92, NaOCl or NaOBr98 and molecular oxygen.111
The mechanism of generation of the iron(IV)-oxo species is thought to occur through
two electron oxidations of the corresponding FeII complex in the case of PhIO, RCO3H,
ClO-, KHSO5, O3, NaOCl or NaOBr.46,93,96 In the case of hydroperoxides the FeII
complex is oxidized to the FeIII-OOR species, which undergoes homolytic cleavage of the
O-O bond to produce the corresponding FeIV(O) species.46,100,112 The formation of the
FeIV(O) species by molecular oxygen was proposed to occur in a mechanism similar to
methane monoxygenase (MMO), in which the oxygen molecule is activated by a
dinuclear non-heme iron(II) complex to produce the di(µ-oxo)diiron(IV) intermediate
which, upon homolytic cleavage, forms two molecules of the FeIV(O) species.46,113 The
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generated FeIV(O) species is reduced to the iron(II) complex with the substrate (Scheme
1.846,111,113). Recently, the generation of FeIV(O) species from the reaction of the iron(II)
complexes with H2O2 and O2 in the presence of substrates with weak C-H bonds such as
alkenes (proton and electron donors) was demonstrated.40,114
Scheme 1.8. Generation of FeIV(O) species by molecular oxygen

1.7. Synthetic Mononuclear Non-Heme Iron(IV)-Oxo Species as Catalysts
1.7.1. Oxygen-Atom Transfer
The ability of non-heme iron(IV)-oxo species to oxidize organic substrates through
oxygen-atom transfer was reported with several ferryl species including the oxidation of
triphenylphosphine to the corresponding oxide using [FeIV(O)(TMC)]2+,109 the
epoxidation of alkenes with [FeIV(O)(TPA)]2+ and [FeIV(O)(Bn-TPEN)]2+,96,106 and the
oxidation of sulfides to sulfoxides with several ferryl species that had the following order
of reactivity [FeIV(O)(TPA)]2+ > FeIV(O)(Bn-TPEN)]2+ > [FeIV(O)(N4Py)]2+ >
[FeIV(O)(TMC)]2+.103,111,115 Oxygen-atom transfer also occurred between different nonheme iron(IV)-oxos. Interestingly, the rate of oxygen-atom transfer between ferryl
species followed the same order as the oxygen-atom transfer to sulfides;
[FeIV(O)(TPA)(MeCN)]2+

>

FeIV(O)(Bn-TPEN)]2+

[FeIV(O)(TMC)(MeCN)]2+.116,117,115

>

[FeIV(O)(N4Py)]2+

>
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1.7.2. C-H Oxidation
The synthetic mononuclear non-heme iron(IV)-oxo species that contain pentadentate
ligands like FeIV(O)(Bn-TPEN)]2+ and [FeIV(O)(N4Py)]2+ have demonstrated their ability
to oxidize C-H bonds including alkylbenzenes and the strong C-H bond in cyclohexane
(BDE = 99 kcal/mol), in addition to their abilities to oxidize benzyl alcohol.11,118
Furthermore, the kinetic studies showed very large primary kinetic isotope effects (KIEs)
in these oxidation reactions (KIE = 28 and 50 in the cases of C-H oxidation of
ethylbenzene and the oxidation of benzylic alcohol, respectively, when deuterated
substrates were used). Such large KIEs are indicative of a hydrogen-atom transfer (HAT)
mechanism46,119 taking place, generating a carbon centered radical which undergoes
radical rebound with the generated FeIII-OH species and oxidizes to form the
corresponding alcohol (Scheme 1.9).11
Scheme 1.9. Proposed mechanism for the oxidation of C-H bonds with non-heme
iron(IV)-oxo species11

In addition, these KIEs rule out the possibility of an ROS species like HO• being
responsible for the oxidation (Fenton chemistry) and agree with the KIE observed in the
hydrogen atom abstraction reactions performed by the Taurine α-ketoglutarate
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dioxygenase (TauD, KIE = ~37) and the methane monooxygenase (MMO, KIE = >
50).46,49,119
1.7.3. Oxidation of Aromatic Compounds
The hydroxylation of anthracene by [FeIV(O)(Bn-TPEN)]2+ and [FeIV(O)(N4Py)]2+ is
an example of iron(IV)-oxo species that oxidizes aromatic compounds.120 The N4Py and
Bn-TPEN ferryl species oxidized anthracene and produced anthraquinone in high
yields.120 The mechanism of this reaction was proposed to occur through electrophilic
attack from the iron-oxo group of the ferryl species on the π-system of the aromatic ring
to form a tetrahedral radical or cationic σ-complex (intermediates a and b in Scheme
1.9).46,120,121 The proposed mechanism was supported by a large negative Hammett ρ
value of _3.9 obtained from studying the effect of electron-donating groups in the para
position. Furthermore, an inverse KIE of 0.9 was obtained when the rate of hydroxylation
of anthracene was compared to the rate of hydroxylation of deuterated anthracene
(Scheme 1.10).120
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Scheme 1.10. Proposed mechanism for the aromatic hydroxylation of anthracene120
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1.7.4. Oxidative N-Dealkylation
The non-heme iron(IV)-oxo species [FeIV(O)(N4Py)]2+ and [FeIV(O)(TMC)(MeCN)]2+
mediated the N-dealkylation of N,N-dimethylaniline forming N-methylaniline and
formaldehyde.46,122 This oxidative N-dealkylation is performed in nature by non-heme
iron enzymes.123 Mechanistic investigation of this reaction was achieved by studying the
effect of para substituents (electron-donating and -withdrawing groups) on the aromatic
ring on the rate of oxidative N-dealkylation in addition to the determination of inter- and
intramolecular KIEs. Hammett ρ values of _2.5 in addition to inter- and intramolecular
KIEs values < 5 were measured in these mechanistic studies.46,122 Based on these
Hammett ρ values and the magnitude of the KIEs, the authors of this study suggested that
the oxidative N-dealkylation occurred via a rate-determining ET followed by PT (Scheme
1.11).46,122
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Scheme 1.11. Proposed mechanism for oxidative N-demethylation by ferryl species.122

1.7.5. Oxidation of Biomolecules
The oxidation of DNA was reported by iron complexes of ligands mimicking the
metal-binding domain of bleomycin such as the PYML and PMAH ligands (Figure
1.6).124,125 These complexes were found to have similar catalytic activity to the activated
bleomycin as they caused double-strand breaks in DNA in the presence of oxygen.124,125
Furthermore, it was found that the treatment of FeII and FeIII complexes of PMA with O2
and H2O2 generate [FeIII(PMA)-OOH] which was characterized with EPR spectroscopy
and agreed with the activated bleomycin species [FeIII(BLM)-OOH].124,125 These studies
helped in achieving an understanding of the catalytic activity of bleomycin and its
mechanism of action.124,125

Figure 1.6. Structures of PYML and PMAH ligands44
The cleavage of DNA by an N4Py iron complex was demonstrated.126 This DNA
cleavage was achieved by tethering the N4Py ligand to acridine and reacting the resulting
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ligand with iron.126 This iron(II) complex cleaved DNA in the presence of oxygen and in
the absence of reductant.126 This cleavage of DNA showed the ability of the iron(II)
complex of N4Py to activate oxygen and use it as terminal oxidant for oxidation of
biomolecules, which suggested it may also oxidize proteins.126 In addition, the Fe(III)
hydroperoxo species of Me-TPEN (analogue of Bn-TPEN) caused DNA cleavage similar
to the DNA cleavage produced by activated bleomycin. This Fe(III) hydroperoxo species
was generated from the reaction of the iron(II) complex of Me-TPEN and H2O2.127
1.7.6. Oxidation of Amino Acids
The oxidation of amino acid residues with reactive oxygen species has been
thoroughly investigated.4,19 In contrast, the use of metal-based oxidants to oxidize amino
acid residues has received less attention.29,128 This lack of knowledge should be addressed
as metal-based oxidants are more selective, less reactive and non-diffusible. In addition,
their reactivity can be varied by modifying the structure of their ligands. All these
properties of metal-based oxidants inspired our group to investigate the oxidation of
amino acids with ferryl species.
In order to accomplish a better understanding on how iron-based oxidants react with
amino acid residues and proteins, our group synthesized seven amino acid substrates with
the formula Ac-AA-NHtBu where AA= Gly, Val, Ala, Phe, Tyr, Trp and Met.12 These
substrates were synthesized to mimic the structure of amino acid residues in polypeptide
chains.12,13 Our group screened the best conditions for generation of the iron-based
oxidant

by

reacting

[FeII(N4Py)(MeCN)](ClO4)2,

[FeII(TPA)](OTf)2

or

[FeII(BPMEN)](OTf)2 with oxidants such as KHSO5 (Oxone), PhIO, H2O2 or
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CH3CO3H.12 The best generation of the iron-based oxidant was obtained when
[FeII(N4Py)(MeCN)](ClO4)2 was reacted with of KHSO5; these conditions were used in
the oxidation of the amino acid substrates.12
Two important observations resulted from this study: the first is the formation of
products characteristic of a backbone cleavage of the peptide when Ac-Gly-NHtBu was
reacted with 1 mol % of [FeII(N4Py)(MeCN)](ClO4)2 and five equivalents of KHSO5.12
More importantly, none of these products were observed with KHSO5 or when Fe(ClO4)2
or FeIIEDTA complexes were used instead of [FeII(N4Py)(MeCN)](ClO4).12 These results
suggested that [FeII(N4Py)(MeCN)](ClO4)2 generated [FeIV(O)(N4Py)]2+, which was
capable of backbone cleavage of the glycine amino acid substrate.12 The decay of the
generated [FeIV(O)(N4Py)]2+ upon treatment with ten equivalents of Ac-Gly-NHtBu and
the detected KIE of 4.8 when the rate of decay of [FeIV(O)(N4Py)]2+ upon reaction with
Ac-Gly-NHtBu was compared to rate of decay of [FeIV(O)(N4Py)]2+ upon reaction with
Ac-2,2-d2-Gly-NHtBu supported the cleavage of the α C-H bond by [FeIV(O)(N4Py)]2+.12
Interestingly, the valine and alanine substrates did not react under these conditions.12 The
second observation was the oxidation of the side chains of tryptophan, tyrosine and
methionine

substrates

using

similar

oxidation

systems

(1-10

mol

%

[FeII(N4Py)(MeCN)](ClO4)2 and 2-3 equivalents of KHSO5 depending on the
substrate).12
This study demonstrated that the [FeIV(O)(N4Py)]2+ was capable of backbone cleavage
and side chain oxidation of amino acid model substrates. These important results raised
more questions on how each amino acid of the twenty natural amino acids will behave
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with N4Py ferryl species, which paved the way for the studies investigated in this
dissertation.
1.8. Effect of Ligand Structures on the Stability and Reactivity of Mononuclear
Non-Heme Iron(IV)-Oxo Species
The structure of the ligand has an important role in stabilizing the ferryl species as
well as in determining its reactivity.46 This effect was observed by moving away from
carboxylate-rich ligands towards nitrogen-containing heterocyclic ligands.97 These
nitrogen-rich ligands stabilize the formation of their corresponding ferryl species.
Examples of these ligands include the TPA ligand, which catalyzes the stereospecific
hydroxylation of alkanes with H2O2 oxidant.96 The oxygen and deuterium labeling studies
established that radical chain auto-oxidation is not involved in these oxidations and the
stereospecific hydroxylation was observed when prochiral substrates were used.90,129,130
All these experiments suggested that these hydroxylation reactions occurred via a
mechanism involving high-valent iron(IV)-oxo species. Even among the pyridine-based
ligands, the stability of the generated iron(IV)-oxo species depends on the ligand
structure.46 For example, the [FeIV(O)(TPA)]2+ is stable at low temperature (_ 40 oC) for
several days but decomposes upon warming to form [(Fe2(µ-O)(µ-OAc)(TPA)2]3+ while
other ferryl species bearing tetra and pentadentate ligands like [FeIV(O)(TMC)]2+ and
[FeIV(O)(N4Py)]2+ are stable at room temperature.11,96,109
The ligand structure affects the reactivity of the ferryl species, which is demonstrated
in the different rate of sulfide oxidation with ferryl species having different ligand
structures. The order of reactivity of ferryl species with sulfides is [FeIV(O)(TPA)]2+ >
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FeIV(O)(Bn-TPEN)]2+ > [FeIV(O)(N4Py)]2+ > [FeIV(O)(TMC)]2+.116,117,115 In addition, the
reactivity of the ferryl species is affected by the axial ligand bound trans to the iron-oxo
group.94,108,131 Due to this crucial role of the ligand structure, many studies focused on the
design and synthesis of new ligands and their metal complexes, their stabilities and
subsequent generation of their corresponding ferryl species. The main goal of these
studies is to understand the structural features in the ligand that stabilize the ferryl species
or improve its reactivity or selectivity. The identification of these structural features will
be useful for the design of new ferryl species that can oxidize amino acids and protein
selectively. In the following section, the chiral Bn-CDPy3 and its analogues which are
ligands synthesized by our lab, will be discussed.16
1.9. Chiral Bn-CDPy3 Ligand, a New Class of Chiral Pentadentate Ligands
The design of the chiral ligand Bn-CDPy3 was inspired by the Bn-TPEN ligand which
is an achiral pentadentate ligand that was used in the synthesis of the [FeIV(O)(BnTPEN)]2+. As the [FeIV(O)(Bn-TPEN)]2+ demonstrated high reactivity,116 our lab thought
of designing a chiral structural analogue of Bn-TPEN, Bn-CDPy3, by exchanging the
1,2-ethylenediamine moiety for trans-1,2-diaminocyclohexane (Figure 1.7). In the BnCDPy3 ligand, the structure of the R-TPEN is mixed with the trans-1,2diaminocyclohexane scaffold, which is a key constituent in several catalysts for
asymmetric reactions.132,133
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Figure 1.7. Structure of Bn-CDPy3 and Bn-TPEN
The cyclohexane moiety added complexity to the structure of the ligand and increased
the number of coordination modes that could be accessed by the Bn-CDPy3.15,16 The
synthesis of Bn-CDPy3 and its Co(III) complex showed that out of five possible isomers,
one isomer was found to be the most stable.16 This study was fully investigated
experimentally by additional studies that will be described in this dissertation.
1.10. Thesis Statement
The use of iron-based oxidants to oxidize amino acids and proteins is an
underexplored research area. This lack of information about how non-heme ferryl species
can oxidize peptides and proteins compared to the myriad oxidations studies describing
the mechanism of action and the products of the oxidation of peptides with reactive
oxygen species,134 was the motivation for this dissertation research work. The goals of
this dissertation research are (1) to investigate the reactivity of the N4Py ferryl species
with amino acid model substrates; (2) to compare the reactivity of amino acid model
substrates with N4Py ferryl species to their reactivity with other ferryl species; (3) to
design and synthesize new ligands (Bn-TPEN derivatives) to be used as new ferryl
complexes; (4) to synthesize and characterize metal complexes of the chiral Bn-CDPy3
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(cyclohexane analogue of the Bn-TPEN ligand), study their coordination environment
and determine the most stable isomer.
The first goal of this dissertation is to establish fundamental knowledge on how N4Py
ferryl species react with amino acid residues in the polypeptide chains (Chapter 2). The
strategy toward accomplishing this goal started with the synthesis of amino acid model
substrates that mimic the structure of amino acid residues in polypeptide chain.12,13
Subsequently, these amino acid substrates were reacted with [FeIV(O)(N4Py)]2+ and the
reaction was investigated using kinetic studies and product analysis.14 The kinetic studies
measured the rate of reactivity of these amino acid substrates with ferryl species. The
oxidation studies and kinetic studies were used as tools for mechanistic studies by
providing information about the oxidation products and kinetic isotope effect (KIE)
respectively.
The second goal is to compare the reactivity of amino acid model substrates with
N4Py ferryl species to their reactivity with other ferryl species which leads to the
establishment of an order of reactivity for the ferryl species with amino acids (Chapter 2).
The strategy used to achieve this goal is to measure the rates of reactivity of the most
reactive amino acids with 3 different well-characterized ferryl species, which are the
[FeIV(O)(Me-N4Py)]2+, [FeIV(O)(Bn-TPEN)]2+, [FeIV(O)(TMC)(MeCN)]2+, and compare
these rates to the rates of reactivity of the same amino acids with [FeIV(O)(N4Py)]2+.
Furthermore, oxidation and kinetic studies are used to understand the mechanism of these
reactions.
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The third goal is to design and synthesize new ligands (Bn-TPEN derivatives) to be
used as new ferryl complexes for amino acid oxidation (Chapter 3). The strategy used in
accomplishing this goal is the design of some new Bn-TPEN analogues. These structural
analogues were designed by substituting the ethylenediamine moiety by 1,3diaminopropane moiety and the benzyl group with ethyl or methyl as in Et-TPPN and PrTPPN or by replacing the pyridine rings by pyrazine rings as in Bn-TPZEN.
The fourth goal is to synthesize and characterize metal complexes of the chiral BnCDPy3 (cyclohexane analogue of the Bn-TPEN ligand), study their coordination
environment and determine the most stable isomer (Chapter 3). The strategy used to
reach this goal is to synthesize the iron and zinc complexes of chiral Bn-CDPy3,
characterize these complexes with several spectroscopic techniques, and determine the
structure of the preferred isomer experimentally.
Experimental methods and characterization of new compounds are included as
sections in Chapter 2 and 3. Finally, the dissertation conclusion and future directions are
presented in Chapter 4.
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CHAPTER 2
INVESTIGATION OF THE REACTIVITY OF FERRYL SPECIES WITH
AMINO ACID MODEL SUBSTRATES
2.1 Introduction
The first step in studying the reaction of ferryl species with proteins is to investigate
how these ferryl species will react with the structural unit of proteins, amino acid
residues. For this reason, our study started with the synthesis of amino acid model
substrates that mimic the structure of amino acid residues in a polypeptide chain.13
Subsequently, these amino acid substrates were reacted with the N4Py, Me-N4Py, BnTPEN and TMC ferryl species which are well characterized.11,44,89,109 The oxidation
reactions were investigated by two methods which are the kinetic studies and the product
analysis. The kinetic studies provided the rate of reaction of these amino acid substrates
and established the order of reactivity of these amino acids substrates with ferryl species.
Furthermore, the kinetic isotope effect experiments using deuterated substrates provided
necessary information for understanding the reaction mechanisms. On the other hand, the
analysis of products lead to the identification of the reaction products and clarified the
mechanism of the reaction between the ferryl species and each reactive amino acid model
substrate.
This chapter describes my contributions in the synthesis of amino acid substrates,
kinetic studies and product analysis that were performed to investigate the reaction of
amino acid substrates with N4Py ferryl species.14 In addition, the chapter describes the
kinetic studies performed for the oxidation of the five reactive amino acids (Cys, Tyr,
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Trp, Met and Gly) with Me-N4Py, Bn-TPEN and TMC ferryl species including the
comparison of the reactivity of these five substrates with Me-N4Py, Bn-TPEN and TMC
ferryl species to their reactivity with N4Py ferryl species. Furthermore, a discussion of
the results that explain the importance of the results and reaction mechanisms are
described. Finally, the chapter ends with a conclusion that summarizes the work and
explains the significance of the study.
2.2. Results
2.2.1. Synthesis of Amino Acid Model Substrates
2.2.1.1. Synthesis of Acidic Amino Acid Substrates
Acetyl-protected amide substrates (Ac-AA-NHtBu), which resemble aspartic acid and
glutamic acid residues of proteins have been synthesized and used for oxidation with
iron-based oxidants for both kinetic and mechanistic studies. The synthesis of the aspartic
acid substrate (Ac-Asp-NHtBu) started from the protected aspartic acid Boc-Asp(OBn)OH (4) which was coupled with 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (EDAC) and tert-butylamine at 0 oC furnishing Boc-protected amide 3 in
53% yield. Deprotection of 3 using trifluoroacetic acid followed by acetylation of the
resulting TFA salt with acetyl chloride and triethylamine provided acetylated aspartate
amide 2 in 60% yield. Deprotection of 2 with Pd/C in EtOAc/AcOH (10:1) mixture under
1 atm of H2 furnished the substrate 1 in 96% yield (Scheme 2.1).
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Scheme 2.1. Synthesis of Ac-Asp-NHtBu
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Boc-Glu(OBn)-OH (8) was coupled with EDAC and tert-butylamine at 0 oC furnishing
Boc protected amide 7 in 53% yield. Deprotection of 7 using trifluoroacetic acid followed
by acetylation of the resulting TFA salt with acetyl chloride and triethylamine provided
acetylated glutamate amide 6 in 61% yield. Deprotection of 6 was achieved with Pd/C in
EtOAc/AcOH (10:1) mixture under 1 atm of H2 to furnish the substrate 5 in 88% yield
(Scheme 2.2).
Scheme. 2.2. Synthesis of Ac-Glu-NHtBu
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2.2.1.2. Improving the Synthesis of Tryptophan Substrate
When I joined kodanko group the synthesis of the tryptophan substrate (Ac-TrpNHtBu) was developed by Anil Ekkati.12,13 The synthesis started form the L-tryptophan
(12) which was acetylated with Ac2O/AcOH producing Ac-Trp-OH (11) in 96% yield.
Conversion of 11 into the tryptophan substrate 9 was done in 2 steps: Coupling 11 with
DCC and para-nitrophenol (PNP) forming the activated ester 10 in a 45% yield, followed
by coupling of 10 with tert-butylamine producing Ac-Trp-NHtBu (9) in 30% yield
(Scheme 2.3).
Scheme 2.3. Synthesis of Ac-Trp-NHtBu (reported by Anil Ekkati)
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I developed a more efficient method for synthesis of the substrate 9 in which Ltryptophan (12) was acetylated with Ac2O/AcOH producing Ac-Trp-NHtBu (11) in 96%
yield. Direct coupling of 11 with tert-butylamine using EDAC furnished the tryptophan
substrate 9 in 48 % yield.13 The overall yield of this method was doubled with respect to
the first method (Scheme 2.4).
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Scheme 2.4. Modified synthesis of Ac-Trp-NHtBu.
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2.2.1.3. Improving the Synthesis and Purification of Histidine Substrate
The synthesis of the histidine amino acid model substrate was developed by Anil
Ekkati.13 However, when the histidine substrate was subjected to kinetic experiments
inconsistent results were obtained. The different rates of reactivity of the histidine
substrate with the N4Py were indicative of a possible inorganic impurity within the
histidine substrate. Separately synthesized batches of histidine substrate were subjected to
elemental analysis and none of these batches matched with expected values. These
impurities were thought to be inorganic impurities as the

13

C NMR and the 1H NMR

showed pure substrates.
The synthesis of the histidine substrate started by coupling the commercially available
Boc-His(Tos)-OH (13) with tert-butylamine in presence of the HBTU (O-(Benzotriazol1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate) under an inert atmosphere
which produced Boc-His(Tos)-NHtBu (14) in 62% yield. The tert-butyl amide substrate
was reacted with TFA in order to remove the Boc group followed by acetylation of the
resulting TFA salt using acetic anhydride to yield the Ac-His(Tos)-NHtBu (15) in 57%
yield. The last step was the tosyl deprotection which was achieved by using sodium in
ammonia at low temperature (_78 oC) under inert atmosphere producing Ac-His-NHtBu
(16) in 53% yield (Scheme 2.5). More importantly, further purification of the Ac-His-
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NHtBu was achieved using ion-exchange chromatography to remove any traces of
inorganic impurities. This ion-exchange chromatography purification produced Ac-HisNHtBu which was subjected to elemental analysis and matched with the expected values.
Scheme 2.5. Synthesis and purification of the histidine substrate.
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2.2.2. Synthesis of Ligands and Generation of their Corresponding Ferryl Species
The synthesis of the N4Py ligand was achieved in three steps according to literature
procedure using the dipyridyl ketone as starting material (Scheme 2.6).135 The Me-N4Py
ligand was synthesized by alkylation of the N4Py ligand with methyl iodide according to
literature44 (Scheme 2.6). The synthesis of the Bn-TPEN ligand was achieved in one step
from N-benzylethylenediamine according to reported procedure (Scheme 2.7).136 The
TMC ligand was purchased from commercially available sources (Figure 2.1).

Figure 2.1. Structure of TMC ligand
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Scheme 2.6. Synthesis of N4Py and Me-N4Py ligands
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Scheme 2.7. Synthesis of Bn-TPEN ligand
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formation

of
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[FeII(N4Py)(MeCN)](ClO4)2

and

[FeII(Me-

N4Py)(MeCN)](ClO4)2 complexes was achieved by reacting the N4Py and Me-N4Py
ligands with Fe(ClO4)3 in a 1:1 MeOH:MeCN solvent mixture, according to reported
procedure.44 The generation of the [FeIV(O)(N4Py)]2+ and [FeIV(O)(Me-N4Py)]2+species
was

performed

by

reacting

the

[FeII(N4Py)(MeCN)](ClO4)2

and

[FeII(Me-

N4Py)(MeCN)](ClO4)2 complexes with KHSO5 in 1:1 H2O:MeCN solvent mixture.12,14
The synthesis of [FeII(Bn-TPEN)(OTf)](OTf) complex was carried out by reacting the
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Bn-TPEN ligand with Fe(OTf)2•2MeCN according to litterature.11 The generation of the
[FeIV(O)(Bn-TPEN)]2+

species

was

performed

by

reacting

the

[FeII(Bn-

TPEN)(OTf)](OTf) complex with 2 equivalents of PhIO in MeCN.11 The synthesis of the
[FeII(TMC)(OTf)2] complex was achieved by reacting the TMC ligand with
Fe(OTf)2•2MeCN in dichloromethane according to reported procedure.109 The generation
of

the

[FeIV(O)(TMC)(MeCN)]2+

was

performed

by

reacting

the

[FeII(TMC)(MeCN)(OTf)](OTf) complex with KHSO5 in 1:1 H2O:MeCN solvent
mixture.
2.2.3. Kinetic Studies for the Oxidation of Substrates with N4Py Ferryl Species
2.2.3.1. Acidic Amino acid Substrates (Glu and Asp)
The rates of reaction of glutamic acid 5 and aspartic acid 1 substrates with the N4Py
ferryl species were measured by monitoring the decay of [FeIV(O)(N4Py)]2+ which has a
λmax = 680 nm using UV-vis spectroscopy under pseudo-first-order conditions.14 The
decay of the N4Py ferryl species upon reaction with glutamic acid substrate 5 and
aspartic acid substrate 1 was first-order. From this decay, pseudo-first-order rate
constants of 1.3(1)×10-5 s-1 and 1.7(3)×10-5 s-1 were measured for the glutamic acid
susbstrate 5 and aspartic acid substrate 1 respectively (Figure 2.2 and 2.3). When these
pseudo-first-order rate constants were compared to the rate of decay of the N4Py ferryl in
absence of the substrate (5.0(2)×10-6), realtive rate constants (krel) of 3.4 and 2.6 were
calculated for the aspartic acid substrate 1 and the glutamic acid susbstrate 5 respectively.
These relative rate constants indicated that these substrates react slowly with the N4Py
ferryl species.
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Figure 2.2. Time course of the decay of [FeIV(O)(N4Py)]2+ (1 mM) upon treatment with
N-Ac-Glu-NHtBu (10 equiv) in 1:1 H2O:MeCN at 25 °C (absorbance at 680 nm = red
line, calculated fit = blue line)

Figure 2.3. Time course of the decay of [FeIV(O)(N4Py)]2+ (1 mM) upon treatment with
N-Ac-Asp-NHtBu (10 equiv) in 1:1 H2O:MeCN at 25 °C (absorbance at 680 nm = red
line, calculated fit = blue line)
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2.2.3.2. Histidine Amino Acid Model Substrate
The rate of reaction of histidine substrate with the N4Py ferryl species was measured
by monitoring the decay of [FeIV(O)(N4Py)]2+ using UV-vis spectroscopy under pseudofirst-order conditions (Figure 2.4).14 A pseudo-first-order rate constant of 3.8(2)×10-5 sec1

was measured for the histidine substrate. Comparing this pseudo-first-order rate

constant to the rate of decay of the N4Py ferryl in the absence of the substrate (5.0(2)×106

), a realtive rate constant (krel) of 7.8 was measured. This relative rate indicated that the

histidine substrate is not significantly reactive with N4Py ferryl from a kinetic standpoint
(at least krel =10, to be considered reactive).

Figure 2.4. Time course of the decay of [FeIV(O)(N4Py)]2+ (1 mM) upon treatment with
N-Ac-His-NHtBu (10 equiv) in 1:1 H2O:MeCN at 25 °C (absorbance at 680 nm = red
line, calculated fit = blue line)
2.2.3.3. Lysine•HCl Salt Amino Acid Model Substrate
A pseudo-first-order rate constant of 1.4(2)×10-5 sec-1 was measured for the reaction
of the hydrochloride salt of the lysine substrate with the N4Py ferryl (Figure 2.5). This
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pseudo-first-order rate constant indicated that the hydrochloric salt of the lysine substrate
has a slower rate of reactivity with N4Py ferryl than the free base of the lysine substrate
(t1/2 = 4 min, measured by Suneth Kalapugama).14 These data suggested that the decay of
the N4Py ferryl was resulting from the basic pH produced by the lysine side chain amine
group. This decomposition of ferryl species at high pH was reported in literature.103 In
order to prove this suggestion, we added dilute aqueous NaOH (pH = 9) to the N4Py
ferryl in the absence of substrate. In this experiment, a rapid decay of the N4Py ferryl was
observed supporting that the decay of N4Py ferryl upon reaction with the free base of the
lysine susbstrate is due to the basic medium produced by the 10 equivalents of the lysine
substrate which was necessary for pseudo-first-order conditions.14

Figure 2.5. Time course of the decay of [FeIV(O)(N4Py)]2+ (1 mM) upon treatment with
HCl salt of N-Ac-Lys-NHtBu (10 equiv) in 1:1 H2O:MeCN at 25 °C (absorbance at 680
nm = red line, calculated fit = blue line)
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2.2.3.4. Measurement of Second-Order Rate Constants
The reactivity of five amino acid substrates was found to be at least ten times faster
than the decay of N4Py ferryl species in absence of substrate (kobs control = 5.0 × 10-6 s1

). The reactivity of these amino acid substrates in descending order was cysteine,

tyrosine, tryptophan, methionine and glycine. In order to verify whether this observed
reactivity is resulting from the amino acid substrate, determination of the second-order
rate constants was accomplished for these five substrates. Second-order rate constants
were measured for tryptophan, methionine and glycine (Table 2.1).
Table 2.1. Second-order rate constants for tryptophan, methionine and glycine substrates
Substrate

Second order rate constant (M-1s-1)

Tryptophan

1.6

Methionine

3.2×10-1

Glycine

5.7×10-3

The second-order rate constant was determined by reacting different concentration of
the amino acid substrate (5, 10, 15, 20, 25 mM) with the N4Py ferryl species and
measuring the rate of decay of the ferryl species observed with each concentration. The
second-order rate constant was obtained by plotting the pseudo-first-order rate constants
against concentrations of the substrate (Figure 2.6, 2.7, 2.8). These graphs showed linear
relationship between the concentration of the amino acid substrate and the rate of decay
of N4Py ferryl species with excellent correlation (R2 > 0.96). Thus, these results proved
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that the decay of N4Py ferryl species resulted from oxidation of the amino acid substrate
in a bimolecular reaction. 14

Figure 2.6. Plot of pseudo-first-order rate constants (kobs) for [FeIV(O)(N4Py)]2+ against
the concentrations of Ac-Trp-NHtBu to determine the second-order rate constant at
298±2K

Figure 2.7. Plot of pseudo-first-order rate constants (kobs) for [FeIV(O)(N4Py)]2+ against
the concentrations of Ac-Met-NHtBu to determine the second-order rate constant at
298±2K

49

Figure 2.8. Plot of pseudo-first-order rate constants (kobs) for [FeIV(O)(N4Py)]2+ against
the concentrations of Ac-Gly-NHtBu to determine the second-order rate constant at
298±2K
2.2.3.5. Kinetic Isotope Effect
The decay of the ferryl species upon addition of amino acid substrates was due to
oxidation of amino acids as suggested from the linear relationship between the
concentration of substrates and the pseudo-first-order decay rates of ferryl species. The
next logical step was the investigation of the reaction mechanism and product isolation.
Investigation of the reaction mechanism was achieved by determining kinetic isotope
effects (Figure 2.9, 2.10) and analyzing the reaction products.
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Figure 2.9. Comparison between the time course of the decay of [FeIV(O)(N4Py)]2+ (1
mM) upon treatment with N-Ac-Met-NHtBu (10 equiv) in 1:1 H2O:MeCN at 25 °C
(absorbance at 680 nm = red line) and the time course of the decay of [FeIV(O)(N4Py)]2+
(1 mM) upon treatment with N-Ac-Met-NHtBu (10 equiv) in 1:1 D2O:CD3CN at 25 °C
(absorbance at 680 nm = blue line)

Figure 2.10. Comparison between the time course of the decay of [FeIV(O)(N4Py)]2+ (1
mM) upon treatment with N-Ac-Trp-NHtBu (10 equiv) in 1:1 H2O:MeCN at 25 °C
(absorbance at 680 nm = red line) and the time course of the decay of [FeIV(O)(N4Py)]2+
(1 mM) upon treatment with N-Ac-Trp-NHtBu (10 equiv) in 1:1 D2O:CD3CN at 25 °C
(absorbance at 680 nm = blue line)
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Kinetic isotope effects were determined by measuring the rate of reaction of amino
acid substrates with N4Py ferryl species under the same conditions described previously
using deuterated solvents (CD3CN:D2O, 1:1). The KIE was measured by dividing the rate
of reaction of substrates by the rate of reaction of deuterated substrate kH/kD. Kinetic
isotope effects were determined for tryptophan, histidine, methionine and lysine amino
acid substrates (Table 2.2). Kinetic isotope effects of 5.20 for tryptophan, 0.97 for
histidine and 1.06 for methionine were observed. The magnitude of the KIE for
tryptophan (5.20) suggested that electron-transfer proton-transfer could be the mechanism
of the reaction between the N4Py ferryl and the tryptophan substrate based on previous
studies.137 The KIE obtained with methionine and histidine (approximately 1), indicated
that the KIE obtained with the tryptophan (5.20) was not due to the effect of deuterated
solvent because substrates derived from methionine and histidine were treated under the
same conditions and showed no KIE within error of measurement.
Table 2.2. Measured kinetic isotope effects for the tryptophan, methionine and histidine
substrates
KIE
Substrate
Rate in H2O/CH3CN Rate in D2O/CD3CN
Tryptophan

1.7(1)×10-2 s-1

3.3(1)×10-3 s-1

5.20

Methionine

3.2(1)×10-3 s-1

3.0(2)×10-3 s-1

1.06

Histidine

3.8(2)×10-3 s-1

3.5(2)×10-3 s-1

0.97

2.2.3.6. Product Characterization
The oxidation products were characterized for two goals. The first goal was to identify
the oxidation products to accomplish further understanding of the reaction mechanism.
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The second goal was to verify that the observed decay of the ferryl species was resulting
from the reaction between N4Py ferryl species with amino acid substrates and not due to
other effects (pH, concentration, etc…). In the following section, oxidation studies for
tryptophan, glutamic acid, aspartic acid, methionine, lysine, histidine and glycine
substrates with N4Py ferryl species will be delineated.
2.2.3.6.1. Tryptophan
In order to understand the mechanism of oxidation of tryptophan substrate, the
oxidation products were analyzed. The reaction of tryptophan substrate with N4Py ferryl
showed a mixture of products. These products were detected by ESMS (M + H = 318),
suggesting products with a single oxygen atom added to the tryptophan substrate most
likely at the position 3 of the indole ring based on previous studies.138 Because of the
complexity of the mixture the attempts to isolate the products, to fully characterize them,
were unsuccessful.14
Furthermore, faster decomposition of [FeIV(O)(N4Py)]2+ (λmax = 680 nm) than the
regeneration of [FeII(MeCN)(N4Py)]2+ (λmax = 450 nm) was observed using UV-vis
spectroscopy.14 This result suggested the formation of a long-lived FeIII intermediate
which is likely the [FeIII(OH)(N4Py)]2+ species. More importantly, EPR spectroscopy
detected trace amount of organic radical in the reaction of tryptophan substrate with the
N4Py ferryl species (Figure 2.11).14
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Figure 2.11. EPR spectrum showing the organic radical resulting from the reaction of NAc-Trp-NHtBu with [FeIV(O)(N4Py)](ClO4)2 at 0 oC
2.2.3.6.2. Methionine
Oxidation studies for the methionine substrate were done by treating the
[FeIV(O)(N4Py)]2+ with 1 equivalent of the methionine substrate. The amino acid
oxidation product was isolated from the N4Py ferryl decomposition product using ionexchange chromatography. Two oxidation products were characterized using 13C and 1H
NMR in addition to mass spectrometry. The products were identified as a mixture of two
diastereomeric sulfoxide derivatives of the methionine substrate (31%) with a recovered
methionine amino acid model substrate (54%).14 In order to confirm the identity of the
oxidation products, the sulfoxide derivative of methionine substrate was synthesized
using Oxone, isolated and characterized. The 1H NMR of the synthesized sulfoxide
derivative matched with the 1H NMR of the oxidation product of the methionine
substrate.14

54

2.2.3.6.3. Histidine and Lysine substrate
The reaction of the pure histidine substrate with [FeIV(O)(N4Py)]2+ was investigated.
This reaction showed only recovered starting material and N4Py decomposition product
with no oxidized amino acid product. Likewise, the lysine substrate reaction with
[FeIV(O)(N4Py)]2+ showed only recovered lysine amino acid substrate and N4Py
decomposition product but no oxidation products of lysine substrate were observed. In
order to determine whether the basic pH was responsible of the decay of
[FeIV(O)(N4Py)]2+, sodium hydroxide was added to the generated [FeIV(O)(N4Py)]2+ to
make alkaline medium (pH = 9). This basic media caused the decay of the generated
[FeIV(O)(N4Py)]2+, confirming that the basic pH was responsible of the decay of
[FeIV(O)(N4Py)]2+.14
2.2.3.6.4. Acidic Amino Acid substrates (Aspartic and Glutamic Acids)
The

reaction

of

Ac-Glu-NHtBu

and

Ac-Asp-NHtBu

with

10

mol

%

[Fe(N4Py)(MeCN)](ClO4)2 and 10 mol% Oxone did not show any oxidation product
and did not change the green color of the generated [FeIV(O)(N4Py)]2+ for 2 days, this
was in contrast to reactive amino acid substrates like the tryptophan substrate that showed
complex mixture of products in few minutes and immediately changed the green color of
the generated [FeIV(O)(N4Py)]2+. After the workup, only starting materials, glutamic and
aspartic acid substrates were observed.
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2.2.4. Kinetic Studies for the Comparison of Substrate Reactivity with N4Py to MeN4Py, Bn-TPEN and TMC Ferryl Species
After determining the reactivity of the twenty natural amino acid substrates with N4Py
ferryl species, our group established the order of reactivity of these substrates with N4Py
ferryl species. Ashley Campanali found that the cysteine is the most reactive substrate
(Kobs = 1.7(1) s-1, krel = 3.4 × 105). She found that the second most reactive substrate is
the tyrosine substrate which is followed by the tryptophan, methionine and glycine
substrates respectively which were studied by Anil Ekatti (Table 2.3).14
Table 2.3. kobs and krel (determined by Ashley Campanali and Anil Ekkati) for the five
reactive substrates (Cys, Tyr, Trp, Met and Gly)12,14
Substrate

kobs(s-1)

Cysteine

1.7(1)

Tyrosine

3.4(1)×10

Tryptophan

krel
340000
-1

68000

1.7(1)×10

-2

3400

Methionine

3.2(1)×10-3

640

Glycine

5.8(2)×10

-5

12

The other fifteen substrates showed slow reactivity (krel < 10) and were considered not
significantly reactive. These data motivated us to determine whether these amino acid
substrates will react in a similar way with other ferryl species. In order to answer this
question, the focus of my studies shifted to the investigation of the reactivity of the five
reactive amino acid substrates (Cys, Tyr, Trp, Met and Gly) with different ferryl species
in order to compare rates with the N4Py ferryl species. This comparison of reactivity will
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provide important information about the factors that control the reactivity of amino acid
substrates with ferryl species and how to use these factors to design and synthesize new
ferryl species which are more stable, more reactive or more selective than the N4Py
ferryl.
2.2.4.1. Measurement of Observed and Relative Rate Constants for the Five
Reactive Amino Acid Substrates with Me-N4Py, Bn-TPEN and TMC Ferryl Species
The rates of reactivity of the five reactive substrates (cysteine, tyrosine, tryptophan,
methionine and glycine) with the Me-N4Py, Bn-TPEN and TMC ferryl species were
determined. These rates were measured by monitoring the decay of

[FeIV(O)(Me-

N4Py)]2+, [FeIV(O)(Bn-TPEN)]2+ [FeIV(O)(TMC)(MeCN)]2+ at 680, 740 and 820 nm
respectively under the same pseudo-first-order conditions that were used with the N4Py
ferryl species. This kinetic study demonstrated that these five substrates react with these
ferryl species with the same order of reactivity (Cys > Tyr > Trp > Met > Gly) but with
different magnitudes (reactivity of these substrates was the highest with [FeIV(O)(BnTPEN)]2+ followed by [FeIV(O)(N4Py)]2+ and [FeIV(O)(Me-N4Py)]2+ which were more
reactive than [FeIV(O)(TMC)(MeCN)]2+. The pseudo-first-order rate constants were
measured for the reaction of the five reactive substrates with the Me-N4Py, Bn-TPEN
and TMC ferryl species (Table 2.4).
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Table 2.4. Pseudo-first-order rate constants (s-1) for the reaction of the five reactive
amino acid substrates with N4Py, Me-N4Py, Bn-TPEN and TMC ferryl species
Substrate

N4Py

Me-N4Py

Bn-TPEN

TMC

Cysteine

1.7(1)

1.8(1)

21(2)

1.2(1)×10

Tyrosine

3.4(1)×10

3.0(2)

3.7(1)×10

Tryptophan

1.7(1) ×10

Methionine

3.2(1)×10

Glycine

5.8(2)×10

-1

-2

-3

-5

-1

3.0(1)×10

-2

1.5(1)×10

-4

4.1(1)×10

-5

5.6(3)×10

4.0(1)×10
1.8(2)×10
5.8(5)×10

-1

-3

-1

-2

-4

-4

5.6(4)×10

-4

3.9(1)×10

-4

1.5(1)×10

These pseudo-first-order rate constants were compared to the pseudo-first-order rate
constants obtained for the five reactive substrates with the N4Py ferryl species. The
comparison of the pseudo-first order rate constants obtained with N4Py and Me-N4Py
ferryl species suggested that the N4Py and Me-N4Py ferryl species have similar reactivity
with the cysteine, tyrosine, tryptophan and glycine substrates. On the other hand, the
comparison of the pseudo-first order rate constants obtained for the reaction of
methionine substrate with N4Py and Me-N4Py ferryl species showed that the methionine
substrate reacts eight times slower with the Me-N4Py ferryl species than with the N4Py
ferryl species (Figure 2.12). In addition, the regeneration of the Fe(II) species at 450 nm
corresponded with the decay of the ferryl species at 680 nm in the reaction of methione
substrate with Me-N4Py and N4Py ferryl species.
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Figure 2.12. Comparison between the time course of the decay of [FeIV(O)(N4Py)]2+ (1
mM) upon treatment with N-Ac-Met-NHtBu (10 equiv) in 1:1 H2O:MeCN at 25 °C
(absorbance at 680 nm = red line) and the time course of the decay of [FeIV(O)(MeN4Py)]2+ (1 mM) upon treatment with N-Ac-Met-NHtBu (10 equiv) in 1:1 H2O:MeCN at
25 °C (absorbance at 680 nm = blue line)
The pseudo-first-order rate constants obtained for the reaction of these five reactive
substrates with the Bn-TPEN ferryl indicated that the five reactive substrates (Cys, Tyr,
Trp, Met and Gly) react with the Bn-TPEN ferryl species faster than with the other ferryl
species (N4Py, Me-N4Py and Bn-TPEN). For example, the glycine substrate reacts 10
times faster with the Bn-TPEN ferryl species than with the N4Py ferryl (Figure 2.13).
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Figure 2.13. Comparison between the time course of the decay of [FeIV(O)(N4Py)]2+ (1
mM) upon treatment with N-Ac-Gly-NHtBu (10 equiv) in 1:1 H2O:MeCN at 25 °C
(absorbance at 680 nm = red line) and the time course of the decay of [FeIV(O)(BnTPEN)]2+ (1 mM) upon treatment with N-Ac-Gly-NHtBu (10 equiv) in 1:1 H2O:MeCN at
25 °C (absorbance at 740 nm = blue line).
The comparison between the reactivity of N4Py ferryl and TMC ferryl species with
the five reactive substrates demonstrated that the TMC ferryl reacts with slower rates
than the N4Py ferryl species. An example of this slow reactivity is observed with the
tyrosine substrate which reacts 92 times slower with TMC ferryl than with N4Py ferryl
species (Figure 2.14).
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Figure 2.14. Comparison between the time course of the decay of [FeIV(O)(N4Py)]2+ (1
mM) upon treatment with N-Ac-Tyr-NHtBu (10 equiv) in 1:1 H2O:MeCN at 25 °C
(absorbance at 680 nm = red line) and the time course of the decay of
[FeIV(O)(TMC)(MeCN)]2+ (1 mM) upon treatment with N-Ac-Tyr-NHtBu (10 equiv) in
1:1 H2O:MeCN at 25 °C (absorbance at 820 nm = blue line)
In addition, the rate of reaction of the five reactive substrates with N4Py, Me-N4Py,
Bn-TPEN and TMC ferryl species were compared to the rate of reaction of glycine
substrate with these ferryl species and relative rates (krels) were calculated (Table 2.5).
Table 2.5. Relative rate constants for the five reactive amino acid substrates with N4Py,
Me-N4Py, Bn-TPEN and TMC ferryl species
Substrate

N4Py

Me-N4Py

Cysteine

2.9×10

Tyrosine

5.9×10

Tryptophan

2.9×10

Methionine

5.5×10

Glycine

1

4

3

2

1

3.2×10
5.4×10
2.7×10

4

3

2

Bn-TPEN
4

2.6×10

3

5.2×10

2

6.9×10

1

TMC
8.0×10
2.5×10
3.7

7.3

3.1×10

2.6

1

1

1

2

1
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The relative rate of each substrate varied between different ferryl species. For
example krel for the methionine substrate was 55, 7.3, 31 and 2.6 with the N4Py, MeN4Py, Bn-TPEN and TMC ferryl species respectively. This difference in relative rates
suggested that sterics play an important role in the reactivity of amino acid substrates
with ferryl species.
2.2.4.2. Measurement of Second-Order Rate Constants for the Five Reactive Amino
Acid Substrates with Me-N4Py, Bn-TPEN and TMC Ferryl Species
Second-order rate constants for the reaction of the five reactive substrates (Cys, Tyr,
Trp, Met and Gly) with Me-N4Py, Bn-TPEN and TMC ferryl species were determined.
These second-order rate constants were measured by reacting 4 concentrations of each
substrate with Me-N4Py, Bn-TPEN and TMC ferryl species and measuring the rate of
decay of ferryl species with each concentration (Table 2.6).
Table 2.6. Second-order rate constants (M-1s-1) for the five reactive amino acid substrates
with Me-N4Py, Bn-TPEN and TMC ferryl species (second-rate constant for glycine with
TMC was not determined because the glycine substrate reacts with TMC with the same
rate obtained with the background decomposition)
Substrate

Me-N4Py

Cysteine

1.9×10

Tyrosine

3.0×10

2.9×10

Tryptophan

1.4

3.6×10

Methionine

3.1×10

Glycine

5.5×10

2

1

-2

-3

Bn-TPEN
1.1×10

3

2

1

1

1.5×10

-1

3.8×10

-2

6.0×10

-2

1.7
7.0×10

TMC

4.1×10
-2

n.d
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A linear relationship was obtained between increasing the concentration of substrate
and the rate of decay of ferryl species which proved that the decay of Me-N4Py, BnTPEN and TMC ferryl species resulted from oxidation of the amino acid substrates in a
bimolecular reaction.
2.2.4.3. Product Analysis
Investigation of the products of the reactions of the cysteine, tyrosine, tryptophan and
methionine amino acid substrates with Me-N4Py, Bn-TPEN and TMC ferryl species
showed the same oxidation products observed in the reaction of these substrates with
N4Py ferryl species (Table 2.7).
Table 2.7. Oxidation products obtained in the reaction of cysteine, tyrosine, tryptophan
and methionine substrates with N4Py, Me-N4Py, Bn-TPEN and TMC ferryl species
Substrate

Oxidation Product

Cysteine

Cysteine dimer

Tyrosine

Tyrosine polymer

Tryptophan

Complex mixture of products (Trp + O )

Methionine

Sulfoxide derivatives

In addition, the oxidation products of the reaction of glycine substrate with Me-N4Py
ferryl species were investigated under single-turnover conditions and compared to the
single-turnover oxidation experiment of glycine substrate with the N4Py ferryl species.
The single-turnover oxidation of glycine substrate with Me-N4Py ferryl species showed
the formation of N-acetylformamide and the absence of dipyridyl ketone or any N4Py
decomposition product. These results were different from the single-turnover oxidation of
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glycine substrate with N4Py ferryl species that was reported by Anil Ekkati in which no
oxidation product were detected while dipyridylketone and recovered glycine substrate
were the major products isolated.14
These experiments supported that in the single-turnover oxidation of glycine with
N4Py ferryl species, the reaction starts by generation of glycyl radical which rapidly
abstracts a hydrogen atom from the tertiary carbon of N4Py causing decomposition of the
N4Py to dipyridylketone (Scheme 2.8). On the other hand, in the single-turnover
experiment of glycine substrate oxidation with Me-N4Py ferryl, the glycyl radical
generated can not induce the decomposition of the Me-N4Py (Scheme 2.8). Thus,
oxidation of the glycyl radical results in backbone cleavage and formation of Nacetylformamide with recovered Me-N4Py ligand. These oxidation experiments using the
N4Py and Me-N4Py ferryl indicated that structural modification of the ligand can affect
the stability as well as the reactivity of the amino acid substrate with the ferryl species.
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Scheme 2.8. Comparison between the N4Py and Me-N4Py single-turnover reactions with
the substrate Ac-Gly-NHtBu.

Ferryl + Glycine substrate

O
N
H

NHtBu
O

MeN4Py

N4Py

O
MeN4Py

N
N

+

N
H
O
glycine
oxidation

N

NHtBu

N
H

+

O

N

N

N4Py radical
O

H

O
N
H

NHtBu
O

+

O
N
H

N

NHtBu

N
H

O

N

O
N4Py
decomposition

oxidation
N
N
MeN4Py
no decomposition

N

H

O

OH

O

+

NHtBu

N

N

dipyridylketone
H

N-acetyl formamide

2.3. Discussion of Results
2.3.1. Synthesis of Substrates
Amino acid substrates were designed to produce substrates that mimic the amino acid
residues within a polypeptide chain. The N-termini of these amino acids model substrate
were acetylated and tert-butyl amides were introduced at the C-termini in order to block
the weak C-H bond α to the next amide nitrogen. The syntheses of acidic amino acid
substrates (aspartic and glutamic) were straightforward and produced the amino acid
model substrates Ac-Asp-NHtBu and Ac-Glu-NHtBu in good yields.
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The first reported synthesis of tryptophan substrate was low-yielding and timeconsuming. The synthesis was achieved from acetylated tryptophan in two steps, the
formation of PNP ester and the coupling of this reactive ester with tert-butylamine. This
synthesis suffered from low yields especially after recrystallization of the tryptophan
substrate to remove any PNP (p-nitrophenol) ester impurities. Thus, a new synthesis of
the tryptophan substrate was designed to overcome the drawbacks of the previous
synthesis. In the new synthesis, direct condensation of the acetylated tryptophan in
presence of EDAC (1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride)
coupling reagent produced the tryptophan substrate in 48% yield and in one step (Scheme
2.3 and 2.4).
The first synthesis of histidine substrate was producing histidine substrate with
inorganic impurities. These impurities are most probably sulfites resulting from the
Na/NH3 deprotection of the tosyl-protected histidine substrate (Scheme 2.5). These
impurities were not detectable by 1H NMR and 13C NMR but caused inconsistent results
when the histidine substrate was reacted with the N4Py ferryl species. Furthermore, when
the histidine substrate was analyzed by elemental analysis, the data did not match with
the expected elemental analysis for the pure histidine substrate indicative of the presence
of impurity. At this point a modification of the histidine substrate synthesis was required
to obtain pure substrate to be used for kinetic experiments. This modification was
achieved by careful purification of each step of the synthesis using column
chromatography in addition to an ion-exchange purification of the substrate after the
tosyl-deprotection step to remove any inorganic impurities. The modified synthesis of
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histidine substrate produced highly pure histidine substrate that matched with expected
elemental analysis data for pure substrate and produced consistent results in kinetic
experiment from different histidine substrate batches.
In order to prove that the fast decay of N4Py ferryl with the lysine substrate was due to
the alkaline media (pH > 9) caused by the high concentration of the free base of the
lysine substrate (10 equivalents, under pseudo-first-order conditions), the synthesis of the
HCl salt of lysine amino acid substrate was required. The HCl salt of lysine substrate was
reacted with the N4Py ferryl species and the reaction was slower than the reaction of
N4Py ferryl species with the lysine substrate. Furthermore, the fact that the addition of
sodium hydroxide to the generated N4Py ferryl species in absence of substrate resulted in
fast decomposition of the ferryl supported that our observed fast reaction with lysine
substrate is due to the alkaline media of the reaction.
2.3.2. Kinetic Studies for the Oxidation of Substrates with N4Py Ferryl Species
2.3.2.1. Tryptophan Substrate
The tryptophan substrate was the third most reactive substrate with N4Py ferryl
species. A second-order rate constant of 1.6(4) M-1s-1 was determined.14 The observed
faster decomposition of [FeIV(O)(N4Py)]2+ (λmax = 680 nm) than the regeneration of
[FeII(MeCN)(N4Py)]2+ (λmax = 450 nm) suggested that the [FeIII(OH)(N4Py)]2+ species is
formed as an intermediate. The formation of tryptophan radical intermediate was
supported by the detected trace amount of the organic radical by EPR spectroscopy
immediately after the addition of Ac-Trp-NHtBu to [FeIV(O)(N4Py)]2+.
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More importantly, KIE of 5.2 was measured for the decomposition of N4Py ferryl
species by Ac-Trp-NHtBu in D2O/CD3CN when compared to that in the H2O/CH3CN
solvent. This experiment was achieved after full deuterium-exchange of all three acidic
protons of the Ac-Trp-NHtBu which was accomplished after 48 hours according to 1H
NMR analysis. The observed kinetic isotope effect (kH/kD) of 5.2 suggested electrontransfer proton-transfer (ET-PT) as the mechanism of reaction. This suggested
mechanism was based on the oxidation of tryptophan in D2O by the heme-containing iron
enzyme tryptophan 2,3-dioxygenase in which a KIE of similar magnitude (4.4) was
observed and a mechanism in which removal of the indole proton was proposed to be at
least partially rate-determining.137 The suggested ET-PT mechanism is more likely than
hydrogen-atom transfer (HAT) mechanism because ferryl species that mediate oxidation
by HAT showed KIE of higher magnitudes in previous studies (KIE = 28 in the C-H
oxidation of ethylbenzene.11 However, hydrogen-atom transfer (HAT) mechanism can
not be ruled out based on the magnitude of KIE alone. The oxidation products observed
were consistent with the addition of a single oxygen atom most likely at the position 3 of
the indole ring of the tryptophan substrate based on previous studies138 which is in
agreement with the proposed ET-PT mechanism (Scheme 2.9).
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Scheme 2.9. Proposed mechanism for the oxidation of tryptophan substrate with N4Py
ferryl species14

2.3.2.2. Methionine Substrate
The methionine substrate was the fourth most reactive substrate, resulting in the decay
of [FeIV(O)(N4Py)]2+ to occur 640 times faster than the control reaction.14 In addition, the
rate constant obtained for the reaction of Ac-Met-NHtBu with [FeIV(O)(N4Py)]2+ agrees
well with previous data from reactivity studies of [FeIV(O)(N4Py)]2+ with aromatic
sulfides.103 A second-order rate constant of 3.2(4)×10-1 M-1s-1 was measured for the
methionine amino acid substrate. The rates of the N4Py ferryl species were equal within
error in D2O/CD3CN to those in the H2O/CH3CN solvent. Thus, the loss of a proton did
not occur during the rate-limiting step.14 Furthermore, these data demonstrated that the
solvent effect was negligible for the oxidations by [FeIV(O)(N4Py)]2+ in D2O/CD3CN,
which supports the hypothesis that the loss of a proton from the oxidized substrate was
responsible for generating the KIEs with the Cys, Tyr and Trp substrates.14 In the
oxidation studies, the fact that when equimolar amounts of [FeIV(O)(N4Py)]2+ and AcMet-NHtBu were reacted together a mixture of two diastereomeric sulfoxides was

69

formed and no sulfone product was detected, indicated that the first oxidation of sulfide
to sulfoxide occurred at a faster rate than the subsequent oxidation of sulfoxide to
sulfone, in accord with previous studies.14,103 Based on the characterized sulfoxide
oxidation products and the lack of KIE observed, an oxygen-atom transfer reaction
occurring between the N4Py ferryl and the methionine substrate was proposed (Scheme
2.10).
Scheme 2.10. Proposed mechanism for the oxidation of methionine substrate with N4Py
ferryl species14

2.3.2.3. Histidine, Lysine and Acidic Amino Acid Substrates (Asp and Glu)
The histidine substrate was less reactive than the five highly reactive substrates (Cys,
Tyr, Trp, Met and Gly and caused the decay of the [FeIV(O)(N4Py)]2+ with a rate =
3.8×10-5 s-1. The rate of reaction of histidine substrate with N4Py in D2O/CD3CN was
slightly faster than in H2O/CH3CN solvents which suggested a mechanism involving an
electrophilic attack on the aromatic ring. However, product analysis did not show any
oxidized histidine products suggesting that the observed N4Py ferryl decay could be
produced by the basic media which was also observed in the reaction of the basic lysine
substrate. These results for histidine amino acid substrate oxidation are in stark contrast
to the reported oxidation of histidine amino acids with ROS which produced 2-oxo
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immidazole derivatives.134 This difference in oxidation indicates the higher selectivity
that the ferryl species have compared to ROS in oxidation reactions.
The product analysis for the acidic amino acid substrates, glutamic acid and aspartic
acid showed only recovered starting materials with no oxidation products. This result and
the slow rate of decay observed with these substrates suggested that these substrates have
low reactivity or unreactive towards the oxidation with ferryl species which contradicted
their reactivity toward ROS and proved the selectivity of the N4Py ferryl species.14,134
2.3.3. Kinetic Studies for the Comparison of Substrate Reactivity with N4Py to MeN4Py, Bn-TPEN and TMC Ferryl Species
This kinetic study demonstrated that the five reactive substrates react with N4Py, MeN4Py, Bn-TPEN and TMC ferryl species with the same order of reactivity (Cys > Tyr >
Trp > Met > Gly) but with different magnitudes. The order of reactivity of ferryl species
with amino acid substrates was established, showing that [FeIV(O)(Bn-TPEN)]2+ >
[FeIV(O)(N4Py)]2+ ≥ [FeIV(O)(Me-N4Py)]2+ > [FeIV(O)(TMC)(MeCN)]2+ in their
reactivity with amino acid substrates.
Furthermore, the different relative rates obtained for the same substrate with different
ferryl species indicated that sterics control the reactivity of these reactive substrates with
ferryl species. In addition, an effect consistent with sterics was observed with the
methionine substrate that reacted 8 times slower with the Me-N4Py ferryl species than
with the N4Py ferryl species. Product analysis showed the formation of the sulfoxide
products in both reactions. In addition, the regeneration of the Fe(II) species at 450 nm
corresponded with the decay of the ferryl species at 680 nm in the reaction of methione
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substrate with Me-N4Py and N4Py ferryl species. These results indicate that the two
reactions proceed with oxygen-atom transfer mechanism and that this slower reactivity is
emerging from the increase in steric hindrance in the Me-N4Py ferryl with respect to the
N4Py ferryl species. This steric hindrance is produced by the methyl group in Me-N4Py
ligand which may have caused the contraction of the cavity that bears the Fe=O group
which makes the approach of large atoms like sulfur to the Fe=O group more difficult.
This explanation is in accord with the observation that the Cys, Tyr, Trp and glycine
substrates rate constants from their reaction with N4Py ferryl are slightly higher than with
Me-N4Py ferryl (maximum factor is 1.4). This small factor of 1.4 with respect to the
factor of 8 observed with methionine substrate can be explained by considering that these
substrates react with ferryl species by hydrogen-atom transfer or electron-transfer protontransfer and the Vander Waal radius of hydrogen is significantly smaller than sulfur. Thus
the sulfur approach to Fe=O group will be affected more than the hydrogen approach
which results in larger difference in rate constants between the Me-N4Py and N4Py
species.
The analysis of oxidation products suggested that the N4Py, Me-N4Py, Bn-TPEN and
TMC ferryl species react with similar mechanism with the 5 reactive substrates because
they form the same products of oxidation with these ferryls. Furthermore, the singleturnover oxidation experiment for the glycine substrate with the Me-N4Py ferryl showed
that the Me-N4Py ferryl species shows higher stability towards oxidizing conditions than
the N4Py ferryl species.
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2.4. Conclusion
The reactivity of the twenty natural amino acid substrates that mimic the amino acid
residues in polypeptides with N4Py ferryl species has been established and the order of
reactivity of these substrates has been determined.14 Based on the calculated krel, five
substrates (Cys, Tyr, Trp, Met and Gly) were classified as significantly reactive. The
mechanisms of reactions of these five substrates were thoroughly investigated and
mechanisms of reactions were proposed based on KIE and oxidation products. The
reactivity of these five substrates with N4Py was compared to their reactivity with other
ferryl species to determine the factors that control the reactivity of amino acid substrates
with ferryl species.
This fundamental study of the amino acid substrate with ferryl species is significant
because little information was known about how ferryl species react with amino acids.
The information described in this study is useful for the scientists working in the field of
protein oxidation and enzyme inhibition. The identification of the five reactive substrates
suggested that using ferryl species can target these residues selectively in a protein or
enzyme. In addition, our lab is currently using the data from the study described in this
dissertation to apply it in enzyme inhibition and peptide oxidation projects.139
Furthermore, the order of reactivity of ferryl species with amino acids substrates
([FeIV(O)(Bn-TPEN)]2+

>

[FeIV(O)(N4Py)]2+

≥

[FeIV(O)(Me-N4Py)]2+

>

[FeIV(O)(TMC)(MeCN)]2+) was established. In addition, the relative rate of reactivity of
the substrate changes from one ferryl species to another indicating that modifying the
structure of the ligand will tune the reactivity of the ferryl species. These data are
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important because they indicate that by changing the ligand structure we can design a
ferryl species which is more selective, more stable or more reactive with amino acid
substrates. Studies that investigate the structure activity relationship (SAR) of ferryl
species that oxidize amino acid substrates could use the preliminary data from our
research to understand the structural features that generate a better oxidant for protein
oxidation.
2.5. Experimental13,14
2.5.1. General Considerations:
All reagents were purchased from commercial suppliers and used as received. NMR
spectra were recorded on a Varian FT-NMR Mercury-300, 400 or 500 MHz
spectrometer. Mass spectra were recorded on a Waters ZQ2000 single quadrupole mass
spectrometer using an electrospray ionization source. IR spectra were recorded on a
Nicolet FT-IR spectrophotometer. HPLC was performed on an Agilent 1200 Preparative
Purification System equipped with a multi-wavelength detector. UV-vis spectra were
recorded

on

a

Varian

Cary

50

spectrophotometer.

The

complex

[FeII(N4Py)(MeCN)](ClO4)2 used in this study was synthesized according to the literature
procedures. N-acetyl-amino acids were synthesized from commercially available amino
acids using standard literature procedures. All reactions were performed under ambient
atmosphere unless otherwise noted.
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2.5.2. Experimental Procedures and Tabulated Characterization Data for New
Compounds:
O
HO
AcHN
O

NHtBu

Chemical Formula: C 11H20N 2O4
Molecular Weight: 244.29

4-Acetamido-5-(tert-butylamino)-5-oxopentanoic acid13
EDAC (3.12 g, 20.4 mmol) was added to a mixture of Boc-Glu(OBn)-OH (5.00 g,
14.8 mmol) and CH2Cl2 (100 ml) at 0 oC under an inert atmosphere. After 5 min, tertbutylamine (3.10 ml, 37.2 mmol) was added dropwise and the mixture was allowed to stir
overnight. The reaction mixture was washed with ammonium chloride (1×75 ml). The
organic layer was dried over anhydrous sodium sulfate and the solvent was removed in
vacuo. The crude product was purified by silica gel column chromatography (60% ethyl
acetate:hexane) to yield white solid Boc-Glu(OBn)-NHtBu (3.10 g , 53%) . 1H NMR
(CDCl3) δ 7.34 (m, 5H), 6.09 (s, 1H), 5.34 (d, J = 8.1 Hz, 1H), 5.11 (s, 2H), 4.05 (m,
1H), 2.46 (m, 2H), 2.07 (m, 1H), 1.90 (m, 1H), 1.43 (s, 9H), 1.30 (s, 9H).13
A mixture of Boc-Glu(OBn)-NHtBu (4.00 g, 10.2 mmol), CH2Cl2 (25 ml) and
trifluoroacetic acid (25 ml) was stirred for 3 h at rt under an inert atmosphere, the
reaction was monitored by TLC until complete consumption of the starting material.
Trifluoroacetic acid was removed in vacuo to yield TFA·H-Glu(OBn)-NHtBu (7.0 g,
quantitative).13
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Triethylamine (4.65 ml, 33.3 mmol) was added dropwise to a mixture of TFA•HGlu(OBn)-NHtBu (5.40 g, 13.4 mmol) and CH2Cl2 (100 ml) at 0 oC under an inert
atmosphere. After 5 minutes, acetyl chloride (1.30 ml, 17.3 mmol) was added; the
reaction was allowed to warm to rt while stirring for 4 h, the reaction progress was
monitored by TLC. The reaction mixture was stirred with sodium bicarbonate (30 ml) for
5 minutes, dried over anhydrous sodium sulfate and concentrated. The crude product was
purified by silica gel column chromatography (50% ethyl acetate:hexane) and (10%
MeOH: CHCl3) to yield the white solid N-Ac-Glu(OBn)-NHtBu (2.68 g, 61 %). 1H NMR
(CDCl3) δ 7.30 (m, 5H), 6.53 (d, J = 7.3 Hz, 1H), 6.26 (s, 1H), 5.11 (dd, J = 12.2, 8.16
Hz, 2H), 4.38 (dd, J = 7.3, 5.7 Hz, 1H), 2.55 (m, 1H), 2.43 (m, 1H), 2.11 (m, 1H), 1.93
(s, 3H), 1.26 (s, 9H).13
Pd /C (0.04 g, 0.4 mmol) was added to a solution of N-Ac-Glu(OBn)-NHtBu (0.25 g,
0.75 mmol) in ethyl acetate (10 ml) and acetic acid (1 ml) and was placed under a
hydrogen atmosphere overnight. The reaction mixture was filtered and the filtrate was
concentrated from hexane (3×5 ml) to yield a white solid, N-Ac-Glu-NHtBu 5 (0.16 g,
88%). m.p = 179-181 o C.

1

H NMR (DMSO) δ 7.87 (d, J = 8.1 Hz, 1H), 7.49 (s, 1H),

4.20 (m, 1H), 2.49 (s, 1H), 2.16 (m, 2H), 1.82 (s, 3H), 1.75 (m, 1H), 1.66 (m, 1H), 1,23
(s, 9H);

13

C NMR (DMSO) 173.9, 170.6, 169.1, 52.0, 50.1, 30.3, 28.4, 28.1, 22.5; IR

(KBr) 3350, 3320, 3268, 3093, 2969, 2937, 1725, 1656, 1575, 1540, 1458, 1434, 1412,
1394, 1375, 1367, 1311, 1287, 1255, 809 cm-1; LRMS(ESMS) calcd for C11H21N2O4
(M+H): 245, found: 245.13
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O

OH

AcHN
O

NHtBu

Chemical Formula: C 10H 18N2 O4
Molecular Weight: 230.26

3-Acetamido-4-(tert-butylamino)-4-oxobutanoic acid13
EDAC (3.12 g, 20.4 mmol) was added to a mixture of Boc-Asp(OBn)-OH (5.00 g,
15.5 mmol) and CH2Cl2 (100 ml) at 0 oC under an inert atmosphere. After 5 min, tertbutylamine (3.10 ml, 37.2 mmol) was added dropwise and the reaction mixture was
allowed to stir overnight. The mixture was washed with ammonium chloride (1×75 ml).
The organic layer was dried over anhydrous sodium sulfate and concentrated in vacuo.
The crude product was purified by silica gel column chromatography (60% ethyl
acetate:hexane) to yield the white solid Boc-Asp(OBn)-NHtBu (3.10 g, 53%) . 1H NMR
(CDCl3) δ 7.32 (m, 5H), 6.28 (s, 1H), 5.60 (s, 1H), 5.11 (dd, J = 12.2, 11.4 Hz , 2H), 4.37
(m, 1H), 2.97 (dd, J = 17.0, 4.1, Hz, 1H), 2.65 (m, 1H), 1.43 (s, 9H), 1.26 (s, 9H).13
A mixture of Boc-Asp(OBn)-NHtBu (3.80 g, 10.1 mmol), CH2Cl2 (25 ml) and
trifluoroacetic acid (25 ml) was stirred for three hours at rt under an inert atmosphere.
The reaction was monitored by TLC until complete consumption of the starting material;
trifluoroacetic acid was removed in vacuo to yield TFA·H-Asp-(OBn)-NHtBu (6.10 g,
quantitative).13
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TFA•H-Asp-(OBn)-NHtBu (5.40 g, 13.7 mmol) was dissolved in CH2Cl2 (100 ml) and
triethylamine (4.85 ml, 33.5 mmol) was added dropwise at 0 oC under an inert
atmosphere. After 5 minutes, acetyl chloride (1.35 ml, 17.4 mmol) was added; the
reaction was allowed to warm to rt while stirring for 4 h, the reaction progress was
monitored by TLC. The reaction mixture was stirred with sodium bicarbonate (30 ml) for
5 minutes, dried over anhydrous sodium sulfate and concentrated. The crude product was
purified by silica gel column (50% ethylacetate:hexane) and (10% MeOH:CHCl3), to
yield (2.63 g, 60 %) of N-Ac-Asp(OBn)-NHtBu. 1H NMR (CDCl3) δ 7.34 (m, 5H), 6.68
(d, J = 6.5 Hz, 1H), 6.35 (s, 1H), 5.15 (dd, J = 18.7, 12.2 Hz, 2H), 4.67 (m, 1H), 2.96 (dd,
J = 13.0, 4.1 Hz, 1H), 2.61 (m, 1H), 1.99 (s, 3H), 1.29 (s, 9H).13
Pd /C (0.03 g, 0.03 mmol) was added to a solution of N-Ac-Asp(OBn)-NHtBu (0.25 g,
0.78 mmol) in ethyl acetate (10 ml) and acetic acid (1 ml) and was placed under a
hydrogen atmosphere overnight. The reaction mixture was filtered and the filtrate was
concentrated from hexane (3×5 ml) to yield a white solid of N-Ac-Asp-NHtBu (6) (0.17g,
96 %) m.p = 133-134 o C. 1H NMR (DMSO) δ 8.04 (d, J = 8.1 Hz, 1H), 7.34 (s, 1H), 4.46
(m, 1H), 2.54 (m, 1H), 2.44 (m, 1H), 1.81 (s, 3H), 1.21 (s, 9H); 13C NMR (DMSO) 171.8,
169.9, 169.2, 50.1, 49.8, 36.6, 28.4, 22.5; IR(KBr) 3369, 3293, 3082, 2972, 1743, 1654,
1616, 1555, 1454, 1408, 1390, 1367, 1296, 1257, 1224, 1183 cm-1; LRMS(ESMS) calcd
for C10H19N2O4 (M+H) : 231, found : 231.13
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2-Acetamido-N-tert-butyl-4-(methylsulfinyl)butanamide14
The iron(II) complex [FeII(N4Py)(MeCN)] (ClO4)2 (53.4 mg, 80.0 µmol) was
dissolved in MeCN (40 ml) and stirred with PhIO (35.4 mg, 160 µmol) for 1 h, resulting
in a green-colored solution of [FeIV(O)(N4Py)](ClO4)2 (2 mM). This solution was added
to a solution of Ac-Met-NHtBu (20.0 mg, 80.0 µmol) in H2O (40 ml) and stirred for 1 h.
The solution turned from the original green color to an orange-yellow color, indicating
the decomposition of [FeIV(O)(N4Py)]2+. Solvent was removed in vacuo; the residue was
dissolved in MeOH (5 ml) and passed through ion-exchange resin (Dowex 50wx4; 100
mesh), which was preactivated with 0.1 M HCl. The ligand, N4Py, as well as its FeII
complex adhered to the column. The methanolic solution of the oxidation product of NAc-Met-NHtBu was concentrated in vacuo to yield a yellowish white solid (17.0 mg,
85%). 1 H NMR revealed a mixture of 1.7:1 starting material (54%) to sulfoxide
derivative (31%).14
Procedure for preparative scale synthesis14
A solution of Ac-Met-NHtBu (40.0 mg, 162 µmol) in 1:1 H2O/CH3CN was treated
with oxone (50.0 mg, 81.0 µmol). After 90 seconds, the reaction was quenched by the
addition of Na2S2O3 (22.0 mg, 162 µmol). The reaction mixture was concentrated to
remove MeCN, and the aqueous layer was extracted with CH2Cl2 (3×1 ml). The organic
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layer was dried over anhydrous sodium sulfate and concentrated in vacuo. The product
was purified by silica gel chromatography (gradient; 1-10% MeOH/CH2Cl2), to yield the
2-Acetamido-N-tert-butyl-4-(methylsulfinyl)butanamide (15 mg, 35%) as mixture of
sulfoxide diastereomers as a colorless liquid. 1H and 13C NMR spectra were complicated
due to the presence of two diastereomers; only key peaks are reported. 1H NMR (CDCl3):
δ 7.03 (m, 1H), 6.85 (m, 2H), 6.7 (s, 1H), 4.55 (m, 2H), 2.84 (m, 4H), 2.68 (s, 3H), 2.62
(s, 3H), 2.36 (m, 1H), 2.18 (m, 3H), 2.05 (s, 6H), 1.36 (s, 18H).

13

C NMR (CDCl3): δ

170.8, 169.8, 52.0, 50.6, 49.2, 38.8, 37.6, 28.9, 27.6, 26.7, 23.4. IR (CHCl3): 3290, 2966,
2925, 1650, 1549, 1451, 1430, 1392, 1365, 1259, 1226, 1032, 667 cm-1. LRMS (ESMS)
calcd for C11H23N2O3S (M+H)+: 263. Found: 263.14
General Procedure for Kinetic Experiments.14
Reactions of the species [FeIV(O)(N4Py)]2+ with amino acid substrates were conducted
at 298 ± 2K under pseudo-first-order conditions. Rate constants represent the average of
at least three runs. The reactions were monitored using a UV-vis spectrophotometer and
were performed using the following standard procedure. A 2 mM solution of
[FeII(N4Py)(MeCN)](ClO4)2 in 3:1 H2O:MeCN (1.0 ml, 2 µmol) was treated with a
solution of 1 equiv of oxone in H2O (100 µl, 2 µmol). The solution was allowed to stand
for 10 min, during which a color change from orange-red to green was noted. After 10
min, the [FeIV(O)(N4Py)]2+ species was fully generated, as judged by maximization of
the absorbance at 680 nm. The green solution of [FeIV(O)(N4Py)]2+ was treated with a 10
equiv solution of the amino acid substrate in 1:3 H2O:MeCN (900 µl, 20 µmol). After
mixing (less than 10s), the reaction was monitored by UV-vis spectroscopy. The
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absorbance traces for the decomposition of [FeIV(O)(N4Py)]2+ (λ = 680 nm) showed firstorder decay and fit well to the single exponential equation [A=∆A(1 - ekt) + A0)] for
substrates. Studies to determine KIE were conducted in the same manner as above except
using the deuterated solvents CD3CN and D2O.
EPR Studies.14
EPR spectra were collected on a Bruker X-Band EPR spectrometer. Samples were
prepared according to the aforementioned general procedure for kinetic studies, except
that the solutions of [FeIV(O)(N4Py)]2+ and the amino acid substrates were cooled to 0 oC
before mixing and were freeze-quenched in liquid N2.
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CHAPTER 3
SYNTHESIS AND CHARACTERIZATION OF DERIVATIVES OF THE BnTPEN LIGAND AND THEIR METAL COMPLEXES
3.1. Introduction
The synthesis of nitrogen-rich pentadentate ligands was a focus of organic and
inorganic research in the last few decades. Interest in pentadentate ligands is attributed to
their unique coordination chemistry. These nitrogen-rich pentadentate ligands coordinate
to an octahedral metal center with their five nitrogens and leave the sixth position
available for coordination with another group.15 Examples of groups that occupy the sixth
position in the octahedral complex of nitrogen-rich pentadentate ligands include the
imidio140, nitrosyl141, azide142, nitrido92, cyanides143, halogens143, hydroperoxo124,144,145
and oxo groups.11,94,108,146 These nitrogen-rich pentadentate ligands are capable of
stabilizing high-valent metal centers and generating species that were difficult to obtain
with ligands of lower denticity.46, 89 This wide range of functional groups that bind to the
sixth coordination position has given the nitrogen-rich pentadentate ligands wide range of
reactivity. An important example of these reactivities is the capability of these nitrogenrich pentadentate ligands to form metal complexes that mediate atom-transfer and grouptransfer reactions. Examples of these reactions include oxygen-atom transfer to alkenes to
produce the corresponding epoxides and N-tosyl group-transfer to alkenes to form the
corresponding aziridines which are catalyzed by the iron complexes of these nitrogenrich pentadentate ligands.104,147
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One of the important applications of nitrogen-rich pentadentate ligands is their ability
to stabilize iron (IV)-oxo species (ferryl). Examples of nitrogen-rich pentadentate ligands
that stabilized ferryl species include N4Py, Me-N4Py, Py-TMC and Bn-TPEN ligands
(Figure 3.1).
N
N

N

N

N

N

N
N

N
N
Bn-TPEN

N

N

N4Py

N

N

N

N

N
N

Me
N

Me-N4Py

N

Py-TMC

Figure 3.1. Pentadentate ligands that generate and stabilize ferryl species
The generation of ferryl species from nitrogen-rich pentadentate ligands was achieved
by the oxidation of the ferrous complexes of these pentadentate ligands with a suitable
oxidant like oxone or iodosyl benzene.11,12,93 Ferryl species generated from these ligands
have shown a wide range of reactivity and several applications in C-H oxidation11,
oxidative

N-dealkylation122,

alkene

epoxidation96,

sulfide

oxidation115,

DNA

cleavage126,127 and amino acids oxidation.12,14 Amongst these ferryl species, [FeIV(O)(BnTPEN)]2+ has demonstrated faster rates of reactivity in sulfide and C-H oxidations than
[FeIV(O)(N4Py)]2+. Similarly, faster rates of reactivity with amino acid substrates have
been observed with [FeIV(O)(Bn-TPEN)]2+ than with [FeIV(O)(N4Py)]2+, [FeIV(O)(MeN4Py)]2+ and [FeIV(O)(TMC)]2+ as mentioned in Chapter 2 of the dissertation. Therefore,
we decided to modify the structure of Bn-TPEN ligands by synthesizing new derivatives
and their metal complexes to generate a more selective oxidant for amino acid residues
and proteins.
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The nitrogen-rich pentadentate ligands used to generate and stabilize ferryl species
lacked the element of chirality. For this reason the Kodanko group synthesized the chiral
Bn-CDPy3 to study the effect of chirality on these ligands and their corresponding metal
complexes.16

N

N
N

N

N

N

N
Bn-TPEN

N

N

N

Bn-CDPy3

Figure 3.2. Structure of Bn-TPEN and Bn-CDPy3 ligands
The ligand Bn-CDPy3 is a trans-1,2-diaminocyclohexane derivative of the ligand BnTPEN (Figure 3.2). Mirvat Hammoud (Kodanko lab) synthesized the ligand Bn-CDPy3
and the [Co(Bn-CDPy3)Cl]Cl2 complex and observed that one single coordination
geometry (isomer C) is formed as a major isomer over all the other possible isomers for
the [Co(Bn-CDPy3)Cl]Cl2 complex (Figure 3.3). 16

Figure 3.3. Possible isomers for the [Co(Bn-CDPy3)Cl]2+ complex15,16
The possibility of five different coordination geometries emerges from the fact that the
cyclohexane moiety added complexity to the structure by differentiating the
diaminocyclohexane backbone. This cyclohexane moiety created a C1 symmetric ligand
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that can access more coordination geometries besides the chirality element that gave
access to additional diastereomeric coordination modes that were equivalent or
enantiomeric in case of the Bn-TPEN ligand. The observation of isomer C as the major
isomer in the [Co(Bn-CDPy3)Cl]2+ raised two important questions. Was this isomer
favored only with cobalt or it will be demonstrated in other metal complexes? If this was
general, then what are the factors causing this stability of isomer C? In order to address
these questions more investigations were needed.
This chapter describes the synthesis of the Et-TPPN, Pr-TPPN and Bn-TPZEN which
are three new derivatives of the Bn-TPEN ligand in addition to the synthesis and
characterization of the chiral Bn-CDPy3 and its iron and zinc metal complexes
(enantioenriched and racemic forms) and cobalt complex (entioenriched form). A
discussion of these results is included along with a conclusion that explains the
importance of these results.
3.2. Results
3.2.1. Synthesis of the Bn-TPEN Diaminopropane Derivatives
The 1,3-diaminopropane derivatives of Bn-TPEN were synthesized starting from the
1,3-diaminopropane starting material based on a reported procedure.148,149,150 The aim of
the synthesis was to replace the ethylenediamine moiety in Bn-TPEN by a 1,3diaminopropane group. Two new diaminopropane derivatives were synthesized which are
the Et-TPPN and the Pr-TPPN (Figure 3.4).
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Figure 3.4. 1,3-diaminopropane derivatives of Bn-TPEN
The synthesis of the 1,3-diaminopropane derivatives of Bn-TPEN started by reacting
the 1,3-diaminopropane (1) with 1 equivalent of pyridine-2-carboxaldehyde followed by
reduction of the resulting imine with NaBH4 producing the 1,3-diaminopropane dipyridyl
compound 2 in 70% yield.149 Diaminopropane dipyridyl 2 was then reacted with another
equivalent of pyridine-2-carboxaldehyde to produce the tripyridyl aminal 3 in 60%
yield.150 The aminal 3 was reduced with NaBH3CN in the presence of TFA to yield the
tripyridyl 1,3-diaminopropane 4.150 The tripyridyl 1,3-diaminopropane 4 was either
alkylated with 1.5 equivalent of ethyl iodide to form the Et-TPPN derivative 5 in 62%
yield or subjected to alkylation with 1.1 equivalent of propyl iodide to yield the Pr-TPPN
derivative 6 in 60% yield (Scheme 3.1).
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Scheme 3.1. Synthesis of 1,3-diaminopropane derivatives of Bn-TPEN
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3.2.2. Synthesis of the Bn-TPEN Pyrazine Derivative
The synthesis of the pyrazine derivative of Bn-TPEN ligand (Bn-TPZEN) was
designed to replace the three pyridine rings in the Bn-TPEN ligands by three pyrazine
rings. The synthesis was performed by alkylation of the N-benzylethylenediamine (7)
with 4 equivalents of 2-chloromethylpyrazine in presence of 4 equivalents of KI and
K2CO3 producing the Bn-TPZEN derivative 8 in 68% yield after purification by column
chromatography (Scheme 3.2).
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Scheme 3.2. Synthesis of Bn-TPZEN
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Preliminary data showed that the iron(II) complexes of these new Bn-TPEN
derivatives react with iodosyl benzene to generate the corresponding ferryl species.
However, the characterization of these ferryl species was not of publication quality due to
the failure to obtain acceptable elemental analysis for the iron complexes of these ligands.
3.2.3. Synthesis and Characterization of the Chiral Bn-CDPy3 and its Metal
Complexes
3.2.3.1. Synthesis of the Chiral Bn-CDPy3
The chiral ligand Bn-CDPy3 was synthesized in both racemic and enantioenriched
forms starting from racemic trans-1,2-diaminocyclohexane (9) and from the
enantioenriched ligand (1R,2R)-(_)-1,2-cyclohexanediamine (10, 99% ee) respectively
according to a literature procedure.15,16 The synthesis of the chiral Bn-CDPy3 started by
the dipyridyldiamine 12 which is obtained from the trans-1,2-diaminocyclohexane in two
steps.15,16 Reaction of dipyridyldiamine 12 with 1 equivalent of 2-pyridinecarboxaldehyde
produced the aminal derivative 13 which was isolated by alumina chromatography in
88% yield.16 Reduction of the aminal 13 with NaBH3CN and TFA produced the
tripyridyldiaminocyclohexane

14

in

96%

yield.16

Alkylation

of

the
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tripyridyldiaminocyclohexane 14 with 1 equivalent of Bn-Br produced the Bn-CDPy3 15
in 99% yield (Scheme 3.3).15,16
Scheme 3.3. Synthesis of the chiral Bn-CDPy315,16

3.2.3.2. Synthesis of the Bn-CDPy3 Metal Complexes
The zinc(II), iron(II) (2 complexes) and cobalt(III) complexes of Bn-CDPy3 were
synthesized in both racemic and enantioenriched forms. The racemic complexes were
used for X-ray crystallographic studies to facilitate the crystallization process and the
complexes derived from the enantioenriched Bn-CDPy3 were used for circular dichroism
(CD) studies.
The cobalt complex was synthesized by reacting the Bn-CDPy3 15 with 1 equivalent
of trans-[Co(Py)4Cl2]Cl•6H2O in dichloromethane solvent in the dark. After 12 h, a
purple solid of [Co(Bn-CDPy3)Cl]Cl2 (16) was obtained as a mixture of isomers (5:1
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major:minor) in addition to trace amounts of other isomers. This mixture was
recrystallized from EtOH with ether vapor diffusion to obtain > 10:1 major:minor
isomers.15,16 The iron(II) complex [Fe(Bn-CDPy3)Cl]Cl (17) was prepared from the
reaction of 15 with 1 equivalent of FeCl2 in dichloromethane and recrystallization of the
resulting yellow solid from MeCN with ether vapor diffusion. The iron(II) complex
[Fe(Bn-CDPy3)Cl]Cl (17) was obtained in 63% yield as microcrystalline yellow solid
after recrystallization.15 The yellow crystals of [Fe(Bn-CDPy3)Cl]Cl were not suitable
for X-ray crystallographic analysis so the complex was reacted with 1 equivalent of
AgClO4 in MeCN to exchange anions to produce the [Fe(Bn-CDPy3)Cl]ClO4 complex
(18). This complex was recrystallized from MeCN with ether vapor diffusion to give Xray quality crystals of [Fe(Bn-CDPy3)Cl]ClO4 in 34% yield.15 The zinc complex [Zn(BnCDPy3)Cl]2ZnCl4 (19) was obtained as a colorless solid in 47% yield from the reaction
of 15 with 1.5 equivalent of ZnCl2 in THF15 (Scheme 3.4).15,16
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Scheme 3.4. Synthesis of Bn-CDPy3 metal complexes15

3.2.4. Characterization of Bn-CDPy3 Metal Complexes
3.2.4.1. X-ray Structure of [Fe(Bn-CDPy3)Cl]ClO4
The iron(II) complex [Fe(Bn-CDPy3)Cl]ClO4 (18) was obtained as yellow crystals
suitable for X-ray crystallography. The X-ray structure of this complex showed that the
[Fe(Bn-CDPy3)Cl]ClO4 complex (18) has a solid state conformation similar to the
[Co(Bn-CDPy3)Cl]Cl2 (16) crystal structure which was reported by Mirvat Hammoud
(Kodanko group).15,16 The [Fe(Bn-CDPy3)Cl]ClO4 complex crystals were obtained as a
racemate in the triclinic space group P1 with Z = 2 (Figure 3.5).15
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Figure 3.5. X-ray structure of the [Fe(Bn-CDPy3)Cl]ClO4 complex (18)15
The iron center has an N5Cl donor atom set with the three pyridyl rings in mer
geometry. The crystals show a slightly distorted octahedral geometry with bond angles
ranging from 78.32(5)o to 104.09(4)o (Table 3.1).15
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Table 3.1. Important bond angles for the [Fe(Bn-CDPy3)Cl]ClO4 complex (18)15
Bond angle

Bond angle (deg)

N(1)_Fe(1)_Cl(1)

172.08(4)

N(2)_Fe(1)_Cl(1)

100.32(4)

N(3)_Fe(1)_Cl(1)

104.09(4)

N(4)_Fe(1)_Cl(1)

94.43(4)

N(5)_Fe(1)_Cl(1)

95.28(4)

N(1)_Fe(1)_N(2)

78.39(5)

N(3)_Fe(1)_N(1)

78.32(5)

N(3)_Fe(1)_N(2)

154.70(5)

N(3)_Fe(1)_N(4)

82.4(5)

N(3)_Fe(1)_N(5)

94.69(5)

N(4)_Fe(1)_N(1)

78.32(5)

N(4)_Fe(1)_N(2)

102.43(5)

N(5)_Fe(1)_N(1)

92.01(5)

N(5)_Fe(1)_N(2)

76.39(5)

The bond lengths to the iron center in the [Fe(Bn-CDPy3)Cl]ClO4 complex were in
accord with [Fe_N5]average distances of the [FeII(Bn-TPEN)(Cl)]PF6 paramagnetic
complex143,144 suggesting that the [Fe(Bn-CDPy3)Cl]ClO4 complex has a high-spin Fe(II)
ion (Table 3.2).15

93

Table 3.2. Important bond lengths for the [Fe(Bn-CDPy3)Cl]ClO4 complex
Bond

Bond length (Å)

Fe(1)-N(1)

2.2356(1)

Fe(1)-N(2)

2.2677 (1)

Fe(1)-N(3)

2.1629 (1)

Fe(1)-N(4)

2.2019(1)

Fe(1)-N(5)

2.1818 (1)

Fe(1)-Cl(1)

2.3390 (4)

3.2.4.2. UV-vis and CD Spectroscopy of [Fe(R,R-Bn-CDPy3)Cl]Cl
Enantioenriched [Fe(R,R-Bn-CDPy3)Cl]Cl complex was used for UV-vis and CD
studies. The enantioenriched [Fe(R,R-Bn-CDPy3)Cl]Cl complex formed a yellow
solution in MeOH that showed two absorbances in the UV-vis absorption spectrum with
λmax at 413 and 362 nm and є =1910 and 1790 M-1cm-1, respectively (Figure 3.6).15 These
intensities are in agreement with data for similar high-spin Fe(II) complexes.
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Figure 3.6. UV-vis spectrum for the enantioenriched [Fe(R,R-Bn-CDPy3)Cl]Cl complex
Circular dichroism (CD) analysis of the enantioenriched [Fe(R,R-Bn-CDPy3)Cl]Cl
complex showed a negative maximum at 508 nm with no exciton coupling (Figure 3.7).15

Figure 3.7. CD spectrum for the enantioenriched [Fe(R,R-Bn-CDPy3)Cl]Cl complex
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3.2.4.3. Paramagnetic

1

H NMR and Magnetic Susceptibility of [Fe(R,R-Bn-

CDPy3)Cl]Cl
The [Fe(Bn-CDPy3)Cl]Cl complex was subjected to 1H NMR spectroscopic analysis.
The data showed a paramagnetically shifted and relatively sharp

1

H NMR with

resonances that ranged from -25 to 160 ppm. This paramagnetic 1H NMR suggested that
the [Fe(Bn-CDPy3)Cl]Cl complex is a high-spin Fe(II) complex (S = 2). In order to
confirm this high-spin nature, molar susceptibility of 4.9 µB was measured for the solid
[Fe(Bn-CDPy3)Cl]Cl complex which agrees with an S = 2 Fe(II) complex.15,143
Interestingly, the paramagnetic 1H NMR shared a distinct pattern with the [Co(BnCDPy3)Cl]Cl2 diamagnetic 1H NMR.15,16 In the 1H NMR of the two complexes, two
resonances corresponding to the protons located at the 2-position of the pyridine rings are
shifted downfield (9.70, 9,04 ppm in the 1H NMR of [Co(Bn-CDPy3)Cl]Cl2 and 160, 141
ppm in the 1H NMR of [Fe(Bn-CDPy3)Cl]Cl while the third 2-pyridine C-H resonance is
shifted upfield (7.34 ppm in the 1H NMR of [Co(Bn-CDPy3)Cl]Cl2 and 89 ppm in the 1H
NMR of [Fe(Bn-CDPy3)Cl]Cl). This similar pattern is important as it suggests that the
[Co(Bn-CDPy3)Cl]Cl2 and [Fe(Bn-CDPy3)Cl]Cl have the same conformation in
solution. This assignment is also in accord with calculations from Schlegel’s lab and with
literature precedence.101
3.2.4.4. UV-vis and CD spectroscopy of [Co(R,R-Bn-CDPy3)Cl]Cl2
The enantioenriched [Co(R,R-Bn-CDPy3)Cl]Cl2 complex was used for UV-vis and
CD studies. The enantioenriched [Co(R,R-Bn-CDPy3)Cl]Cl2 complex (16) formed a
purple solution in MeOH that showed an absorbance in the UV-vis absorption spectrum
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with λmax at 555 nm and є = 159 M-1cm-1 which is identical to the UV-vis spectrum
obtained for the racemic [Co(Bn-CDPy3)Cl]Cl2 complex15,16 (Figure 3.8).

Figure 3.8. UV-vis spectrum for the enantioenriched [Co(R,R-Bn-CDPy3)Cl]Cl2
complex15
Circular dichroism (CD) spectrum of the enantioenriched [Co(R,R-Bn-CDPy3)Cl]Cl2
complex showed a positive maximum at 415 nm and a bisignate couplet centered at the
maximum absorbance (555 nm) which is characteristic of a negative Cotton effect with
excition coupling (Figure 3.9).15
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Figure 3.9. CD spectrum for the enantioenriched [Co(R,R-Bn-CDPy3)Cl]Cl2 complex15
3.2.4.5. 1-D and 2-D Spectroscopic Study of [Zn(R,R-Bn-CDPy3)Cl]2(ZnCl4)
The complex [Zn(R,R-Bn-CDPy3)Cl]2(ZnCl4) was obtained as colorless solid which
was not suitable for X-ray crystallography. In order to characterize the structure of the
[Zn(R,R-Bn-CDPy3)Cl]2(ZnCl4) complex, a series of 1-D and 2-D NMR experiments,
IR, ESMS and elemental analysis were performed.
The 1H NMR spectrum showed two resonances that correspond to the protons located
at the 2-position of the pyridine rings shifted downfield (9.24 and 8.84 ppm) while the
third 2-pyridine C-H resonance shifted upfield (7.72 ppm). The same pattern was
observed in the [Co(Bn-CDPy3)Cl]Cl and [Fe(Bn-CDPy3)Cl]Cl complexes consistent
with the three metal complexes adopting the same conformation in solution (Figure
3.10).15
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Figure 3.10. Similar pattern (indicated by red arrows) observed in 1H NMR of the (a)cobalt, (b)-zinc and (c)-iron complexes15
The 1H NMR of the zinc complex showed three regions based on chemical shifts
(Figure 3.11), the upfield region (0.80-2.25 ppm, assigned to the cyclohexane protons),
the midfield region (3.20-5.00 ppm, assigned to benzylic and picolinic protons) and the
downfield region (7.30-9.30 ppm, assigned to the aromatic protons on pyridine and
benzene rings).
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Figure 3.11. 1H NMR of the [Zn(R,R-Bn-CDPy3)Cl]2(ZnCl4) complex
The 13C DEPT experiment (distortion enhancement by polarization transfer) showed 2
C-H peaks in the aliphatic range at 62 and 68 ppm. These C-H peaks were assigned as the
diaminocyclohexane methine carbons (Figure 3.12).15
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Figure 3.12. 13C DEPT spectrum for the [Zn(R,R-Bn-CDPy3)Cl]2(ZnCl4) complex15
In order to identify the structure of the zinc complex, 2-D NMR studies were carried
out. The first 2-D NMR experiment was COSY (correlation spectroscopy) which showed
the 1H-1H correlations in the zinc complex. The COSY indicated 4 strong correlations
between 8 protons (1 correlation between each two protons, Figure 3.13) in the
cyclohexane area. From these correlations we assigned the 4 methylene groups of the
cyclohexane as (2A, 2B, 3A, 3B, 4A, 4B, 5A and 5B).
The proton assigned as 1 (located at 1.91 ppm) didn’t show any correlation in the
cyclohexane area and was suggested to be one of the two methine protons of the
cyclohexanediamine. Integration of the protons in the upfield region (0.80-2.25 ppm) was
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equal to nine suggesting that the last C-H proton might exist in the midfield region. This
suggestion was supported by the presence of one of the methine proton at 3.2 ppm in the
1

H NMR of the cobalt complex.16 A closer look at the 1H NMR of the zinc complex

showed that a peak integrated as 1 proton was hidden below the CH3OH peak at 3.3 ppm
(1H NMR is in the CD3OD and has traces of CH3OH). This proton also didn’t show any
correlation with protons in the upfield region (cyclohexane) or in the midfield region
(benzylic and methylene protons attached to pyridine). All these observations suggest that
the second methine proton (assigned as 6) is located at 3.25 ppm. Thus, the methine
proton assigned as 1 is shifted upfield (1.91) while the methine proton assigned as 6 is
located at 3.25 ppm The difference in chemical shift observed with the two methine
protons (1 and 6) is emerging from their different chemical environments. Because, the
methine proton assigned as 1 is present in close proximity to one of the pyridine rings,
this pyridine ring caused shielding of this proton while the other methine proton (6) is not
shielded by pyridine rings.
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Figure 3.13. COSY correlations in the upfield region15
The COSY also showed 4 strong correlations between 8 protons in the midfield region
(1 correlation between each two protons, Figure 3.14). Based on the structure of BnCDPy3 and chemical shifts, these correlations suggested that these protons correspond to
three methylene protons attached to three pyridine rings (picolinic) and one benzylic
methylene protons. These protons were assigned as 4 sets (7a, 7b, 13a, 13b, 19a, 19b, 25a
and 25b).
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Figure 3.14. COSY correlations in the midfield region15
In the downfield region (7.30-9.30 ppm, assigned to aromatic protons), COSY showed
several strong correlations. Despite the overlap of protons in some parts of the upfield
region, 3 sets of aromatic protons were detected based on correlations. The first set
includes protons assigned as 15, 16, 17 and 18. In this set, H18 (9.2 ppm, furthest
downfield) which was assigned as a proton at the 2-position of the pyridine ring based on
literature151 correlates with H17 that correlates with H16 which in turn correlates with
H15. The second set includes protons assigned as 12 (8.8 ppm, assigned as proton at 2pyridine position), 11, 10 and 9. In this second set H12 correlates with H11 that correlates
with H10 which in turn correlates with H9. The third set has H24 (7.72 ppm assigned as
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proton at 2-pyridine position) that correlates with H23 which correlates with H22 that
was in correlation with H21. These 3 sets of aromatic protons (4 protons each set) were
assigned as the 12 pyridyl hydrogens on the pyridine rings of the zinc complex of BnCDPy3. Based on integration, the 5 phenyl protons were assigned as H27 and H31 that
overlap with H9 forming a multiplet 7.49 ppm and H28, H29 and H30 that overlap with
H11, H15, H17 and H23; forming a multiplet at 7.37 ppm (Figure 3.15).15

Figure 3.15. COSY correlations in the downfield region15
The COSY study allowed us to assign the connections between protons in each region
but the connectivity between these regions remains unknown. For example from COSY
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we suggested that we have 4 methylene in the midfield region (picolinic and benzylic
protons) and 3 sets of pyridine protons and 2 sets of phenyl protons but we can not
suggest which CH2 in the midfield region is connected to the pyridine set having H9-H12
protons and which CH2 is benzylic. In order to answer the connectivity question and
characterize the structure of the Bn-CDPy3 zinc complex and compare it to the calculated
zinc models from Schlegel’s lab, HMQC and NOESY experiments were performed with
the help of Dr. Bashar Ksebati.
The HMQC (heteronuclear multiple quantum correlation) experiment was required to
identify the 2 methine protons of the diaminocyclohexane moiety. The 13C DEPT showed
2 C-H at 62 ppm and 68 ppm, thus protons that will correlate with these carbons in
HMQC will be the 2 methine protons of the diaminocyclohexane moiety. The HMQC
showed correlation between H1 (1.91 ppm) and the carbon at 68 ppm while H6 (3.28
ppm) correlates with the carbon at 62 ppm which supported the COSY data that
suggested that the methine protons are located at 3.28 ppm and 1.91 ppm (Figure 3.16).15
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Figure 3.16. HMQC experiment for [Zn(R,R-Bn-CDPy3)Cl]2(ZnCl4)15
The NOESY (nuclear overhauser effect spectroscopy) experiment was required to
reveal the 1H-1H interactions through-space. The NOESY spectrum is expected to show
strong cross-peaks between each methylene group in the midfield region to the pyridine
or phenyl group directly attached to it. The NOESY experiment was also required to see
whether the experimental structure will agree with the calculated zinc model for isomer C
by looking for the expected NOESY peaks from calculated zinc models and compare it to
the experimental NOESY.
The NOESY experiment showed a strong cross-peak between H21 (located in the
pyridine ring bearing H22, H23 and the 2-pyridyl proton H24) and 19A suggesting that
the methylene group assigned as 19 is connected to the pyridine bearing H21-H24
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aromatic protons. Similarly, the methylene group labeled as 13 was suggested to be
connected to pyridine bearing H15-H18 while the methylene group labeled as 7 was
suggested to be connected to pyridine bearing H9-H12 and the methylene group labeled
as 25 was suggested to be connected to the phenyl group. More importantly, the NOESY
data agreed with the expected NOESY peaks from calculated zinc models (Figure 3.17).
For example, the calculated isomer C for Bn-CDPy3 zinc complex suggests that the
methylene protons assigned as H13B and H25A are located close to the 2 axial
cyclohexane H6 and H2B protons thus strong peaks are expected between H6 and H13B,
H2B and H13B, H25A and H6. The experimental NOESY showed all these cross peaks
in addition to other peaks such as the cross-peaks between H1-H7A, and H5A-H19A
supporting that the zinc Bn-CDPy3 complex adopts the geometry of isomer C.

108

Figure 3.17. Examples of NOESY cross-peaks (highlighted in yellow and red circles) in
accord with calculations15
These experimental data agreed well with the calculations from our collaborators in
Schlegel lab that the zinc(II) complex of Bn-CDPy3 favors isomer C over the other
possible coordination geometries (Table 3.1).15
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Table 3.3. Relative energies of the five isomers of the cation [Zn(Bn-CDPy3)Cl]+ in
kcal/mol15
Relative Energies kcal/mol

Zn(II) complex Isomers

0

C

2.49

A

7.76

B

12.44

D

12.44

E

3.2.4.6. Overlap Study between Enantiomer of Isomer A and Isomer C
The experimental data of the [Zn(R,R-Bn-CDPy3)Cl]2ZnCl4 were in agreement that
the zinc complex favors isomer C. This isomer C stability for the zinc complex was also
observed with the [Fe(Bn-CDPy3)Cl]Cl and [Fe(Bn-CDPy3)Cl]ClO4 as well as in the
[Co(Bn-CDPy3)Cl]Cl2. The stability of isomer C over isomer A was not understood as
both isomers shared a mer geometry of the three pyridyl N-donors with two coplanar and
one perpendicular to the M-X axis and the X group trans to N(1). These geometrical
properties explained the stability of A and C over B, D and E isomers15,16 but the question
that emerged is what favors isomer C over isomer A. In order to answer this question, an
overlap study between isomer C and the enantiomer of isomer A (ent-A, to obtain same
stereochemistry as isomer C) was carried out with the help of Dr. Kodanko.15 This study
used the [Co(Bn-CDPy3)Cl]Cl2 complex as model for the zinc and iron complexes. The
stability of C over A was explained by the rotation of 2-pyridyl methylene group by 16o
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and bending of 18o relative to the Co-N-N-N plane to avoid a nonbonding interaction
with axial hydrogen of the cyclohexane (Figure 3.18).15

Figure 3.18. Destabilizing interactions in isomer ent-A and overlap between ent-A and C
isomers15
The resulting rotation causes lengthening of the bond between pyridine and the metal
center by 0.018 Å which generates ligand–metal binding and ligand strain that
destabilizes isomer A relative to isomer C.15 The same destabilizing interactions of
isomer A were found in the zinc and iron complexes.
3.3. Discussion of Results
The syntheses of the 1,3-diaminopropane and pyrazine Bn-TPEN derivatives provided
new Bn-TPEN analogues that can be used by our lab to synthesize their corresponding
iron complexes and generate ferryl species. Preliminary data demonstrated the generation
of ferryl species from the metal complexes of these Bn-TPEN derivatives but more
purification is required to obtain the metal complexes of these ligands in pure form that
match with the expected elemental analysis. This purification can be achieved by our
group by using different solvent mixtures for recrystallization of these iron(II) complexes
and the design of different synthetic routes that produce these complex in pure form. The
synthesis and characterization of Bn-CDPy3 and its metal complexes enabled us to
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understand the coordination chemistry of Bn-CDPy3 and its metal complexes. X-ray
crystallographic analysis of [Fe(Bn-CDPy3)Cl]ClO4 indicated that the [Fe(BnCDPy3)Cl]ClO4 favors isomer C. This observed stability of isomer C over the other 4
possible coordination geometries (A, B, D and E) was previously observed in the
[Co(Bn-CDPy3)Cl]Cl2 crystal structure.16 In addition, the similar pattern in the 1H NMR
of the zinc, iron and cobalt Bn-CDPy3 complexes suggested that the three metal
complexes have similar conformation in solution. This suggestion was supported by
calculations from our collaborators in Schlegel’s lab and confirmed by the 2-D NMR
spectroscopic analysis of the [Zn(R,R-Bn-CDPy3)Cl]2ZnCl4 complex that proved that the
zinc complex adopts the geometry of isomer C.15
The stability of isomer C over other isomers was attributed to steric and electronic
factors. These factors were understood from the X-ray crystallographic analysis of the
iron(II) complex [Fe(Bn-CDPy3)Cl]ClO4 and the Co(III) complex [Co(R,R-BnCDPy3)Cl]Cl2. In addition, we observed that the factors that stabilized the metal
complexes of Bn-CDPy3 ligand were found to be the same factors that stabilized the
metal complexes of Bn-TPEN having the general formula of [Fe(II)(Bn-TPEN)X] where
X= Br, Cl.144 This observation was expected due to the structure similarity between BnCDPy3 and Bn-TPEN ligands. These factors are having the X group trans to the basic
amine donor (N1) and having two pyridine rings adopting a coplanar conformation with
respect to the Fe-X bond, while the third pyridine ring is perpendicular to that axis.15
Based on these factors, isomers B, D and E would not be expected to be as stable as
isomers A and C because these three isomers do not have their X group trans to the basic
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amine donor (N1).15 The two isomers A and C have the X group trans to the basic amine
donor (N1) and two pyridine rings adopting a coplanar conformation with respect to the
Fe-X bond, while the third pyridine ring is perpendicular to that axis.15 In order to
understand why isomer C is favored over A, an overlap study between isomer C and entA (enantiomer of isomer A) was performed with the help of Dr. Kodanko. This study
indicated that the stability of isomer C over isomer A may be attributed to the rotation of
2-pyridyl methylene group by 16o and bending of 18o relative to the Co-N-N-N plane to
avoid a nonbonding interaction with axial hydrogen of the cyclohexane. This rotation
caused ligand–metal binding and ligand strain that destabilized isomer A and favored
isomer C.15
3.4. Conclusion
The synthesis of Bn-TPEN analogues such as the diaminopropane derivatives and
pyrazine derivatives is significant as these new ligands will be investigated by my
colleagues in Kodanko group to generate more stable and more reactive ferryl species
and other reactive metal-based oxidants. The synthesis and characterization of the BnCDPy3 and its metal complexes were accomplished and the coordination environment of
the Bn-CDPy3 and its metal complexes was investigated. Experimental characterization
techniques such as X-ray crystallography and NMR spectroscopy agreed with the
theoretical calculations from Schlegel’s lab that a single coordination geometry (isomer
C) is favored over the other 4 possible coordination geometries.15 The importance of this
study lies in the ability to identify the most stable isomer in metal complexes of chiral
ligands using different experimental techniques and comparing the resulting data with
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calculated models. This methodology links the theory that explains why certain isomers
are more stable than others to the experimental observations leading to the design of
chiral ligands and metal complexes that favor one single isomer. In addition, the ability to
predict and control the coordination geometry can dictate the asymmetric environment
around the metal center which can affect the enantioslectivity during catalysis. Chiral
ligands like Bn-CDPy3 and their corresponding metal complexes are ideal for
enantioselective catalysis as the structure of the metal complexes is identified which will
help in product characterization and mechanistic studies. Furthermore, knowing that the
chiral Bn-CDPy3 and its metal complexes including iron are favoring one single isomer
is promising as the generation of ferryl species from these chiral ligands and their
analogues might be used in enantioselective oxidation reactions.
3.5. Experimental15
3.5.1. General Considerations
All reagents were purchased from commercial suppliers and used as received. NMR
spectra were recorded on a Varian FT-NMR Unity-300, Mercury-400, or Oxford-500
MHz spectrometer. Mass spectra were recorded on a Waters ZQ2000 single quadrupole
mass spectrometer using an electrospray ionization source. IR spectra were recorded on a
Nicolet FT-IR spectrophotometer. UV-vis spectra were recorded on a Varian Cary 50
spectrophotometer. CD spectral data were recorded on a Chirascan Circular Dichroism
Spectrophotometer. Reactions were performed under ambient atmosphere. Oxygen and
moisture sensitive reaction are performed inside an MBraun Labmaster 130 glove box.
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X-ray crystallographic data were collected on a Bruker P4/CCD diffractometer.
Molecular modeling studies were performed with the program MacPyMol.
3.5.2. Experimental Procedures and Tabulated Characterization Data for New
Compounds

N1-propyl-N1,N3,N3-tris(pyridin-2-ylmethyl)propane-1,3-diamine.
N1,N1,N3-tris(pyridin-2-ylmethyl)propane-1,3-diamine (540 mg, 1.60 mmol) was
dissolved in acetonitrile (25 ml). Propyl iodide (167 µl, 1.76 mmol), was added to the
solution under nitrogen atmosphere, followed by diisopropyl ethyl amine (0.51 ml, 3.20
mmol). The reaction was stirred under nitrogen atmosphere overnight. The residue was
evaporated, dissolved in 40 ml of 1N NaOH and extracted with dichloromethane (4x60
ml). The organic layer was dry filtered over sodium sulfate. The crude product was
purified using alumina column chromatography using 100 % chloroform as eluting
system yielding 363 mg of yellow oil of Pr-TPPN. 1H NMR (CDCl3): δ 8.38 (m, 3H),
7.46 (m, 3H), 7.34 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 7.3 Hz, 1H), 7.00 (m, 3H), 3.66 (s,
4H), 3.54 (s, 2H), 2.44 (m, 2H), 2.35 (m, 2H), 2.24 (m, 2H), 1.60 (m, 2H), 1.30 (m, 2H)
0.67 (m, 3H).

13

C NMR (CD3OD): δ 161.9, 160.1, 149.0, 148.9, 136.5, 136.4, 123.0,

122.9, 121.8, 60.7, 60.6, 56.5, 52.8, 52.5, 24.9, 20.4, 12.0. IR (thin film): 3062, 3008,
2956, 2932, 2870, 2811, 1589, 1569, 1472, 1433, 1362, 1307, 1248, 1180, 1148, 1125,

115

1090, 1047, 994, 978, 892, 840, 757, 729, 635, 613 cm-1. LRMS (ESMS) calc’d for
C24H32N5 (M+H)+: 390, found: 390.

N1-ethyl-N, N, N3-tris(pyridin-2-ylmethyl)propane-1,3-diamine.
N1,N1,N3-tris(pyridin-2-ylmethyl)propane-1,3-diamine (100 mg, 0.29 mmol) was
dissolved in acetonitrile (5 ml). Ethyl iodide (35 µl, 0.43 mmol), was added to the
solution under nitrogen, followed by diisopropyl ethyl amine (0.1 ml, 0.56 mmol). The
reaction was stirred under nitrogen atmosphere overnight. The residue was evaporated,
dissolved in 8 ml of 1N NaOH and extracted with dichloromethane (3x30 ml). The
organic layer was dry filtered over sodium sulfate yielding 67 mg of yellow oil of EtTPPN. 1H NMR (CDCl3): δ 8.41 (m, 3H), 7.50 (m, 3H), 7.39 (d, J = 8.0 Hz, 2H), 7.26 (d,
J = 7.3 Hz, 1H), 7.02 (m, 3H), 3.70 (s, 4H), 3.59 (s, 2H), 2.50 (m, 2H), 2.41 (m, 4H),
1.65 (m, 2H), 0.90 (m, 3H).

13

C NMR (CDCl3): δ 160.4, 159.7, 148.7, 148.6, 136.1,

136.0, 122.6, 122.5, 121.6, 121.4, 60.3, 59.9, 59.7, 52.4, 51.4, 47.7, 24.4, 11.6. IR (thin
film): 3060, 3026, 3007, 2928, 2811, 1666, 1589, 1569, 1493, 1473, 1453, 1433, 1363,
1310, 1246, 1147, 1127, 1090, 1075, 1028, 994, 979, 760, 699, 614 cm-1. LRMS (ESMS)
calc’d for C23H30N5 (M+H)+: 376, found: 376.
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N
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N

Bn-TPZEN
Chemical Formula: C24H26N8
Molecular Weight: 426.52

N1-benzyl-N1,N2,N2-tris(pyrazin-2-ylmethyl)ethane-1,2-diamine

(Bn-TPZEN).

Potassium iodide (2.90 mmol, 0.48 g) and potassium carbonate (2.90 mmol, 0.40 g) were
added to a solution of N-benzyl ethylenediamine (0.11 ml, 0.72 mmol) in 15 ml of dry
MeCN. The mixture was refluxed for 16 h under nitrogen atmosphere. The solvent was
evaporated in vacuo and the yellow oil obtained was purified by an alumina column
chromatography with 95:5 EtOAc:MeOH eluent. The product was obtained as yellow oil
(68%, 0.21 g). 1H NMR (CDCl3): δ 8.64 (s, 1H), 8.59 (s, 2H), 8.40 (m, 6H), 7.22 (m,
5H), 3.81 (s, 4H), 3.73 (s, 2H), 3.58 (s, 2H), 2.74 (m, 4H);
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C NMR (CDCl3): δ 155.7,

154.7, 145.4, 144.0, 143.8, 143.4, 143.2, 138.7, 129.0, 128.6, 127.5, 59.5, 58.4, 52.4,
52.1; IR (thin film): 3056, 2925, 2821, 1577, 1527, 1494, 1473, 1452, 1401, 1368, 1305,
1233, 1154, 1100, 1075, 1056, 1018, 978, 831, 740, 700 cm-1 LRMS (ESMS) calc’d for
C24H27N8 (M+H)+: 427, found: 427.
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(R,R)-N1-benzyl-N,N,N2-tris(pyridin-2-ylmethyl)cyclohexane-1,2-diamine

(Bn-

CDPy3, 15). Enantioenriched 15 was synthesized according to reported procedure
starting from the enantioenriched starting material (1R,2R)-(-)-1,2-cyclohexanediamine
(99% ee).16 1H, 13C NMR and mass spectral data for enantioenriched 15 matched data for
the racemic compound. [α]D = 51.1° (c = 1.0, MeOH).15
[Fe(Bn-CDPy3)Cl]Cl (17). A solution of the enantioenriched ligand (R,R)-Bn-CDPy3
(0.20 g, 0.42 mmol) in CH2Cl2(12 ml) was stirred with FeCl2 (0.05 g, 0.42 mmol) inside
the glove box for 4 hours to give a yellow solution. The solution was filtered and
concentrated under high vacuo inside the glove box. The resultant golden yellow solid
was recrystallized by vapor diffusion from MeCN/Et2O inside the glove box yielding
yellow needle crystals of 17•3H2O (0.16 g, 63%). mp = 155-156 °C; χmol = 4.90 µB;
paramagnetic 1H NMR (CD3OD): 160.2, 140.5, 108.4, 99.1, 96.4, 89.1, 57.4, 56.6, 52.4,
49.5, 41.6, 40.0, 26.1, 24.4, 19.2, 15.4, 11.5, 9.4, 7.5, 4.5, 3.0, 2.5, 1.9, 1.7, 1.3, -0.8, -7.4,
-21.3, -24.5. IR (thin film): 3411, 3060, 3027, 2933, 2860, 2359, 1602, 1570, 1482, 1443,
1384, 1352, 1316, 1296, 1245, 1204, 1155, 1099, 1077, 1052, 1016, 978, 960, 931, 884,
816, 758, 708 cm-1 Anal.Calcd for C31H41Cl2FeN5O3 (17•3H2O): C, 56.55; H, 6.28; N,
10.64. Found: C, 56.44; H, 5.89; N, 10.67.15
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[Fe(Bn-CDPy3)Cl]ClO4 (18). The complex [Fe(Bn-CDPy3)Cl]ClO4 (18) was obtained
by ion exchange of [Fe(Bn-CDPy3)Cl]Cl (17) and AgClO4. A stock solution of AgClO4
(0.04 g, 0.18 mmol) in MeCN (2.5 ml) was prepared in the glove box. The complex
[Fe(Bn-CDPy3)Cl]Cl (17) (0.02 g, 0.035 mmol) was dissolved in MeCN (0.5 ml) and
mixed with 0.5 ml of the prepared AgClO4 solution and stirred for 5 minutes resulting in
formation of a white precipitate of AgCl. The precipitate was removed by filtration and
[Fe(Bn-CDPy3)Cl]ClO4 crystallized by vapor diffusion with 3 ml of Et2O yielding
yellow crystals of 18•H2O

(10 mg, 34%). These crystals were subjected to X-ray

crystallographic analysis. mp = 146-148 °C; IR (thin film): 3409, 3065, 2936, 2860,
1657, 1604, 1482, 1444, 1142, 1109, 1090, 1017, 763, 708, 661, 625 cm-1 Anal.Calcd for
C31H37Cl2FeN5O5 (18•H2O): C, 54.24; H, 5.43; N, 10.20. Found: C, 54.20; H, 5.35; N,
10.34.15
[Zn(Bn-CDPy3)Cl]2(ZnCl4) (19). The ligand (R,R)-Bn-CDPy3 (0.20 g, 0.42 mmol)
was dissolved in THF (5 ml) and stirred with ZnCl2 (0.09 g, 0.63 mmol) inside the glove
box overnight. An immediate white precipitate was formed that disappeared upon
stirring. The solution was concentrated under high vacuo in glove box. The resultant
colorless solid was stirred with ether overnight in the glove box. The suspension was
filtered and the colorless solid was dried under vacuo then outside the glove box in a
shlenk tube at 120 oC overnight to remove any traces of THF solvent yielding a colorless
solid in (0.27 g, 47%). mp = 190 °C decomposition; 1H NMR (CD3OD): δ 9.24 (d, J =
4.9 Hz, 1H), 8.84 (d, J = 4.9 Hz, 1H), 8.02 (m, 1H), 7.93 (m, 1H), 7.80 (m, 1H), 7.72 (d,
J = 4.9 Hz, 1H), 7.59 (d, J = 8.1 Hz, 1H), 7.49 (m, 3H), 7.37 (m, 7H), 4.82 (d, J = 17.8
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Hz, 1H), 4.70 (d, J = 15.4 Hz, 1H), 4.58 (d, J = 13.8 Hz, 1H), 4.37 (d, J = 16.2 Hz, 1H),
4.20 (d, J = 15.4 Hz, 1H), 3.94 (d, J = 17.0 Hz, 2H), 3.47 (d, J = 13.8 Hz, 1H), 3.28 (m,
1H), 2.04 (d, J = 13.0 Hz, 1H), 1.91 (dt, J = 11.4, 3.2 Hz, 1H), 1.69 (d, J = 17.0 Hz, 1H),
1.60 (dt, J = 12.2, 3.2 Hz, 1H), 1.45 (d, J = 12.2 Hz, 1H), 1.19 (m, 2H), 0.98 (m, 1H),
0.87 (m, 1H).
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C NMR (CD3OD): δ 155.8, 155.7, 154.5, 148.1, 147.8, 145.9, 140.6,

140.4, 139.7, 134.6, 130.7, 128.6, 125.3, 124.6, 124.5, 123.9, 123.6, 123.5, 68.8, 64.0,
62.8, 62.5, 54.5, 53.7, 29.2, 26.1, 24.6, 24.5; IR (thin film): 3466, 3061, 2938, 2861,
2281, 1604, 1574, 1484, 1443, 1384, 1315, 1295, 1204, 1156, 1101, 1084, 1053, 1019,
978, 934, 885, 853, 763, 708 cm-1; Anal.Calcd for C63H72Cl6N10OZn3 (19•H2O): C,
53.87; H, 5.25; N, 10.13; Found: C, 53.81; H, 5.08; N, 9.91.152 LRMS (ESMS): 576.2
(ZnBn-CDPy3Cl).15
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CHAPTER 4
CONCLUSION
4.1. Goals Accomplishment and Suggestions
4.1.1. To Investigate the Reactivity of the N4Py Ferryl Species with Amino Acid
Model Substrates
The order of reactivity of the twenty natural amino acid substrates with the N4Py
ferryl species was established by our group.14 In addition, mechanistic investigations of
the five significantly reactive substrates (cysteine, tyrosine, tryptophan, methionine and
glycine) were performed.14 In these mechanistic studies, second-order rate constants and
kinetic isotope effects were measured; product isolation and characterization were carried
out in order to understand mechanisms of reaction of these significantly reactive
substrates with N4Py ferryl species. I contributed to this study by measuring the
reactivity of aspartic acid, glutamic acid, histidine, valine, alanine and lysine•HCl amino
acid substrates with N4Py ferryl species. In addition, besides measuring the second-order
rate constant for the glycine substrate, my work also focused on mechanistic
investigations of the methionine and tryptophan substrates. Based on the magnitude of
the KIE obtained for the tryptophan substrate (5.2) we proposed an ET-PT mechanism for
the oxidation of tryptophan with N4Py ferryl. For the methionine substrate we suggested
an oxygen-atom transfer mechanism based on the sulfoxide derivative product that was
isolated and characterized, in addition to the lack of KIE.14
The study of the reactivity of the twenty natural amino acid substrates (these substrates
mimic the structure of amino acid residues in polypeptide chains) with the N4Py ferryl
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species that I performed with my colleagues in the Kodanko group built fundamental
knowledge on how the N4Py ferryl species reacts with amino acid residues. This was
done by establishing the order of reactivity of substrates and proposing mechanisms for
their oxidation. Thus, the investigation of the reactivity of the N4Py ferryl species with
amino acid model substrates was successfully performed building a preliminary study of
the reactivity of amino acid substrates with N4Py ferryl species that may prove to be
useful for the fields of protein oxidation and enzyme inhibition.
4.1.2. To Compare the Reactivity of Amino Acid Model Substrates with N4Py Ferryl
Species to their Reactivity with other Ferryl Species
After the kinetic and mechanistic investigation of the reaction of the twenty natural
amino acid substrates with the N4Py ferryl species, it was necessary to know whether
other ferryl species would react in the same manner. In order to answer this question, I
measured the rate of reaction of the five significantly reactive substrates (cysteine,
tyrosine, tryptophan, methionine and glycine) with Me-N4Py, Bn-TPEN and TMC ferryl
species and compared them to the rates obtained for these substrates with N4Py ferryl
species. In addition, I compared the rates of reactivity of the cysteine, tyrosine,
tryptophan and methionine substrates to the rate of reactivity of the glycine substrate in
order to determine relative rates (krel).

Furthermore, I carried out mechanistic

investigations of the reaction of these five substrates with Me-N4Py, Bn-TPEN and TMC
ferryl species. These mechanistic studies were performed by measuring the second-order
rate constants for the five significantly reactive substrates with Me-N4Py, Bn-TPEN and
TMC ferryl species and studying the oxidation products of these reactions.
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Important conclusions were deduced based on the results of these kinetic and
mechanistic studies. The first conclusion is that the order of reactivity of the five amino
acid substrates is the same with the N4Py, Me-N4Py, Bn-TPEN and TMC ferryl species
(cysteine > tyrosine > tryptophan > methionine > glycine substrates). Secondly, the BnTPEN ferryl is the most reactive followed by N4Py and Me-N4Py which are more
reactive than TMC ferryl species. The fact that the relative rates of these substrates
change from one ferryl species to another lead to the third conclusion, which was that
modifying the structure of the ligand changes the reactivity of its corresponding ferryl
species with the amino acid substrates, thus steric factors are playing an important role in
controlling these reactions.
These conclusions are important as they indicate that by changing the ligand structure
we can obtain a ferryl species that is more reactive (Bn-TPEN), more stable (Me-N4Py),
or more selective (TMC) than N4Py ferryl species. Thus, ligand design projects may lead
to the synthesis of new ferryl species with better oxidation properties. By providing all
the above data and conclusions the goal of comparing the reactivity of amino acid model
substrates with N4Py ferryl species to their reactivity with other ferryl species was
successfully accomplished.
4.1.3. To Design and Synthesize New Bn-TPEN Derivatives
The Et-TPPN and Pr-TPPN ligands which are 1,3-diaminopropane derivatives of the
Bn-TPEN ligands were synthesized and obtained in moderate yields. The purpose of
substituting the ethylenediamine moiety by the 1,3-diaminopropane is to understand the
effect of this change on the ability of the ligand to generate and stabilize ferryl species.
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The synthesis of ethyl and propyl derivatives was achieved to investigate if this change
will affect the stability of Bn-TPEN ferryl. These 1,3-diaminopropane ligands will be
tested by our group for their ability to generate ferryl species, and from the results of this
study, a better idea about the structural features that stabilize the ferryl species generated
from Bn-TPEN derivatives will be established. The ligand Bn-TPZEN, which is a
pyrazine analogue of Bn-TPEN, was synthesized in moderate yield. The purpose of
incorporating pyrazine rings in place of pyridine rings in the Bn-TPEN structure was to
understand how this change will affect the binding constant of this ligand and its ability
to generate ferryl species.
The preliminary results showed the generation of ferryl species from these new BnTPEN derivatives, but these preliminary data can not be published until the iron(II)
complexes of these ligands that were used to generate these ferryl species are pure and
match with the expected elemental analysis. However, the synthesis and the design of the
new Bn-TPEN derivatives (Et-TPPN, Pr-TPPN and Bn-TPZEN was successfully
accomplished and preliminary data indicated that the generation of their corresponding
ferryl species was successful. In the future, different crystallization methods can be used
in order to form the pure iron complexes, which will be used to generate ferryl species
and determine their stabilities and reactivity. In case these ligands do not generate the
ferryl species, I suggest testing them for HeLa cells cytotoxicity, which is a study
performed by Casey Jackson (Kodanko lab) to test the cytotoxic effects of nitrogen-rich
tetra- and pentadentate ligands on HeLa cells.153
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4.1.4. To Synthesize and Characterize the Chiral Bn-CDPy3 and its Metal
Complexes, Study their Coordination Environment and Determine the Most Stable
Isomer
The synthesis of the chiral Bn-CDPy3 and its zinc and iron complexes was achieved in
both racemic and enantioenriched forms in addition to the synthesis of the
enantioenriched cobalt complex of Bn-CDPy3.15 Several experimental techniques were
used to characterize the Bn-CDPy3 metal complexes including X-ray crystallography,
UV-vis and CD spectroscopy, 1HNMR,
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CNMR, DEPT, IR, ESMS, elemental analysis

in addition to the COSY, NOESY and HMQC 2-D NMR experiments used for the
characterization of the Bn-CDPy3 zinc complex. All these experiments indicated that the
two iron complexes [Fe(Bn-CDPy3)Cl]Cl and [Fe(Bn-CDPy3)Cl]ClO4, the zinc complex
[Zn(R,R-Bn-CDPy3)Cl]2(ZnCl4) and the cobalt complex [Co(Bn-CDPy3)Cl]Cl2 have the
isomer C as the major isomer. The results agreed with calculations from the Schlegel lab.
The stability of this isomer was attributed to a combination of steric and electronic
factors.15
The study of the chiral Bn-CDPy and its metal complexes proved that a single
coordination geometry (isomer C) is favored over the four other possible isomers (A, B,
D and E). This result was very important, because chiral ligands like Bn-CDPy3 that had
one thermodynamically stable isomer in solution would be better for the control of the
asymmetric environment around the metal center, thus high enantioselectivity could be
obtained with catalysts derived from these complexes. Furthermore, the Bn-TPEN ferryl
species have similar structure to the iron(II) chloride complex of Bn-TPEN.101 By
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analogy, the Bn-CDPy3 ferryl species may have isomer C as the most stable isomer like
the iron(II) complex of Bn-CDPy3, which will be useful because identification of the
structure of the Bn-CDPy3 ferryl species will facilitate proposing mechanisms for the
reactions of the ferryl species with substrates. In addition, having one thermodynamically
stable isomer will support the goal of using this ferryl species to mediate enantioselective
oxidations of amino acids and peptides. In conclusion, the goal of the synthesis and
characterization of the chiral Bn-CDPy3 and its metal complexes, and studying their
coordination environment and determination of the most stable isomer was accomplished
by providing a full description of the coordination environment of the Bn-CDPy3 Zn(II),
Fe(II) and Co(II) racemic and enantioenriched complexes.
4.2. Conclusion and Future Directions
The studies described in this dissertation were aimed at exploring the reactivity of
ferryl species with amino acids, which is a new area that was not investigated before. We
established fundamental knowledge on the reactivity of ferryl species with amino acid
substrates. This preliminary study will be important for scientists that plan to use ironbased oxidants for protein oxidation and enzyme inhibition. From these studies we
concluded that ferryl species are more selective than the ROS in their reaction with amino
acid substrates as they react significantly with only five substrates.14 We established the
order of reactivity of the twenty natural amino acid substrates with ferryl species. In
addition, we established the order of reactivity of Bn-TPEN, N4Py, MeN4Py and TMC
ferryl species with amino acid substrates. The four ferryl species reacted with cysteine
substrate forming the disulfide dimer of the cysteine substrate and with tyrosine substrate
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producing a polymer of the tyrosine substrate in addition to oxidizing the tryptophan and
methionine substrate. These results indicated a similarity between these non-heme ferryl
species and the ferrylmyoglobin (MbFe(IV)=O), because ferrylmyoglobin reacts with the
cysteine,154 tyrosine,155 tryptophan156 and methionine157 residues producing products
similar to the products observed with the Bn-TPEN, N4Py, MeN4Py and TMC ferryl
species. In addition, ferrylmyoglobin is less reactive than HO• similar to these non-heme
ferryl species. The fact that similar oxidation products were observed when
ferrylmyoglobin and these ferryl species are used as oxidants suggested that these nonheme ferryl species and ferrylmyoglobin have simlar mode of action. This observed
resemblance between the non-heme ferryl species and ferrylmyoglobin is very promising
for our research, because ferrylmyoglobin proved its ability to oxidize the cysteine
proteinases papain and ficin more efficiently than hydrogen peroxide158 and demonstrated
the ability to crosslink the porcine myofibrillar protein159 and bovine serum albumin160
(BSA). Thus, the Bn-TPEN, N4Py, MeN4Py and TMC ferryl species may have the
ability to oxidize cysteine proteinases and proteins which will be the subject of future
studies in our lab.
In addition, because the reactivity of these ferryl species can be tuned by changing the
ligand structure, these ferryl species are capable of having a wide range of reactivity and
stabilities. The idea of tuning the reactivity of these ferryl species leads us to the design
and synthesis of new Bn-TPEN analogues and their metal complexes and understanding
their coordination environment. The design and synthesis of new Bn-TPEN analogues
and their metal complexes described in this dissertation is the first step in a ligand design
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project that will use new ligands and metal complexes in catalysis. Although the
information we obtained from the preliminary studies in this dissertation are very
important and promising, more work is required to implement these studies in protein
oxidation or enzyme inhibition. Some steps towards this goal are being taken by my
colleagues in the Kodanko lab. Examples of other future directions in our lab include
enzyme inhibition using ferryl species and other metal-based oxidants, glutathione
oxidation, HeLa cells cytotoxicity studies and enantioselective oxidation of peptides. In
the following section, a brief description of some current and future research in our lab
that used the preliminary studies described in this dissertation will be mentioned.
Enzyme inactivation can be achieved by modification of its amino acid residues by
oxidation using ferryl species, especially if the active site of the enzyme contains one of
the five reactive amino acid residues. The first steps toward achieving this goal in our lab
were taken by my colleague Jai Prakash who synthesized a new N4Py derivative and
attached it to a protein affinity ligand that binds to the enzyme trypsin.139 Jai
demonstrated that the pregenerated ferryl species from this new ligand reacted with the
trypsin enzyme, producing IC50 values of 50 µM. 139
Glutathione (GSH) oxidation with ferryl species can be achieved because the GSH
structure contains a thiol group like the cysteine substrate. Ashley Campanali showed that
the N4Py ferryl oxidizes GSH to the disulfide GSSG under single-turnover conditions.161
In addition, Ashley demonstrated that [FeII(MeCN)N4Py](ClO4)2 catalyzes the oxidation
of GSH to GSSG in aqueous buffer in the presence of oxygen and this oxidation is
mediated by iron-based oxidants.162
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The first in-cellulo study in our lab was carried out by Casey Jackson in which he
demonstrated that the Bn-TPEN, N4Py and TPEN ligands inhibit growth of HeLa cells
with EC50 values lower than 5 µM.153 In addition, Casey showed that oxidative stress is
playing an important role in the cytotoxicity produced by the Bn-TPEN, N4Py ligands.
This oxidative stress can be produced by these ligands due to their ability to mobilize iron
from ferritin and bind iron at low concentrations, which make them capable of the
generation of iron-based oxidants.39,153 These in-cellulo studies are very important as all
the new synthesized ligands by the Kodanko lab can be tested for their cytotoxic effects.
For examples, the new Bn-TPEN derivatives like Et-TPPN, Pr-TPPN and Bn-TPZEN
might be tested for their cytotoxicity and compared to the cytotoxicity obtained with BnTPEN to determine the structural features in the ligand that affect the cytotoxicity.
The use of ferryl species generated from enantioenriched pentadentate ligands for
enantioselective catalysis is another future direction in our lab. Preliminary data from our
lab demonstrated that ferryl species generated from the enantioenriched derivatives of
Bn-CDPy3 derivatives have the potential of oxidizing substrates selectively.

129

APPENDIX
Characterization spectra for new compounds
1- Ac-Glu-NHtBu
A- 1H NMR
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B- 13C NMR

131

C- IR

132

D-Mass Spectrometry
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2- Ac-Asp-NHtBu
A- 1H NMR
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B- 13C NMR

135

C- IR
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D-Mass Spectrometry
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3- Sulfoxide Derivative of Methionine Substrate
A- 1H NMR
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B- 13C NMR

139

C- IR

140

D-Mass Spectrometry

141

4- Et-TPPN
A- 1H NMR

142

B- 13C NMR

143

C- IR

144

D-Mass Spectrometry

145

5- Pr-TPPN
A- 1H NMR

146

B- 13C NMR

147

C- IR

148

D-Mass Spectrometry

149

6-Bn-TPZEN
A- 1H NMR

150

B- 13C NMR

151

C- IR

152

D-Mass Spectrometry

153

7-[Fe(Bn-CDPy3)Cl]Cl
A-1H NMR

154

B- IR

155

8- [Zn(Bn-CDPy3)Cl]2ZnCl4
A-1H NMR

156

Labeled Proton Spectrum for [Zn(BnCDPy3)Cl]2ZnCl4

157

B-13C NMR

158

C- DEPT

159

D- IR

160

E- 1H COSY

161

162

163

164

165

166

F- NOESY.

167

168

G- HMQC.
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170

171

9-[Fe(Bn-CDPy3)Cl]ClO4
A- IR
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B- Crystal Stucture Data of [Fe(Bn-CDPy3)Cl]ClO4
Table 1. Crystal data and structure refinement for [Fe(Bn-CDPy3)Cl]ClO4
Empirical formula

C37 H48 Cl2 Fe N6 O5

Formula weight

783.56

Temperature

100(2) K

Wavelength

0.71073 A

Crystal system, space group

Triclinic, P-1

Unit cell dimensions a = 9.4228(3) A alpha = 114.517(2) deg.
b = 15.1824(5) A beta = 97.436(2) deg.
c = 15.2967(8) A gamma = 102.973(2) deg.
Volume

1878.10(13) A^3

Z, Calculated density

2, 1.386 Mg/m^3

Absorption coefficient

0.594 mm^-1

F(000)
Crystal size

824
0.28 x 0.28 x 0.26 mm

Theta range for data collection 1.55 to 32.88 deg.
Limiting indices

-14<=h<=14, -23<=k<=21, 0<=l<=23

Reflections collected / unique 69185 / 13686 [R(int) = 0.0343]
Completeness to theta = 28.30
Absorption correction
Max. and min. transmission
Refinement method
Data / restraints / parameters

99.8 %

Semi-empirical from equivalents
0.8608 and 0.8512
Full-matrix least-squares on F^2
13686 / 8 / 458
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Goodness-of-fit on F^2

1.041

Final R indices [I>2sigma(I)]
R indices (all data)
Largest diff. peak and hole

R1 = 0.0509, wR2 = 0.1421

R1 = 0.0614, wR2 = 0.1489
1.821 and -2.082 e.A^-3
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Table 2. Atomic coordinates ( x 10^4) and equivalent isotropic
displacement parameters (A^2 x 10^3).
U(eq) is defined as one third of the trace of the orthogonalized
Uij tensor.
________________________________________________________________
x
y
z
U(eq)
________________________________________________________________
Fe(1)
Cl(1)
N(1)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
N(4)
C(7)
C(8)
C(9)
C(10)
C(11)
C(12)
N(3)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
N(2)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)
N(5)
C(25)
C(26)

2783(1)
4384(1)
1030(2)
-161(2)
423(2)
-179(2)
333(3)
1433(2)
1993(2)
1508(2)
1792(2)
2976(2)
3243(3)
4407(3)
5261(2)
4913(2)
3792(2)
428(2)
-935(2)
-1406(2)
-1759(2)
-414(2)
23(2)
1218(2)
2272(2)
3385(2)
3997(2)
5077(2)
5510(2)
4847(2)
3809(2)
549(2)
-408(2)

3254(1)
1895(1)
13(1)
2552(1)
2507(1)
22(1)
3708(1)
1200(1)
14(1)
2772(1)
435(1)
17(1)
1884(1)
-30(1)
16(1)
1162(1) -1017(1)
24(1)
321(2) -1389(1)
28(1)
227(1)
-760(1)
25(1)
990(1)
212(1)
21(1)
1807(1)
578(1)
17(1)
4303(1)
737(1)
18(1)
3876(1)
288(1)
18(1)
3842(2)
-594(2)
33(1)
3487(2)
-929(2)
40(1)
3174(2)
-379(2)
30(1)
3211(1)
485(1)
22(1)
3558(1)
817(1)
17(1)
4349(1)
2013(1)
14(1)
4609(1)
1641(1)
18(1)
5327(1)
2516(1)
21(1)
4859(1)
3208(1)
21(1)
4572(1)
3561(1)
18(1)
3835(1)
2670(1)
14(1)
3404(1)
2921(1)
14(1)
4053(1)
3911(1)
15(1)
4955(1)
3940(1)
15(1)
5875(1)
4803(1)
19(1)
6659(1)
4786(1)
22(1)
6504(1)
3915(1)
21(1)
5564(1)
3088(1)
18(1)
4801(1)
3094(1)
16(1)
2349(1)
2786(1)
16(1)
2239(1)
3480(1)
16(1)
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C(27)
249(2)
2305(1)
4389(1)
20(1)
C(28)
-621(2)
2224(2)
5038(1)
24(1)
C(29)
-2161(2)
2070(2)
4786(2)
25(1)
C(30)
-2829(2)
1980(2)
3874(2)
23(1)
C(31)
-1961(2)
2060(1)
3224(1)
19(1)
N(6)
-3448(2)
1287(1)
399(2)
31(1)
C(32)
-4028(2)
805(2)
-425(2)
26(1)
C(33)
-4761(3)
184(2) -1482(2)
35(1)
Cl(2)
-2093(1)
2685(1) -2212(1)
23(1)
O(1)
-2977(2)
1909(1) -2025(2)
39(1)
O(2)
-3000(3)
3091(2) -2661(2)
67(1)
O(3)
-1180(3)
3501(2) -1279(2)
62(1)
O(4)
-1186(4)
2263(2) -2835(2)
79(1)
O(5)
7477(3)
8977(2)
4589(2)
91(1)
C(34)
6928(7)
9566(5)
6098(5)
49(1)
C(35)
8069(11) 9843(6)
5546(4)
121(4)
C(36)
8285(9)
8954(9)
3854(6)
100(3)
C(37)
7421(10) 9144(7)
3058(6)
72(2)
C(34')
7452(7)
9566(5)
6306(3)
46(1)
C(35')
6753
9522
5317
75(2)
C(36')
7003(10) 8948(8)
3648(4)
84(2)
C(37')
7978(10) 8415(7)
3007(7)
80(2)
________________________________________________________________
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Table 3. Bond lengths [A] and angles [deg].
_____________________________________________________________
Fe(1)-N(3)
Fe(1)-N(5)
Fe(1)-N(4)
Fe(1)-N(1)
Fe(1)-N(2)
Fe(1)-Cl(1)
N(1)-C(7)
N(1)-C(1)
N(1)-C(13)
C(1)-C(2)
C(2)-N(4)
C(2)-C(3)
C(3)-C(4)
C(4)-C(5)
C(5)-C(6)
C(6)-N(4)
C(7)-C(8)
C(8)-N(3)
C(8)-C(9)
C(9)-C(10)
C(10)-C(11)
C(11)-C(12)
C(12)-N(3)
C(13)-C(14)
C(13)-C(18)
C(14)-C(15)
C(15)-C(16)
C(16)-C(17)
C(17)-C(18)
C(18)-N(2)
N(2)-C(19)
N(2)-C(25)
C(19)-C(20)
C(20)-N(5)
C(20)-C(21)
C(21)-C(22)
C(22)-C(23)
C(23)-C(24)
C(24)-N(5)
C(25)-C(26)

2.1629(14)
2.1818(14)
2.2019(14)
2.2356(13)
2.2677(14)
2.3390(4)
1.485(2)
1.487(2)
1.497(2)
1.504(2)
1.350(2)
1.388(2)
1.390(3)
1.393(3)
1.387(2)
1.343(2)
1.514(2)
1.344(2)
1.387(2)
1.392(3)
1.382(3)
1.384(3)
1.349(2)
1.534(2)
1.544(2)
1.529(2)
1.530(2)
1.535(2)
1.539(2)
1.5075(19)
1.4780(19)
1.498(2)
1.507(2)
1.348(2)
1.391(2)
1.394(3)
1.386(3)
1.387(2)
1.342(2)
1.514(2)
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C(26)-C(31)
C(26)-C(27)
C(27)-C(28)
C(28)-C(29)
C(29)-C(30)
C(30)-C(31)
N(6)-C(32)
C(32)-C(33)
Cl(2)-O(4)
Cl(2)-O(2)
Cl(2)-O(3)
Cl(2)-O(1)
O(5)-C(35)
O(5)-C(36')
O(5)-C(36)
O(5)-C(35')
C(34)-C(35)
C(36)-C(37)
C(34')-C(35')
C(36')-C(37')
N(3)-Fe(1)-N(5)
N(3)-Fe(1)-N(4)
N(5)-Fe(1)-N(4)
N(3)-Fe(1)-N(1)
N(5)-Fe(1)-N(1)
N(4)-Fe(1)-N(1)
N(3)-Fe(1)-N(2)
N(5)-Fe(1)-N(2)
N(4)-Fe(1)-N(2)
N(1)-Fe(1)-N(2)
N(3)-Fe(1)-Cl(1)
N(5)-Fe(1)-Cl(1)
N(4)-Fe(1)-Cl(1)
N(1)-Fe(1)-Cl(1)
N(2)-Fe(1)-Cl(1)
C(7)-N(1)-C(1)
C(7)-N(1)-C(13)
C(1)-N(1)-C(13)
C(7)-N(1)-Fe(1)
C(1)-N(1)-Fe(1)
C(13)-N(1)-Fe(1)
N(1)-C(1)-C(2)
N(4)-C(2)-C(3)

1.398(2)
1.400(2)
1.392(3)
1.392(3)
1.391(3)
1.392(2)
1.139(3)
1.461(3)
1.414(2)
1.4198(18)
1.4310(19)
1.4381(16)
1.4295(10)
1.4305(10)
1.4307(10)
1.4402(10)
1.5401(10)
1.5394(10)
1.5384(10)
1.5400(10)
94.69(5)
82.34(5)
170.26(5)
78.32(5)
92.01(5)
78.32(5)
154.70(5)
76.39(5)
102.43(5)
78.39(5)
104.09(4)
95.28(4)
94.43(4)
172.08(4)
100.32(4)
110.63(12)
110.96(12)
112.12(12)
106.83(9)
108.76(9)
107.31(9)
112.94(13)
122.20(15)
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N(4)-C(2)-C(1)
C(3)-C(2)-C(1)
C(2)-C(3)-C(4)
C(3)-C(4)-C(5)
C(6)-C(5)-C(4)
N(4)-C(6)-C(5)
C(6)-N(4)-C(2)
C(6)-N(4)-Fe(1)
C(2)-N(4)-Fe(1)
N(1)-C(7)-C(8)
N(3)-C(8)-C(9)
N(3)-C(8)-C(7)
C(9)-C(8)-C(7)
C(8)-C(9)-C(10)
C(11)-C(10)-C(9)
C(10)-C(11)-C(12)
N(3)-C(12)-C(11)
C(8)-N(3)-C(12)
C(8)-N(3)-Fe(1)
C(12)-N(3)-Fe(1)
N(1)-C(13)-C(14)
N(1)-C(13)-C(18)
C(14)-C(13)-C(18)
C(15)-C(14)-C(13)
C(14)-C(15)-C(16)
C(15)-C(16)-C(17)
C(16)-C(17)-C(18)
N(2)-C(18)-C(17)
N(2)-C(18)-C(13)
C(17)-C(18)-C(13)
C(19)-N(2)-C(25)
C(19)-N(2)-C(18)
C(25)-N(2)-C(18)
C(19)-N(2)-Fe(1)
C(25)-N(2)-Fe(1)
C(18)-N(2)-Fe(1)
N(2)-C(19)-C(20)
N(5)-C(20)-C(21)
N(5)-C(20)-C(19)
C(21)-C(20)-C(19)
C(20)-C(21)-C(22)
C(23)-C(22)-C(21)
C(22)-C(23)-C(24)
N(5)-C(24)-C(23)

116.21(14)
121.52(15)
119.05(16)
118.96(17)
118.46(16)
122.99(16)
118.33(14)
124.60(11)
114.01(11)
111.15(13)
121.78(16)
115.67(14)
122.51(16)
118.89(19)
119.39(19)
118.54(18)
122.43(17)
118.95(15)
114.84(11)
123.87(12)
113.83(12)
110.81(12)
109.47(12)
110.48(13)
110.93(14)
110.69(14)
110.57(13)
115.58(12)
112.19(12)
109.03(12)
110.60(12)
114.85(12)
111.63(12)
102.32(9)
105.30(9)
111.36(9)
111.89(12)
122.02(15)
115.91(13)
121.98(14)
118.70(16)
119.42(16)
118.26(16)
123.00(16)
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C(24)-N(5)-C(20)
118.60(14)
C(24)-N(5)-Fe(1)
127.40(11)
C(20)-N(5)-Fe(1)
113.88(11)
N(2)-C(25)-C(26)
116.78(13)
C(31)-C(26)-C(27)
118.62(15)
C(31)-C(26)-C(25)
120.93(14)
C(27)-C(26)-C(25)
120.44(15)
C(28)-C(27)-C(26)
120.70(16)
C(27)-C(28)-C(29)
120.17(17)
C(30)-C(29)-C(28)
119.52(17)
C(29)-C(30)-C(31)
120.36(17)
C(30)-C(31)-C(26)
120.59(16)
N(6)-C(32)-C(33)
179.5(2)
O(4)-Cl(2)-O(2)
109.89(18)
O(4)-Cl(2)-O(3)
110.70(19)
O(2)-Cl(2)-O(3)
107.50(13)
O(4)-Cl(2)-O(1)
108.55(12)
O(2)-Cl(2)-O(1)
112.26(14)
O(3)-Cl(2)-O(1)
107.93(12)
C(35)-O(5)-C(36')
128.6(7)
C(35)-O(5)-C(36)
116.6(6)
C(36')-O(5)-C(36)
49.8(5)
C(35)-O(5)-C(35')
48.2(4)
C(36')-O(5)-C(35')
113.0(3)
C(36)-O(5)-C(35')
148.3(5)
O(5)-C(35)-C(34)
100.2(4)
O(5)-C(36)-C(37)
111.4(5)
O(5)-C(35')-C(34')
107.5(3)
O(5)-C(36')-C(37')
105.2(5)
_____________________________________________________________
Symmetry transformations used to generate equivalent atoms:
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Table 4. Anisotropic displacement parameters (A^2 x 10^3).
The anisotropic displacement factor exponent takes the form:
-2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ]

_______________________________________________________________________
U11

U22

U33

U23

U13

U12

_______________________________________________________________________
Fe(1)
Cl(1)
N(1)
C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
N(4)
C(7)
C(8)
C(9)
C(10)
C(11)
C(12)
N(3)
C(13)
C(14)
C(15)
C(16)
C(17)
C(18)
N(2)
C(19)
C(20)
C(21)
C(22)
C(23)
C(24)
N(5)
C(25)

13(1)
22(1)
14(1)
16(1)
17(1)
29(1)
37(1)
29(1)
23(1)
17(1)
20(1)
20(1)
46(1)
53(1)
31(1)
18(1)
15(1)
13(1)
16(1)
22(1)
20(1)
18(1)
14(1)
14(1)
15(1)
13(1)
19(1)
20(1)
16(1)
14(1)
13(1)
18(1)

15(1)
26(1)
14(1)
17(1)
15(1)
19(1)
20(1)
17(1)
18(1)
16(1)
20(1)
20(1)
47(1)
57(2)
39(1)
26(1)
19(1)
14(1)
22(1)
25(1)
28(1)
20(1)
15(1)
13(1)
16(1)
16(1)
18(1)
16(1)
19(1)
20(1)
17(1)
14(1)

12(1)
17(1)
12(1)
14(1)
15(1)
16(1)
18(1)
23(1)
20(1)
15(1)
19(1)
19(1)
32(1)
40(1)
34(1)
23(1)
16(1)
15(1)
19(1)
24(1)
22(1)
16(1)
14(1)
13(1)
12(1)
14(1)
15(1)
22(1)
26(1)
21(1)
16(1)
16(1)

5(1)
7(1)
5(1)
4(1)
6(1)
3(1)
1(1)
2(1)
6(1)
6(1)
11(1)
10(1)
29(1)
35(1)
20(1)
10(1)
7(1)
6(1)
11(1)
14(1)
13(1)
8(1)
7(1)
5(1)
5(1)
5(1)
4(1)
3(1)
10(1)
9(1)
6(1)
6(1)

3(1)
1(1)
4(1)
1(1)
2(1)
-1(1)
-1(1)
1(1)
2(1)
3(1)
8(1)
9(1)
25(1)
35(1)
22(1)
9(1)
5(1)
4(1)
6(1)
11(1)
10(1)
7(1)
4(1)
2(1)
1(1)
1(1)
1(1)
0(1)
1(1)
3(1)
2(1)
4(1)

6(1)
14(1)
5(1)
5(1)
4(1)
8(1)
10(1)
10(1)
9(1)
6(1)
9(1)
9(1)
30(1)
36(1)
20(1)
10(1)
6(1)
6(1)
10(1)
15(1)
14(1)
9(1)
6(1)
5(1)
4(1)
6(1)
6(1)
5(1)
3(1)
5(1)
5(1)
6(1)
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C(26)
C(27)
C(28)
C(29)
C(30)
C(31)
N(6)
C(32)
C(33)
Cl(2)
O(1)
O(2)
O(3)
O(4)
O(5)

17(1) 13(1)
19(1) 23(1)
27(1) 27(1)
28(1) 26(1)
20(1) 27(1)
18(1) 19(1)
27(1) 28(1)
22(1) 23(1)
37(1) 31(1)
29(1) 24(1)
41(1) 28(1)
74(2) 41(1)
84(2) 35(1)
118(2) 68(2)
68(2) 126(3)

16(1)
20(1)
21(1)
25(1)
29(1)
20(1)
37(1)
37(1)
33(1)
23(1)
57(1)
72(2)
43(1)
110(2)
69(2)

6(1)
12(1)
13(1)
14(1)
15(1)
10(1)
15(1)
17(1)
16(1)
14(1)
23(1)
27(1)
22(1)
60(2)
60(2)

3(1)
4(1)
3(1)
5(1)
5(1)
7(1)
13(1) 10(1)
10(1) 10(1)
4(1)
5(1)
9(1)
8(1)
11(1)
7(1)
5(1)
2(1)
10(1) 12(1)
28(1) 11(1)
-30(1) 17(1)
-28(1) -6(1)
99(2) 58(2)
0(1) -10(2)

_______________________________________________________________________
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Table 5. Hydrogen coordinates ( x 10^4) and isotropic
displacement parameters (A^2 x 10^3).
________________________________________________________________
x
y
z
U(eq)
________________________________________________________________
H(1A)
H(1B)
H(3)
H(4)
H(5)
H(6)
H(7A)
H(7B)
H(9)
H(10)
H(11)
H(12)
H(13)
H(14A)
H(14B)
H(15A)
H(15B)
H(16A)
H(16B)
H(17A)
H(17B)
H(18)
H(19A)
H(19B)
H(21)
H(22)
H(23)
H(24)
H(25A)
H(25B)
H(27)
H(28)
H(29)
H(30)
H(31)

-617
-961
-929
-61
1792
2754
2270
1037
2641
4613
6070
5485
1249
-678
-1784
-2306
-585
-2650
-2000
-676
454
-905
2824
1694
3685
5512
6242
5141
1380
-76
1298
-161
-2752
-3882
-2429

2917
-91
2585
744
1241
-1431
-183
-2062
-345
-991
932
639
5021
1246
4289
214
4058
-963
3461
-1529
2938
-590
2983
858
5005
2441
4936
1217
3976
1235
5468
2265
5980
2892
4245
2853
5353
3789
4248
3987
5195
3963
3244
2264
3643
4089
4296
4410
5966
5393
7293
5366
7028
3885
5456
2489
2066
2863
1924
2096
2406
4565
2274
5654
2027
5234
1862
3694
1993
2601

20
20
28
34
31
25
21
21
40
47
37
26
17
21
21
25
25
25
25
21
21
17
18
18
23
26
25
22
19
19
24
29
30
28
23
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H(33A) -4200
447
-1865
42
H(33B) -5792
212
-1608
42
H(33C) -4781
-522
-1682
42
H(34A)
5965
9117
5620
58
H(34B)
6785
10188
6581
58
H(34C)
7309
9217
6444
58
H(35A)
8067
10481
5515
146
H(35B)
9101
9904
5853
146
H(36A)
8451
8283
3534
120
H(36B)
9281
9481
4178
120
H(37A)
6391
8677
2795
86
H(37B)
7928
9029
2518
86
H(37C)
7395
9848
3355
86
H(34D)
6966
8929
6316
56
H(34E)
7302
10137
6857
56
H(34F)
8531
9660
6376
56
H(35C)
5657
9168
5109
90
H(35D)
6913
10219
5390
90
H(36C)
7168
9645
3721
101
H(36D)
5922
8561
3346
101
H(37D)
9002
8883
3219
96
H(37E)
7546
8213
2308
96
H(37F)
8007
7809
3084
96
________________________________________________________________
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Table 6. Torsion angles [deg].
________________________________________________________________
N(3)-Fe(1)-N(1)-C(7)
N(5)-Fe(1)-N(1)-C(7)
N(4)-Fe(1)-N(1)-C(7)
N(2)-Fe(1)-N(1)-C(7)
Cl(1)-Fe(1)-N(1)-C(7)
N(3)-Fe(1)-N(1)-C(1)
N(5)-Fe(1)-N(1)-C(1)
N(4)-Fe(1)-N(1)-C(1)
N(2)-Fe(1)-N(1)-C(1)
Cl(1)-Fe(1)-N(1)-C(1)
N(3)-Fe(1)-N(1)-C(13)
N(5)-Fe(1)-N(1)-C(13)
N(4)-Fe(1)-N(1)-C(13)
N(2)-Fe(1)-N(1)-C(13)
Cl(1)-Fe(1)-N(1)-C(13)
C(7)-N(1)-C(1)-C(2)
C(13)-N(1)-C(1)-C(2)
Fe(1)-N(1)-C(1)-C(2)
N(1)-C(1)-C(2)-N(4)
N(1)-C(1)-C(2)-C(3)
N(4)-C(2)-C(3)-C(4)
C(1)-C(2)-C(3)-C(4)
C(2)-C(3)-C(4)-C(5)
C(3)-C(4)-C(5)-C(6)
C(4)-C(5)-C(6)-N(4)
C(5)-C(6)-N(4)-C(2)
C(5)-C(6)-N(4)-Fe(1)
C(3)-C(2)-N(4)-C(6)
C(1)-C(2)-N(4)-C(6)
C(3)-C(2)-N(4)-Fe(1)
C(1)-C(2)-N(4)-Fe(1)
N(3)-Fe(1)-N(4)-C(6)
N(5)-Fe(1)-N(4)-C(6)
N(1)-Fe(1)-N(4)-C(6)
N(2)-Fe(1)-N(4)-C(6)
Cl(1)-Fe(1)-N(4)-C(6)
N(3)-Fe(1)-N(4)-C(2)
N(5)-Fe(1)-N(4)-C(2)
N(1)-Fe(1)-N(4)-C(2)
N(2)-Fe(1)-N(4)-C(2)

-21.24(10)
73.14(10)
-105.71(10)
148.80(10)
-129.8(2)
98.20(10)
-167.42(10)
13.72(10)
-91.76(10)
-10.4(3)
-140.30(10)
-45.92(10)
135.22(10)
29.74(9)
111.1(3)
87.60(15)
-147.95(13)
-29.44(15)
36.4(2)
-146.76(16)
1.1(3)
-175.60(18)
0.1(3)
-1.1(3)
0.9(3)
0.2(3)
-158.77(15)
-1.2(3)
175.62(15)
159.92(14)
-23.26(18)
84.99(15)
157.8(3)
164.58(15)
-120.26(14)
-18.66(14)
-74.77(12)
-2.0(4)
4.81(11)
79.98(12)
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Cl(1)-Fe(1)-N(4)-C(2)
C(1)-N(1)-C(7)-C(8)
C(13)-N(1)-C(7)-C(8)
Fe(1)-N(1)-C(7)-C(8)
N(1)-C(7)-C(8)-N(3)
N(1)-C(7)-C(8)-C(9)
N(3)-C(8)-C(9)-C(10)
C(7)-C(8)-C(9)-C(10)
C(8)-C(9)-C(10)-C(11)
C(9)-C(10)-C(11)-C(12)
C(10)-C(11)-C(12)-N(3)
C(9)-C(8)-N(3)-C(12)
C(7)-C(8)-N(3)-C(12)
C(9)-C(8)-N(3)-Fe(1)
C(7)-C(8)-N(3)-Fe(1)
C(11)-C(12)-N(3)-C(8)
C(11)-C(12)-N(3)-Fe(1)
N(5)-Fe(1)-N(3)-C(8)
N(4)-Fe(1)-N(3)-C(8)
N(1)-Fe(1)-N(3)-C(8)
N(2)-Fe(1)-N(3)-C(8)
Cl(1)-Fe(1)-N(3)-C(8)
N(5)-Fe(1)-N(3)-C(12)
N(4)-Fe(1)-N(3)-C(12)
N(1)-Fe(1)-N(3)-C(12)
N(2)-Fe(1)-N(3)-C(12)
Cl(1)-Fe(1)-N(3)-C(12)
C(7)-N(1)-C(13)-C(14)
C(1)-N(1)-C(13)-C(14)
Fe(1)-N(1)-C(13)-C(14)
C(7)-N(1)-C(13)-C(18)
C(1)-N(1)-C(13)-C(18)
Fe(1)-N(1)-C(13)-C(18)
N(1)-C(13)-C(14)-C(15)
C(18)-C(13)-C(14)-C(15)
C(13)-C(14)-C(15)-C(16)
C(14)-C(15)-C(16)-C(17)
C(15)-C(16)-C(17)-C(18)
C(16)-C(17)-C(18)-N(2)
C(16)-C(17)-C(18)-C(13)
N(1)-C(13)-C(18)-N(2)
C(14)-C(13)-C(18)-N(2)
N(1)-C(13)-C(18)-C(17)
C(14)-C(13)-C(18)-C(17)

-178.42(11)
-81.15(16)
153.74(13)
37.07(15)
-39.5(2)
142.63(19)
-1.2(3)
176.6(2)
0.3(4)
0.9(4)
-1.2(3)
0.9(3)
-177.02(15)
-162.44(17)
19.64(19)
0.3(3)
162.06(16)
-89.71(12)
80.96(12)
1.38(12)
-22.0(2)
173.64(11)
107.88(14)
-81.45(14)
-161.03(15)
175.62(13)
11.23(15)
71.21(16)
-53.05(17)
-172.42(10)
-164.89(12)
70.85(15)
-48.52(13)
-175.89(13)
59.48(17)
-57.24(19)
55.73(19)
-57.06(19)
-173.39(13)
59.16(17)
44.16(16)
170.52(12)
173.50(12)
-60.14(16)
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C(17)-C(18)-N(2)-C(19)
C(13)-C(18)-N(2)-C(19)
C(17)-C(18)-N(2)-C(25)
C(13)-C(18)-N(2)-C(25)
C(17)-C(18)-N(2)-Fe(1)
C(13)-C(18)-N(2)-Fe(1)
N(3)-Fe(1)-N(2)-C(19)
N(5)-Fe(1)-N(2)-C(19)
N(4)-Fe(1)-N(2)-C(19)
N(1)-Fe(1)-N(2)-C(19)
Cl(1)-Fe(1)-N(2)-C(19)
N(3)-Fe(1)-N(2)-C(25)
N(5)-Fe(1)-N(2)-C(25)
N(4)-Fe(1)-N(2)-C(25)
N(1)-Fe(1)-N(2)-C(25)
Cl(1)-Fe(1)-N(2)-C(25)
N(3)-Fe(1)-N(2)-C(18)
N(5)-Fe(1)-N(2)-C(18)
N(4)-Fe(1)-N(2)-C(18)
N(1)-Fe(1)-N(2)-C(18)
Cl(1)-Fe(1)-N(2)-C(18)
C(25)-N(2)-C(19)-C(20)
C(18)-N(2)-C(19)-C(20)
Fe(1)-N(2)-C(19)-C(20)
N(2)-C(19)-C(20)-N(5)
N(2)-C(19)-C(20)-C(21)
N(5)-C(20)-C(21)-C(22)
C(19)-C(20)-C(21)-C(22)
C(20)-C(21)-C(22)-C(23)
C(21)-C(22)-C(23)-C(24)
C(22)-C(23)-C(24)-N(5)
C(23)-C(24)-N(5)-C(20)
C(23)-C(24)-N(5)-Fe(1)
C(21)-C(20)-N(5)-C(24)
C(19)-C(20)-N(5)-C(24)
C(21)-C(20)-N(5)-Fe(1)
C(19)-C(20)-N(5)-Fe(1)
N(3)-Fe(1)-N(5)-C(24)
N(4)-Fe(1)-N(5)-C(24)
N(1)-Fe(1)-N(5)-C(24)
N(2)-Fe(1)-N(5)-C(24)
Cl(1)-Fe(1)-N(5)-C(24)
N(3)-Fe(1)-N(5)-C(20)
N(4)-Fe(1)-N(5)-C(20)

-26.97(18)
98.87(15)
99.95(15)
-134.20(13)
-142.67(11)
-16.82(14)
-106.85(14)
-35.22(9)
154.70(9)
-130.19(9)
57.77(9)
137.48(12)
-150.89(10)
39.02(10)
114.14(10)
-57.90(9)
16.33(17)
87.96(10)
-82.13(10)
-7.01(9)
-179.05(9)
158.11(13)
-74.45(16)
46.35(13)
-33.17(18)
150.13(14)
0.3(2)
176.78(15)
0.0(2)
-0.2(3)
0.0(3)
0.3(2)
-175.29(12)
-0.5(2)
-177.15(13)
175.73(12)
-0.97(16)
-7.23(14)
-79.0(3)
-85.68(13)
-163.22(14)
97.42(13)
176.99(11)
105.2(3)

187

N(1)-Fe(1)-N(5)-C(20)
98.55(11)
N(2)-Fe(1)-N(5)-C(20)
21.01(10)
Cl(1)-Fe(1)-N(5)-C(20)
-78.36(10)
C(19)-N(2)-C(25)-C(26)
62.94(17)
C(18)-N(2)-C(25)-C(26)
-66.26(17)
Fe(1)-N(2)-C(25)-C(26)
172.76(11)
N(2)-C(25)-C(26)-C(31)
91.27(18)
N(2)-C(25)-C(26)-C(27)
-89.43(18)
C(31)-C(26)-C(27)-C(28)
-1.9(3)
C(25)-C(26)-C(27)-C(28)
178.79(16)
C(26)-C(27)-C(28)-C(29)
0.4(3)
C(27)-C(28)-C(29)-C(30)
1.2(3)
C(28)-C(29)-C(30)-C(31)
-1.1(3)
C(29)-C(30)-C(31)-C(26)
-0.4(3)
C(27)-C(26)-C(31)-C(30)
1.9(2)
C(25)-C(26)-C(31)-C(30)
-178.77(16)
C(36')-O(5)-C(35)-C(34)
122.6(7)
C(36)-O(5)-C(35)-C(34)
-179.0(6)
C(35')-O(5)-C(35)-C(34)
35.0(4)
C(35)-O(5)-C(36)-C(37)
-107.9(10)
C(36')-O(5)-C(36)-C(37)
11.5(7)
C(35')-O(5)-C(36)-C(37)
-55.4(14)
C(35)-O(5)-C(35')-C(34')
-53.7(7)
C(36')-O(5)-C(35')-C(34')
-175.6(5)
C(36)-O(5)-C(35')-C(34')
-125.9(8)
C(35)-O(5)-C(36')-C(37')
121.7(8)
C(36)-O(5)-C(36')-C(37')
27.4(8)
C(35')-O(5)-C(36')-C(37')
175.7(5)
________________________________________________________________
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Least-squares planes (x,y,z in crystal coordinates) and deviations from them
(* indicates atom used to define plane).
6.2151 (0.0059) x + 8.1219 (0.0105) y - 9.8475 (0.0097) z = 1.8310 (0.0011)
* 0.0047 (0.0012) N4
* -0.0076 (0.0012) C2
* 0.0029 (0.0014) C3
* 0.0044 (0.0016) C4
* -0.0072 (0.0015) C5
* 0.0028 (0.0013) C6
0.6757 (0.0027) Fe1
Rms deviation of fitted atoms = 0.0053

3.3897 (0.0081) x + 10.2986 (0.0107) y + 0.7780 (0.0151) z = 5.0152 (0.0028)
Angle to previous plane (with approximate esd) = 49.92 ( 0.08 )
*
*
*
*
*
*

-0.0020 (0.0012) N3
0.0072 (0.0014) C8
-0.0051 (0.0018) C9
-0.0020 (0.0019) C10
0.0071 (0.0017) C11
-0.0053 (0.0014) C12
-0.2342 (0.0047) C13
-0.5728 (0.0031) Fe1

Rms deviation of fitted atoms = 0.0052

- 7.6491 (0.0037) x + 10.3984 (0.0073) y - 5.6765 (0.0097) z = 0.3250 (0.0051)
Angle to previous plane (with approximate esd) = 88.23 ( 0.06 )
* -0.0021 (0.0010) N5
* 0.0020 (0.0011) C20
* -0.0004 (0.0011) C21
* -0.0012 (0.0012) C22
* 0.0011 (0.0012) C23
* 0.0005 (0.0011) C24
-0.1456 (0.0023) Fe1
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Rms deviation of fitted atoms = 0.0014

- 1.4306 (0.0070) x + 13.7076 (0.0049) y - 0.1643 (0.0113) z = 3.0586 (0.0039)
Angle to previous plane (with approximate esd) = 62.21 ( 0.05 )
*
*
*
*
*
*

0.0122 (0.0012) C26
-0.0067 (0.0013) C27
-0.0042 (0.0013) C28
0.0095 (0.0014) C29
-0.0039 (0.0013) C30
-0.0069 (0.0012) C31
1.3848 (0.0029) N2
0.9730 (0.0042) Fe1

Rms deviation of fitted atoms = 0.0078
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ABSTRACT
I-KINETIC AND MECHANISTIC INVESTIGATIONS OF AMINO ACID
SUBSTRATES REACTIVITIES WITH FERRYL SPECIES
II-SYNTHESIS AND CHARACTERIZATION OF DERIVATIVES OF THE
BN-TPEN LIGAND AND THEIR METAL COMPLEXES
by
AHMED IBRAHIM YOUSSEF ABOUELATTA
MAY 2011
Advisor: Dr. Jeremy Jacob Kodanko
Major: Chemistry (Organic)
Degree: Doctor of philosophy
The reactivity of tryptophan, methionine, aspartic acid, glutamic acid, histidine and
hydrochloride salt of lysine amino acid substrates with the N4Py ferryl species was
studied by UV-vis spectroscopy and product characterization. Based on kinetic isotope
effect studies and product analysis, an ET-PT mechanism was proposed for the reaction
of tryptophan substrate with N4Py ferryl and an oxygen-atom transfer mechanism was
proposed for the reaction of methionine substrate with N4Py ferryl species. The reactivity
of the five significantly reactive amino acid substrates (Cys, Tyr, Trp, Met and Gly) was
investigated with Me-N4Py, Bn-TPEN and TMC ferryl species and compared to their
reactivity with N4Py ferryl species. This study indicated that the Bn-TPEN ferryl species
was the most reactive with these five substrates followed by N4Py and Me-N4Py which
were more reactive than TMC ferryl species. The different relative rate constants
obtained for the substrates with different ferryl species and the slow reactivity of
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methionine substrate with Me-N4Py ferryl with respect to N4Py ferryl suggested that
steric factor is involved in controlling these reactions.
Studies towards the modification of the structure of the Bn-TPEN ligand were
achieved and three new Bn-TPEN derivatives were synthesized and characterized. In
addition, the synthesis and characterization of the racemic and enantioenriched Zn(II) and
Fe(II) complexes and the enantioenriched Co(III) metal complexes of the Bn-CDPy3
was performed. These metal complexes were characterized with X-ray crystallography,
circular dichroism, UV-vis, IR, 1-D and 2-D NMR spectroscopy in addition to elemental
analysis and mass spectrometry. Based on these experiments, the three Bn-CDPy3 metal
complexes were found to favor one isomer (C) over the other four possible isomers. The
reason of the stability of isomer C over isomers A, B, D and E was attributed to a
combination of steric and electronic effects.
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